rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGTTCTAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLVLATGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	4	7	4	2	0	18	34	-1	36	41						01,02								CASSLVLATGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCAACAGGGGGCTGGGACACTGAAGCTTTCTTTGGACAA	CASSPTGGWDTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	3	3	4	18	30	42	33	46														CASSPTGGWDTEAFF+TCRBV07-06+TCRBJ01-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAACTGGGACTCGCTACAATGAGCAGTTCTTCGGGCCA	CASSLTGTRYNEQFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	10	3	3	2	18	33	42	36	44						01,02								CASSLTGTRYNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCATTAGCGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSISGPNTGELFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	5	4	0	2	1	18	30	39	32	40						01,02								CASSISGPNTGELFF+TCRBV07-06+TCRBJ02-02	TCRBV07-06*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTATTGAGCAGACAAGGGGTGGGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	1.942200124300808E-4		56	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	2	0	11	4	18	33	49	44	53														X+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGCAGCGGGCCCAGGGGAGACCCAGTACTTCGGGCCA	CASSSAAGPGETQYF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	4	5	4	7	18	31	41	35	48						01,02								CASSSAAGPGETQYF+TCRBV07-06+TCRBJ02-05	TCRBV07-06*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGAGGGGGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSLRGGGTDTQYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	0	1	2	2	18	32	41	34	43														CASSLRGGGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTCGGGACCAGGAAGCTTTGGCACAGATACGCAGTATTTTGGCCCA	CASSSGPGSFGTDTQYF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	51	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-03	01	4	0	7	1	1	12	18	31	37	32	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGPGSFGTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCTAGGACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSLGQGNYGYTF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	42	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	2	2	0	0	18	-1	-1	34	42														CASSLGQGNYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTTATACCGGGACACAAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSFYTGTQATNEKLFF	In	VDJ	5	103	0.0013336440853532214	0.0015871792896216966	54	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	6	0	7	4	18	32	45	39	49														CASSFYTGTQATNEKLFF+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCCCGACGGGAACTCTGGAAACACCATATATTTTGGAGAG	CASSPDGNSGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	8	8	3	0	9	1	19	27	41	36	42														CASSPDGNSGNTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGAAGAAAGGCTAGCGAGACCACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	11	1.4242800911539258E-4		44	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	6	5	5	5	19	30	41	35	46						01,02								X+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCTGTGAGAGCAACTTGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASCESNLPNTGELFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	3	10	0	11	3	19	27	41	38	44						01,02								CASCESNLPNTGELFF+TCRBV07-05+TCRBJ02-02	TCRBV07-05*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCAACCACTAGCACAGATACGCAGTATTTTGGCCCA	CASSSTTSTDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	10	0	5	0	19	32	-1	37	40						01,02								CASSSTTSTDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTTATAGGGGTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLIGVATNEKLFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	2	0	5	3	19	31	41	36	44														CASSLIGVATNEKLFF+TCRBV07-05+TCRBJ01-04	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCAAGGGGCTTCGGGAAACACCATATATTTTGGAGAG	CASSQGASGNTIYF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	5	2	4	2	5	19	31	38	33	43														CASSQGASGNTIYF+TCRBV07-05+TCRBJ01-03	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCAGGACTGGGAGGGAGGGAATATGAGGACACCATATATTTTGGAGAG	CASSAGLGGREYEDTIYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	54	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	9	0	8	7	13	23	36	50	43	63			01,02										Vb 1	CASSAGLGGREYEDTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCACGGCTTGAGACAGGGGGCACGGATACGCAGTATTTTGGCCCA	CASSPRLETGGTDTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	0	6	11	3	23	35	56	46	59			01,02										Vb 1	CASSPRLETGGTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACCCGGGCGGCTTCCAAGAGACCCAGTACTTCGGGCCA	CASSVDPGGFQETQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-05	01	0	8	0	1	4	5	23	39	47	43	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDPGGFQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGATTCGGGACGAGCTGAAGCTTTCTTTGGACAA	CASSVGDSGRAEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-01	01	0	0	7	6	7	3	23	39	51	46	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGDSGRAEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGTCCAGGGACTATGGCTACACCTTCGGTTCG	CASSVSRDYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	3	3	0	23	37	-1	40	45			01,02										Vb 1	CASSVSRDYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCTGGGGCAGGGGGTTAGTCAGCCCCAGCATTTTGGTGAT	CASSLGQGVSQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	1	6	7	4	23	34	48	41	52			01,02										Vb 1	CASSLGQGVSQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTTTGGTGGTAGTAGCAGATACGCAGTATTTTGGCCCA	CASSLVVVADTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	4	8	3	23	34	45	42	48			01,02			01,02							Vb 1	CASSLVVVADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACCCTAGCCCCCTCCAGACCCAGTACTTCGGGCCA	CASSVDPSPLQTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	4	7	6	3	7	23	39	47	42	54			01,02			01,02							Vb 1	CASSVDPSPLQTQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCGGTGGACTGACTTATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	9	1.1653200745804848E-4		43	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	1	10	8	5	5	23	34	44	39	49			01,02			01,02							Vb 1	X+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTGAGCTCCAGGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSVSSRSSGNTIYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	2	4	4	0	6	2	23	37	47	43	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVSSRSSGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTCCCCTGGGGGAGCTGGCTATGGCTACACCTTCGGTTCG	CASSSPGGAGYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-02	01	4	6	1	4	6	6	23	35	46	41	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSSPGGAGYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTGGAGCCAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVEPSSYNEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	10	2	0	3	5	23	34	41	37	46			01,02										Vb 1	CASSVEPSSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCACCTACCCGACGAGGGGCTACACCTTCGGTTCG	CASSTYPTRGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	1	8	11	0	23	35	-1	46	50			01,02										Vb 1	CASSTYPTRGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGGTGGGCCGGGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	11	1.4242800911539258E-4		46	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	1	8	3	7	8	0	23	38	-1	46	51			01,02										Vb 1	X+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD02-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGACTTCGACAGGTTTAATTCACCCCTCCACTTTGGGAAC	CASSDFDRFNSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	4	6	7	2	23	34	47	41	49			01,02										Vb 1	CASSDFDRFNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCACCCAAACGGACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	13	1.683240107727367E-4		37	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	6	1	7	17	7	14	23	33	44	40	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCTTTTTAGCGGGGATACGCAGTATTTTGGCCCA	CASSLFSGDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	4	6	6	0	23	34	-1	40	47			01,02			01,02							Vb 1	CASSLFSGDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGATGGCAGCTACGAGCAGTACGTCGGGCCG	CASSDGSYEQYV	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	36	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	4	5	17	6	14	23	34	43	40	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSDGSYEQYV+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCCCCACCTTGCAAAGTTTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	14	1.8127201160140875E-4		43	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	10	3	7	1	3	11	23	29	34	32	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAAGGGCCGGGACAGAGGACAATGAGCAGTTCTTCGGGCCA	CASRRAGTEDNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	5	5	7	3	23	34	48	41	51			01,02										Vb 1	CASRRAGTEDNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCGAGGGCGGGACTAGTGTCGAATGAGCAGTTCTTCGGGCCA	CASSPRAGLVSNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	8	7	8	5	23	35	51	43	56			01,02			01,02							Vb 1	CASSPRAGLVSNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAGGGAGTTGGGGACAACACAGATACGCAGTATTTTGGCCCA	CASSEGVGDNTDTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	0	6	2	9	1	23	36	51	45	52			01,02										Vb 1	CASSEGVGDNTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCCTCGGACAGACTCGCACAGATACGCAGTATTTTGGCCCA	CASLGQTRTDTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	1	5	1	3	4	23	32	41	35	45			01,02										Vb 1	CASLGQTRTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTATGGGACAGGGAATCGCAGATACGCAGTATTTTGGCCCA	CASSMGQGIADTQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	4	3	5	23	34	46	37	51			01,02										Vb 1	CASSMGQGIADTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAACTAGCCTCGAGCAGTACGTCGGGCCG	CASSLTSLEQYV	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	3	7	17	3	13	23	35	44	38	57			01,02			01,02							Vb 1	CASSLTSLEQYV+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGACGGGGACTGAAGCTTTCTTTGGACAA	CASSVGTGTEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	5	3	0	23	39	-1	42	47			01,02										Vb 1	CASSVGTGTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGCTTACGGGAGGGAAGCTTTCTTTGGACAA	CASSVAYGREAFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	1	8	4	0	23	39	-1	43	50			01,02										Vb 1	CASSVAYGREAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGATCTGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVGSGSTDTQYF	In	VDJ	7	128	0.0016573441060700228	0.001972416981277448	45	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-03	01	0	0	9	0	5	0	23	39	-1	44	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGSGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCCCACGGTTCCCGGGGAGCTGTTTTTTGGAGAA	CASSPTVPGELFF	In	VDJ	8	147	0.0019033561218147917	0.0022651976269358193	39	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	8	5	6	4	3	23	35	42	39	45			01,02			01,02							Vb 1	CASSPTVPGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTGTTAGCGGGGGGAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGGSTGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	5	1	4	2	3	19	33	45	35	48														CASSLLAGGSTGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGCAGGGCGTCTGGAGAACATTCAGTACTTCGGCGCC	CASSQGAGRLENIQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	3	7	3	9	29	45	53	48	62													Vb 16	CASSQGAGRLENIQYF+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGTTCGAAGCAGTACGTCGGGCCG	CASSQGSKQYV	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	33	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	9	17	0	14	29	-1	46	43	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGSKQYV+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGGGGGGGTCCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	1.2948000828672053E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	0	6	0	2	29	-1	54	45	56													Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGCCCCCAAACCGGGGCTATGGCTACACCTTCGGTTCG	CASSQGPPNRGYGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	1	8	3	4	11	0	29	45	-1	56	61													Vb 16	CASSQGPPNRGYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGTAGCCAAGGTGCGGGGAGGGGGAATGAGCAGTTCTTCGGGCCA	CASSQGAGRGNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	9	0	7	5	2	29	45	57	50	59													Vb 16	CASSQGAGRGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATTCAGGACTGAAGCTTTCTTTGGACAA	CASSQFRTEAFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	36	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	5	2	0	29	44	-1	46	50													Vb 16	CASSQFRTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGGCCCCGGTACGGAACACTGAAGCTTTCTTTGGACAA	CASSQVAPVRNTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	1	9	0	1	1	9	29	45	49	46	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQVAPVRNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACCTAACCGGGACCGTCTGGGGGGGCTACACCTTCGGTTCG	CASSHLTGTVWGGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	3	0	7	8	7	10	29	43	55	50	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSHLTGTVWGGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGTTTATTTCTGTGCCAGCAGCCAAGATTCGGGCTAGCGGGGGGGCTCTGACTGTGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	22	2.8485601823078515E-4		61	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	0	5	6	11	10	27	45	33	56													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGGGCAGGACGGAGGGGCAATGAGCAGTTCTTCGGGCCA	CASSQGAGRRGNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	3	6	0	6	0	12	29	-1	49	43	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGAGRRGNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACGGGGTCCACTGAAGCTTTCTTTGGACAA	CASSQTGSTEAFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	4	1	2	29	44	50	45	52													Vb 16	CASSQTGSTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCCGAGTTTCGGCTGGAAACACCATATATTTTGGAGAG	CASSLRVSAGNTIYF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	4	8	5	2	9	0	29	42	-1	51	54						01,02							Vb 16	CASSLRVSAGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGACGCATAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	31	4.0138802568883363E-4		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	4	2	7	0	0	8	29	-1	45	42	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTGAGAGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	33	4.2728402734617773E-4		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	0	5	2	4	5	0	29	46	-1	51	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATTACTGGTCCGAACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	36	4.661280298321939E-4		44	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	4	5	17	21	4	29	43	67	64	71				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCGATAGCAAGTATCTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	2	37	4.79076030660866E-4		55	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-06	01	5	2	6	5	14	5	26	38	56	52	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-06	TCRBV14-01*01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCGCAGGGGCCCGCGAAAAACTGTTTTTTGGCAGT	CASSQGAGAREKLFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	2	8	3	5	29	45	54	48	59													Vb 16	CASSQGAGAREKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGAGACAGGGGCTGGAAACACCATATATTTTGGAGAG	CASSRETGAGNTIYF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	2	2	2	0	0	29	-1	-1	46	54													Vb 16	CASSRETGAGNTIYF+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCCAGGACAGCGCCTAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	42	5.438160348042263E-4		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	1	5	5	3	5	29	45	54	48	59													Vb 16	X+TCRBV14-01+TCRBJ02-04	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACTGGACAACCAAAGATACGCAGTATTTTGGCCCA	CASSHWTTKDTQYF	In	VDJ	2	43	5.567640356328983E-4	6.626088296478928E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	6	5	2	5	29	43	50	45	55													Vb 16	CASSHWTTKDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATCTAGGGAAGGGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	44	5.697120364615703E-4		47	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-02	01	3	0	8	1	4	3	29	43	51	47	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCAGTACGGAGGGAAGACCCAGTACTTCGGGCCA	CASSQYGGKTQYF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	6	10	0	6	7	1	29	40	53	47	54													Vb 16	CASSQYGGKTQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTTAGGGGGGGGCGCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDLGGGASYNEQFF	In	VDJ	2	46	5.956080381189145E-4	7.08837352646583E-4	54	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	9	0	0	4	4	27	44	55	48	59													Vb 16	CASSQDLGGGASYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGAGCACGGGCTACCATCTTAGCTACGCAGTATTTTGGCCCA	CASSQGARATILATQYF	In	VDJ	3	49	6.344520406049306E-4	7.550658756452732E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-03	01	1	8	0	8	6	12	29	45	55	51	67				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGARATILATQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCGACAGACTACAATGAGCAGTTCTTCGGGCCA	CASSQSTDYNEQFF	In	VDJ	3	60	7.768800497203232E-4	9.245704599738038E-4	42	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	5	3	2	1	29	44	51	46	52													Vb 16	CASSQSTDYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCACCAAACCGGGACCTCGAAAAACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	5	91	0.001178268075409157		52	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	3	0	7	17	7	24	29	43	55	50	79				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGACAGGACAGTTCAAGAGACCCAGTACTTCGGGCCA	CASSQGDRTVQETQYF	In	VDJ	5	92	0.001191216076237829	0.001417674705293166	48	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	4	2	0	6	29	-1	53	45	59													Vb 16	CASSQGDRTVQETQYF+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAACTGGGAAGATACAATGAGCAGTTCTTCGGGCCA	CASSQLGRYNEQFF	In	VDJ	6	110	0.0014242800911539258	0.001695045843285307	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	0	8	4	2	3	29	44	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQLGRYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGGGTACAGGGCACAGATACGCAGTATTTTGGCCCA	CASSQGVQGTDTQYF	In	VDJ	8	149	0.001929252123472136	0.0022960166422682795	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	3	4	1	4	0	29	45	-1	49	54													Vb 16	CASSQGVQGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTAACAGAGATGGCTGAAGCTTTCTTTGGACAA	CASSLTEMAEAFF	In	VDJ	8	154	0.0019939921276154963	0.0023730641805994298	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	6	2	6	29	42	48	44	54													Vb 16	CASSLTEMAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCCCGCCAGGGCAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSQSRQGRLNTEAFF	In	VDJ	9	181	0.0023435881499896415	0.0027891208875876414	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	0	6	5	29	44	55	50	60													Vb 16	CASSQSRQGRLNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACGTGGACGGACAATGAGCAGTTCTTCGGGCCA	CASSVTWTDNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	5	1	7	5	7	2	24	36	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVTWTDNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGGGTGGAGTCAGCCCCAGCATTTTGGTGAT	CASSLGWSQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	6	5	3	6	3	5	24	35	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGWSQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGGATTAACAGGGGTCGGGGTTTACGAGCAGTACGTCGGGCCG	CASSGLTGVGVYEQYV	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	2	17	6	21	24	36	49	42	70														CASSGLTGVGVYEQYV+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAAGTACCGGGGAGCTGTTTTTTGGAGAA	CASSVGSTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-02	01	5	1	8	5	3	3	24	36	42	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGSTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTACGGGCACTGAAGCTTTCTTTGGACAA	CASSVGTGTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	4	4	7	0	24	36	-1	43	47						01,02								CASSVGTGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGCCGACGACTATGGTTACACCTTCGGTTCG	CASSADDYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	9	11	7	4	24	35	47	42	51						01,02								CASSADDYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTGGGGACTAGCGGGGGATTTGAGACCCAGTACTTCGGGCCA	CASSLGTSGGFETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	5	3	4	24	36	53	39	57														CASSLGTSGGFETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGACGGGGGGGCCGTAGAGACCCAGTACTTCGGGCCA	CASSVDGGAVETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	4	5	4	24	36	49	41	53														CASSVDGGAVETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCCCGCGGACAGTAACACTGAAGCTTTCTTTGGACAA	CASSPADSNTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	2	6	1	24	35	47	41	48														CASSPADSNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAGCGGGCCCAGGGGGCGACTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	9	1.1653200745804848E-4		55	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	0	2	11	2	24	35	54	46	56														X+TCRBV21-or09_02+TCRBJ02-06	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTTCGTCAGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSFRQGNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	3	4	7	0	24	35	-1	42	47														CASSFRQGNEKLFF+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAGGGGGGAAATACGCAGTATTTTGGCCCA	CASSVEGGNTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	5	1	7	4	3	24	36	46	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGGNTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGATACAGATCGCTTTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	1.4242800911539258E-4		43	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	5	2	2	8	24	35	41	37	49														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTAATCTTAACCGGGGAGCTGTTTTTTGGAGAA	CASSLILTGELFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	10	5	5	2	24	36	43	41	45						01,02								CASSLILTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTTTATGACAGCTACACAGATACGCAGTATTTTGGCCCA	CASSFYDSYTDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	5	2	7	3	24	35	47	42	50														CASSFYDSYTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAACGACAGGGGGTGGCTACACCTTCGGTTCG	CASSVTTGGGYTF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	1	7	5	0	24	36	-1	41	50														CASSVTTGGGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGGGGACAGCCGGACAAATACGCAGTATTTTGGCCCA	CASRGDSRTNTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	5	7	2	8	24	35	44	37	52														CASRGDSRTNTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCCAGTCGAATTTTTGGGGGTGGTTTCTGAAGCTTTCTTTGGACAA	CASPVEFLGVVSEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	10	6	1	6	16	6	24	31	52	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASPVEFLGVVSEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGCTCTTCTATCAGCACAGATACGCAGTATTTTGGCCCA	CASSVGSSISTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	5	4	0	2	10	24	36	41	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGSSISTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGGGACAGAGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASKGQSNTGELFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	5	2	4	3	24	31	42	35	45														CASKGQSNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCTAGCGGGGGGGGCACAGAGACCCAGTACTTCGGGCCA	CASSVSSGGGTETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	4	4	4	24	36	52	40	56														CASSVSSGGGTETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGAATGTGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSVNVGGETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	9	1	4	8	0	24	36	-1	44	50														CASSVNVGGETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGGAACAGGGAATGAACACTGAAGCTTTCTTTGGACAA	CASREQGMNTEAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	0	3	2	24	35	44	38	46														CASREQGMNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCCACCGGGACAGGGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASHRDRGGTGELFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	1	4	6	2	24	31	48	37	50														CASHRDRGGTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCGAGGGATTAGTTGGCACTGAAGCTTTCTTTGGACAA	CASEGLVGTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	11	0	4	2	9	24	31	38	33	47														CASEGLVGTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTCCGCGGGGGGGCCGCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVRGGAASYNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	1	4	5	24	36	49	40	54														CASSVRGGAASYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGAATCGGACTAGCGGGGAGAAATGAGCAGTTCTTCGGGCCA	CASSVGIGLAGRNEQFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	3	7	9	3	24	36	57	45	60														CASSVGIGLAGRNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCTGGACAGTAATCAGCCCCAGCATTTTGGTGAT	CASSLDSNQPQHF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	5	4	3	1	24	35	44	38	45														CASSLDSNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCCAATCTAGCGGGGGCCTACACAGATACGCAGTATTTTGGCCCA	CASSANLAGAYTDTQYF	In	VDJ	3	55	7.121400455769629E-4	8.475229216426535E-4	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	2	2	6	4	24	36	52	42	56														CASSANLAGAYTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTCGCCAGTCCCTACGAGCAGTACGTCGGGCCG	CASSFASPYEQYV	In	VDJ	5	91	0.001178268075409157	0.0014022651976269358	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-07	01	6	4	5	17	6	17	24	35	44	41	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFASPYEQYV+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGCATCTAGCGGGGGGACGGAAGAGACCCAGTACTTCGGGCCA	CASSVASSGGTEETQYF	In	VDJ	6	112	0.00145017609281127	0.001725864858617767	51	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	1	3	7	4	24	36	54	43	58														CASSVASSGGTEETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAAAGGGGACAGTCCCCTATGGGCACAATGAGCAGTTCTTCGGGCCA	CASSEKGTVPYGHNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	54	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	5	5	3	12	24	39	49	42	61														CASSEKGTVPYGHNEQFF+TCRBV06-01+TCRBJ02-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGGGGTAGCGGGGGCCCAAGAGACCCAGTACTTCGGGCCA	CASSEGVAGAQETQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	5	2	1	3	1	23	39	51	42	52														CASSEGVAGAQETQYF+TCRBV06-01+TCRBJ02-05	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGTGAAGCGTGAGGGGATTCACCCCTCCACTTTGGGAAC	CASSEA*GDSPLHF	Stop	VDJ	1	8	1.0358400662937643E-4		42	TCRBV06	TCRBV06-01	01				TCRBJ01	TCRBJ01-06	01	0	5	2	8	3	0	26	43	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEA*GDSPLHF+TCRBV06-01+TCRBJ01-06	TCRBV06-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCGCTCCGGACAGTAAGGTTGAACACTGAAGCTTTCTTTGGACAA	CASSEALRTVRLNTEAFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	54	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	0	5	6	23	40	51	45	57														CASSEALRTVRLNTEAFF+TCRBV06-01+TCRBJ01-01	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAAGCAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSEAGYTGELFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV06	TCRBV06-01	01				TCRBJ02	TCRBJ02-02	01	0	5	3	3	0	1	24	-1	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEAGYTGELFF+TCRBV06-01+TCRBJ02-02	TCRBV06-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAAGGGGCAGGCGATGAAAAACTGTTTTTTGGCAGT	CAISEGAGDEKLFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	42	TCRBV06	TCRBV06-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	4	4	6	3	2	23	39	46	42	48														CAISEGAGDEKLFF+TCRBV06-01+TCRBJ01-04	TCRBV06-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGGACAGGACGGGTGAAAAACTGTTTTTTGGCAGT	CAWSRDRTGEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	0	4	7	1	5	26	38	47	39	52													Vb 20	CAWSRDRTGEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCCGGGCTTCCCGAAAAACTGTTTTTTGGCAGT	CAWSAGLPEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	1	8	0	8	2	5	26	39	45	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSAGLPEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGAGGACAGGTCATATGGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSGGQVIWGNQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	51	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	4	2	2	9	26	39	48	41	57													Vb 20	CAWSGGQVIWGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACCCTAATAACCGGAATCGCTACACCTTCGGTTCG	CAWSDPNNRNRYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	1	8	9	12	3	26	39	54	51	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDPNNRNRYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAAGGAGGGAAATCAGCCCCAGCATTTTGGTGAT	CAWSKEGNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	0	4	2	1	26	38	46	40	47													Vb 20	CAWSKEGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACAGGGTACGGAGGCTACACCTTCGGTTCG	CAWGTGYGGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	8	0	6	26	-1	44	35	50													Vb 20	CAWGTGYGGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAAAGGGGAATATAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSKGEYSNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	2	0	2	4	26	38	45	40	49													Vb 20	CAWSKGEYSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTAAGTGATTTAAGTCAGCCCCAGCATTTTGGTGAT	CAWSLSDLSQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	2	2	8	6	6	6	26	38	46	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSLSDLSQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGAACACAGGGGGCCTTGACGCTTTCTTTGGACAA	CAWRNTGGLDAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	0	11	4	6	26	37	50	41	56													Vb 20	CAWRNTGGLDAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCAGGACAGGGGGCCTGGAGACCCAGTACTTCGGGCCA	CAWARTGGLETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	0	5	4	3	26	35	50	39	53													Vb 20	CAWARTGGLETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGACGACACCGGGGAGCTGTTTTTTGGAGAA	CAWSVDDTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	0	2	7	3	1	1	26	40	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVDDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTCAAGGGAACACTGAAGCTTTCTTTGGACAA	CAWSVQGNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	5	4	1	3	0	26	40	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVQGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCCAAGGGACTAACATCGGGGAGCTGTTTTTTGGAGAA	CAWTQGTNIGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	9	7	5	4	26	36	48	41	52						01,02							Vb 20	CAWTQGTNIGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGGGGGACCGGCGTTGAGCTACACCTTCGGTTCG	CAWSGGPALSYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-02	01	1	0	7	9	1	9	26	39	45	40	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSGGPALSYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTCAGAAGGGGCGGAGCACAGATACGCAGTATTTTGGCCCA	CAWTQKGRSTDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	2	0	6	3	26	36	47	42	50													Vb 20	CAWTQKGRSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGCCGCTAGCAATCAGCCCCAGCATTTTGGTGAT	CAWGAASNQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	7	0	0	0	3	26	-1	40	35	43													Vb 20	CAWGAASNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGGCAGGCGAACACTGAAGCTTTCTTTGGACAA	CAWSRQANTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	1	3	1	26	38	45	41	46			unresolved										Vb 20	CAWSRQANTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGTCGGGAACACTGAAGCTTTCTTTGGACAA	CAWSVVGNTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	1	3	0	26	40	-1	43	46			unresolved			01,02							Vb 20	CAWSVVGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CAWSLTGGTDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	2	1	2	0	26	38	-1	40	48			unresolved										Vb 20	CAWSLTGGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTCGACAGGGTGCGTACGCAGTATTTTGGCCCA	CAFDRVRTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	3	8	2	4	26	33	42	35	46			unresolved										Vb 20	CAFDRVRTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACCGAACACTGAAGCTTTCTTTGGACAA	CAWSVPNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	3	7	1	0	1	26	-1	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGCAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVAGSNQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	1	2	0	26	40	-1	42	47													Vb 20	CAWSVAGSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGCAGGGGATCAGCCCCAGCATTTTGGTGAT	CAWSVAGDQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	5	2	0	26	40	-1	42	48													Vb 20	CAWSVAGDQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGTCGGTGGGGCCGAGCAGCCCCAGCATTTTGGTGAT	CAWGVGGAEQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	7	0	7	9	4	26	35	49	44	53													Vb 20	CAWGVGGAEQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCCCGGGATGAACACTGAAGCTTTCTTTGGACAA	CAWSVPGMNTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	3	0	3	0	26	40	-1	43	48													Vb 20	CAWSVPGMNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACAGAGGGAAATCAGCCCCAGCATTTTGGTGAT	CAWGTEGNQPQHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	5	4	0	5	26	-1	42	35	47													Vb 20	CAWGTEGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTATAGGGGACAGGATGTGAAAACCCAGTACTTCGGGCCA	CAYRGQDVKTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	4	8	4	8	26	33	45	37	53			unresolved										Vb 20	CAYRGQDVKTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCCTAGGCAAGAGACCCAGTACTTCGGGCCA	CAWSPRQETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	4	8	2	2	1	26	37	43	39	44						01,02							Vb 20	CAWSPRQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACCACGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CAWNHEGNQPQHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	11	1	2	5	0	26	36	-1	41	45													Vb 20	CAWNHEGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTGACTGACCCTCGGTCACAGTATTTTGGCCCA	CAWSLTDPRSQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	2	10	12	3	12	26	37	44	40	56						01,02							Vb 20	CAWSLTDPRSQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCTCTTTCGGCTGAAGCTTTCTTTGGACAA	CAWSALSAEAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	6	6	0	26	39	-1	45	48						01,02							Vb 20	CAWSALSAEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGAGATGGCCTTTCCGGGGAGCTGTTTTTTGGAGAA	CAWGDGLSGELFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	10	2	6	0	9	26	-1	39	35	48													Vb 20	CAWGDGLSGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTGGGGGCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CAWSLGAGTGELFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	6	0	4	2	3	26	38	46	40	49													Vb 20	CAWSLGAGTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGCAGGCAAGAGACCCAGTACTTCGGGCCA	CAWSVRRQETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	2	3	0	26	40	-1	43	47													Vb 20	CAWSVRRQETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CAWTGDTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	2	3	0	0	26	-1	-1	36	42													Vb 20	CAWTGDTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGAACAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.0716801325875285E-4		41	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	3	5	2	3	0	26	40	-1	43	47													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGCCAGAGGCGGCTATGGCTACACCTTCGGTTCG	CAWARGGYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	5	4	7	0	26	35	-1	42	46						01,02							Vb 20	CAWARGGYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTTGGGACAGACACCCACAGATACGCAGTATTTTGGCCCA	CALGQTPTDTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	5	2	1	5	26	33	41	34	46													Vb 20	CALGQTPTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATCGGGGCAATGTCAATGAGCAGTTCTTCGGGCCA	CAWNRGNVNEQFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-01	01	4	7	0	6	3	5	26	36	44	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNRGNVNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CAWSVGSYNSPLHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	0	0	9	0	0	0	26	-1	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGSYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCCCTTGTGGCCAGGGGAAACTACGAGCAGTACGTCGGGCCG	CAWSALVARGNYEQYV	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	48	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	17	12	17	26	37	55	49	72													Vb 20	CAWSALVARGNYEQYV+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATCGGGGAATGGCTACACTTTCGGTTCG		Out	VDJ	1	17	2.201160140874249E-4		34	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	8	3	17	2	12	26	38	45	40	57			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGACCCTAATCGTGGCGGGAACTATGGCTACACCTTCGGTTCG	CAWSDPNRGGNYGYTF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	48	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	7	4	2	12	0	26	39	-1	51	56			unresolved			01,02							Vb 20	CAWSDPNRGGNYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGACCCCCGGAGCTTGAAAAACTGTTTTTTGGCAGT	CAWRPPELEKLFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	10	2	7	6	2	26	37	47	43	49													Vb 20	CAWRPPELEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACACCCGGGAAATGAGCAGTTCTTCGGGCCA	CAWSVHPGNEQFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	3	7	5	0	26	40	-1	45	50			unresolved										Vb 20	CAWSVHPGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGCAGGGAATCAGCCCCAGCATTTTGGTGAT	CAWSVAGNQPQHF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	4	2	0	26	40	-1	42	47			unresolved										Vb 20	CAWSVAGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACGGCGGGGGGGCACGATGAGCAGTTCTTCGGGCCA	CAWSTAGGHDEQFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	0	8	3	4	26	38	50	41	54													Vb 20	CAWSTAGGHDEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACGGAGGGGAGGTTCTTATAATTCACCCCTCCACTTTGGGAAC	CAWSVRRGGSYNSPLHF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	51	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	0	9	1	4	6	4	26	40	52	46	56													Vb 20	CAWSVRRGGSYNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTTTTCGGAAACACTGAAGCTTTCTTTGGACAA	CAWSVFGNTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	0	1	8	2	4	0	26	40	-1	44	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVFGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACAGTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CAWGTVSSTDTQYF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	5	0	0	5	26	-1	42	35	47			unresolved										Vb 20	CAWGTVSSTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTCCCAGACGACCGTAAACACTGAAGCTTTCTTTGGACAA	CASQTTVNTEAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	7	2	7	2	4	7	26	33	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CASQTTVNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACTTCTTTGGCTTTCTTTGGACAA	CAWSVTSLAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	3	10	11	1	6	26	40	44	41	50			unresolved			01,02							Vb 20	CAWSVTSLAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTAGAGTCAGGCGGTGGGAGATGGCTACACCTTCGGTTCG	CA*SQAVGDGYTF	Stop	VDJ	1	22	2.8485601823078515E-4		39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	2	6	8	0	26	38	-1	46	51													Vb 20	CA*SQAVGDGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGCGAGGACAGGGCGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAWSARTGRSGANVLTF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	3	1	5	3	26	37	50	42	53			unresolved										Vb 20	CAWSARTGRSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCTTGGGACCCAGTACTTCGGGCCA	CAWSTLGTQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	33	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-05	01	2	0	10	7	6	0	26	38	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSTLGTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCGACCCAAACCAGGGGGGGAATCAGCCCCAGCATTTTGGTGAT	CAWSDPNQGGNQPQHF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	48	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	3	4	1	4	10	2	26	37	54	47	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSDPNQGGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTACGGGCACCCGGACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	27	3.4959602237414543E-4		37	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-07	01	7	1	7	17	10	14	26	33	47	43	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCCCTCGCCCCCGGACGCGGGCTTTCTTTGGACAA	CAWSVPRPRTRAFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	1	7	11	11	4	26	40	55	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVPRPRTRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGCCCGGGAGCTGTTTTTTGGAGAA	CAWSVARELFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	33	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-02	01	0	10	0	9	1	2	26	40	43	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVARELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*02		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCTCGGACAGGGAATTCGGTAGAGCTTTCTTTGGACAA	CAWSTSDREFGRAFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	45	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	3	10	5	10	26	38	51	43	61													Vb 20	CAWSTSDREFGRAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGACAGGGAGTACAGAACACTGAAGCTTTCTTTGGACAA	CAWGQGVQNTEAFF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	1	0	6	26	-1	43	35	49													Vb 20	CAWGQGVQNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGATACAGGGGGAACACTGAAGCTTTCTTTGGACAA	CAWGYRGNTEAFF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	1	4	0	26	35	-1	39	46													Vb 20	CAWGYRGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTATGGGGACTAGCGGCAATGAGCAGTTCTTCGGGCCA	CAWSMGTSGNEQFF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	42	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	0	5	6	3	0	26	38	-1	41	52						01,02							Vb 20	CAWSMGTSGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CAWSEGTNTGELFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	5	2	0	0	1	26	-1	44	39	45													Vb 20	CAWSEGTNTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGGGGGCAGCGTCACCGGGGAGCTGTTTTTTGGAGAA	CAWSVGGSVTGELFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	45	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-02	01	0	6	0	4	1	5	26	40	47	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGGSVTGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGACCCAGGGAGCCGTCACAGATACGCAGTATTTTGGCCCA	CAWGTQGAVTDTQYF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-03	01	5	0	7	2	0	12	26	-1	40	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWGTQGAVTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*02		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACTCTAACACAGGGAGGCGAAACTGAAGCTTTCTTTGGACAA	CAWTLTQGGETEAFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	45	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-01	01	4	3	3	5	7	7	26	36	49	43	56			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWTLTQGGETEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCGGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CAWSTGTGNTEAFF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	4	1	3	0	26	38	-1	41	49													Vb 20	CAWSTGTGNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACCGGAGGGGCGAGCGGGGAGCTGTTTTTTGGAGAA	CAWTGGASGELFF	In	VDJ	2	43	5.567640356328983E-4	6.626088296478928E-4	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	4	10	0	7	2	5	26	36	44	38	49													Vb 20	CAWTGGASGELFF+TCRBV30-01+TCRBJ02-02	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACCCGGGAGACCCAGTACTTCGGGCCA	CAWSTRETQYF	In	VDJ	2	43	5.567640356328983E-4	6.626088296478928E-4	33	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	5	5	3	0	26	38	-1	41	44						01,02							Vb 20	CAWSTRETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGCACCCTGGGTAGGGGGATCTATGGCTACACCTTCGGTTCG	CACTLGRGIYGYTF	In	VDJ	3	51	6.603480422622747E-4	7.858848909777333E-4	42	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	5	1	4	10	2	26	34	50	44	52			unresolved										Vb 20	CACTLGRGIYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACAAGTGGGCCCCTCTGGAAACACCATATATTTTGGAGAG	CAWSVQVGPSGNTIYF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	48	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	8	0	0	6	2	26	40	50	46	52													Vb 20	CAWSVQVGPSGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAGGGAAACTACAATGAGCAGTTCTTCGGGCCA	CAWKGNYNEQFF	In	VDJ	3	56	7.25088046405635E-4	8.629324293088835E-4	36	TCRBV30	TCRBV30-01	02				TCRBJ02	TCRBJ02-01	01	4	0	8	3	1	2	26	36	41	37	43			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKGNYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAAACTTGGGGACACTGAAGCTTTCTTTGGACAA	CAWKLGDTEAFF	In	VDJ	4	71	9.193080588357158E-4	0.0010940750443023345	36	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	4	6	2	3	5	0	26	36	-1	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWKLGDTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCGAGGTCCTAGCGGGGAAATGAGCAGTTCTTCGGGCCA	CARS*RGNEQFF	Stop	VDJ	4	80	0.0010358400662937642		36	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	4	3	7	6	1	26	31	46	37	47													Vb 20	CARS*RGNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTAAAGAACCGACTGGGGGAAAGGTTCAATCACCCCTCCACTTTGGGAAC		Out	VDJ	4	84	0.0010876320696084525		49	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-06	01	7	6	1	10	12	10	26	33	50	45	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGCAGCTTATCGGGGGGCTGTCGAGGCTTTCTTTGGACAA		Out	VDJ	5	91	0.001178268075409157		47	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	1	11	9	8	26	40	56	49	64													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAAGGAGGGGTTACAGCCCCAGCATTTTGGTGAT	CAWSKEGLQPQHF	In	VDJ	5	102	0.0013206960845245494	0.0015717697819554665	39	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	2	10	0	7	2	4	26	38	46	40	50			unresolved										Vb 20	CAWSKEGLQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGCCCCAGTGGACAGGGCTTACAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	107	0.0013854360886679097		44	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	1	3	3	9	3	26	32	49	41	52													Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCGGAACCGATACGCAGTATTTTGGCCCA	CAWSPGTDTQYF	In	VDJ	6	114	0.001476072094468614	0.0017566838739502273	36	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-03	01	2	1	8	6	3	3	26	38	44	41	47			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSPGTDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATCGGACTAGCGGGGGGTGCAGAGACCCAGTACTTCGGGCCA	CAWIGLAGGAETQYF	In	VDJ	6	115	0.001489020095297286	0.0017720933816164574	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	4	2	3	26	36	52	38	55													Vb 20	CAWIGLAGGAETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGATGGGGTCCACTGAAGCTTTCTTTGGACAA	CAWSVMGSTEAFF	In	VDJ	7	142	0.0018386161176714316	0.002188150088604669	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	6	2	4	3	2	26	40	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVMGSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCTTCGACGGTCTTGGGGGGTATACGCAGTATTTTGGCCCA	CAWSFDGLGGYTQYF	In	VDJ	8	150	0.001942200124300808	0.00231142614993451	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	9	1	7	13	1	26	37	56	50	57													Vb 20	CAWSFDGLGGYTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTATAGGGGACAGGGTGTGAAGACCCAGTACTTCGGGCCA	CAYRGQGVKTQYF	In	VDJ	13	255	0.0033017402113113734	0.003929424454888667	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	3	6	4	5	26	33	46	37	51			unresolved										Vb 20	CAYRGQGVKTQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGACGACAGGGTTTAGCACCGAAGCTTTCTTTGGACAA	CAWTTGFSTEAFF	In	VDJ	34	667	0.008636316552724259	0.010278141613375452	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	8	1	9	26	36	44	37	53			unresolved										Vb 20	CAWTTGFSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGATCACCGTACACAAGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	42	810	0.010487880671224362		52	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	6	0	9	4	26	37	49	46	53			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTCGCTGGCAATCAGCCCCAGCATTTTGGTGAT	CAWSVAGNQPQHF	In	VDJ	72	1405	0.018191941164284235	0.02165035827105324	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	0	10	0	2	1	2	26	40	43	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVAGNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGAGCGGGGACACAGATACGCAGTATTTTGGCCCA	CASSPSGDTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	3	2	3	1	19	31	41	34	42													Vb 5.1	CASSPSGDTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLTSGQETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	2	5	1	2	0	19	31	-1	33	42						01,02							Vb 5.1	CASSLTSGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGACATATGGACGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		46	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	6	4	1	10	19	33	39	34	49													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAACCCGGGGGCTAAAGATACGCAGTATTTTGGCCCA	CASSLNPGAKDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	1	6	0	5	5	3	19	34	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLNPGAKDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGAGTGGGACTAGCGGAGGGGAGACCCAGTACTTCGGGCCA	CASSLASGTSGGETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	51	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	0	5	5	5	4	19	35	51	40	55						01,02							Vb 5.1	CASSLASGTSGGETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGAACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAEQGNTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	3	1	4	0	19	35	-1	39	45													Vb 5.1	CASSLAEQGNTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGGATCAGCCCCAGCATTTTGGTGAT	CASSLGQGDQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	1	5	0	0	19	-1	-1	35	44													Vb 5.1	CASSLGQGDQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGAGGGCCCGAAGATACGCAGTATTTTGGCCCA	CASSLGGPEDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	11	0	5	0	5	19	-1	40	35	45													Vb 5.1	CASSLGGPEDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCCAGGGGGTGGAAACACCATATATTTTGGAGAG	CASSLGPGGGNTIYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	4	1	3	3	0	19	35	-1	38	45													Vb 5.1	CASSLGPGGGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCACTCTGACGGGCATGAACACTGAAGCTTTCTTTGGACAA	CASTLTGMNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	6	8	0	0	7	1	19	29	40	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASTLTGMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAACGGGACTAGCGGGCCCATCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	7	9.063600580070438E-5		55	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	0	4	0	4	5	19	31	47	35	52						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATGACAGGGTACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	7	9.063600580070438E-5		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	3	6	1	19	31	44	37	45													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGCCTACCATGAACACTGAAGCTTTCTTTGGACAA	CASSLEPTMNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	4	9	0	3	3	19	35	41	38	44						01,02							Vb 5.1	CASSLEPTMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACAGGGGTCGTGGGGAGAGCAGTTCTTCGGGCCA	CASSLGQGSWGEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	2	2	10	0	9	19	-1	43	35	52													Vb 5.1	CASSLGQGSWGEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCACATCGATCCGGGACAGGGGACGAAAAACTGTTTTTTGGCAGT	CASSPHRSGTGDEKLFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	12	2	19	31	53	43	55													Vb 5.1	CASSPHRSGTGDEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGGACAGGGTGATCAGCCCCAGCATTTTGGTGAT	CASSPGQGDQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	3	5	2	2	19	31	42	33	44													Vb 5.1	CASSPGQGDQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGACAGCGGGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDSGVSNQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	4	6	3	0	3	1	19	31	41	34	42													Vb 5.1	CASSDSGVSNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGTGCCCACCTTGTAACTGAAGCTTTCTTTGGACAA	CASSLGAHLVTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-01	01	0	3	7	5	6	6	19	35	43	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLGAHLVTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGGAAGGGCGGACCTTTCACCCCTCCACTTTGGGAAC	CASSQGRADLSPLHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-06	01	4	1	7	9	11	2	19	31	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSQGRADLSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTAAGACAGGGAAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLRQGSTGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	4	4	3	19	31	42	35	45													Vb 5.1	CASSLRQGSTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCGGGAGGGGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSSGGAVNTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	0	0	0	4	19	-1	40	32	44													Vb 5.1	CASSSGGAVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACGGACAGGGCTACGAGCAGTACGTCGGGCCG	CASSLDGQGYEQYV	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	3	17	2	14	19	35	45	37	59													Vb 5.1	CASSLDGQGYEQYV+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGAACGTCCAGGACAGGGGTTCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	9	1.1653200745804848E-4		53	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	1	2	17	10	16	19	35	54	45	70													Vb 5.1	X+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGTTTGGGGACCCTACAATGAGCAGTTCTTCGGGCCA	CASSLVWGPYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-01	01	0	0	7	2	4	0	19	35	-1	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLVWGPYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTTCACAGGTACTCACAGATACGCAGTATTTTGGCCCA	CASSFSQVLTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	4	2	3	4	19	33	41	36	45													Vb 5.1	CASSFSQVLTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGGACTCCACAAGAGACCCAGTACTTCGGGCCA	CASSPGTPQETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	2	3	3	19	31	40	34	43						01,02							Vb 5.1	CASSPGTPQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGCGCAGGTTCCCTCTCCCAAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLGAGSLSQATNEKLFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	60	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	4	0	3	14	19	35	42	38	56													Vb 5.1	CASSLGAGSLSQATNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCCAGGGGACAGGGGCTTCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	10	1.2948000828672053E-4		47	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	0	2	0	3	3	19	28	41	31	44													Vb 5.1	X+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCCAGGGGGGAGCCGGGGAGCTGTTTTTTGGAGAA	CASSSQGGAGELFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	1	6	2	3	19	32	41	34	44													Vb 5.1	CASSSQGGAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGACAGTCGGGACAGGGACTCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLTVGTGTLAKNIQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	57	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	0	3	0	6	5	19	34	49	40	54													Vb 5.1	CASSLTVGTGTLAKNIQYF+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGGGCGGGGACAGGGGGAGATTCACCCCTCCACTTTGGGAAC	CASRAGTGGDSPLHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	1	8	4	2	19	30	45	34	47													Vb 5.1	CASRAGTGGDSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCACCGGACTAGCGGGGTCAGAGACCCAGTACTTCGGGCCA	CASSTGLAGSETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	4	3	2	19	31	46	34	48													Vb 5.1	CASSTGLAGSETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTTTCGGCGGGACAGCGGACACTGAAGCTTTCTTTGGACAA	CASSFGGTADTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	3	7	3	19	30	44	37	47													Vb 5.1	CASSFGGTADTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATACAGGGGCAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASSIQGQGWNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	1	2	8	19	31	40	33	48													Vb 5.1	CASSIQGQGWNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCGGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPPGGSTDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	8	1	0	4	1	19	31	42	35	43													Vb 5.1	CASSPPGGSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCATTAGTCAACAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSISQQGSTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	2	4	8	2	19	31	46	39	48													Vb 5.1	CASSISQQGSTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCTCCCGAGTTTGGGGGGCCTAACCTACGAGCAGTACGTCGGGCCG	CASSLPSLGGLTYEQYV	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	51	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-07	01	4	6	0	17	12	19	19	31	49	43	68				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLPSLGGLTYEQYV+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGACAGAGATCCATGAACACTGAAGCTTTCTTTGGACAA	CASSFGQRSMNTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	5	0	1	7	19	33	40	34	47													Vb 5.1	CASSFGQRSMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGACCCGTTTACAGGCCCYCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	1.942200124300808E-4		49	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	4	4	8	4	19	35	48	43	52													Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATCCCCAAAAAAATCAGCCCCAGCATTTTGGTGAT	CASSQDPQKNQPQHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-05	01	4	2	8	4	3	10	19	31	36	34	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSQDPQKNQPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCCCGGGACTAGCGGGGGCCCGCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	2.201160140874249E-4		56	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	0	2	2	5	6	19	31	50	36	56													Vb 5.1	X+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCTAGCGGGTCGATCGATGAGCAGTTCTTCGGGCCA	CASSLASGSIDEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	4	8	0	7	19	-1	43	35	50						01,02							Vb 5.1	CASSLASGSIDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTACCGGCAGCTGGAGGGAAGAAAAACTGTTTTTTGGCAGT	CASSFTGSWREEKLFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	10	0	8	11	2	19	33	50	44	52													Vb 5.1	CASSFTGSWREEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTAAAAGAACGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSLKERAGELFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	8	4	6	7	0	19	33	-1	40	44						01,02							Vb 5.1	CASSLKERAGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCAGGGGGCAAAACTGAAGCTTTCTTTGGACAA	CASSLAGGKTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	0	5	0	3	19	-1	43	35	46													Vb 5.1	CASSLAGGKTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAGGGACAGGGGGCTATCGATGAGCAGTTCTTCGGGCCA	CASSQGQGAIDEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	8	2	5	19	31	45	33	50													Vb 5.1	CASSQGQGAIDEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAGACAGGGAGGGCAGATACGCAGTATTTTGGCCCA	CASSLETGRADTQYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	2	3	4	1	4	19	35	43	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLETGRADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAAACGCAGTCTAAATGAAAAACTGTTTTTTGGCAGT	CASSLKRSLNEKLFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-04	01	1	4	5	5	5	4	19	34	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLKRSLNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCCGGACAGGGGGCGAGCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGASGELFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	0	7	3	3	19	31	45	34	48													Vb 5.1	CASSPGQGASGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCTTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	28	3.625440232028175E-4		43	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	0	4	10	0	1	2	19	35	38	36	40						01,02							Vb 5.1	X+TCRBV05-01+TCRBJ02-04	TCRBV05-01*01	TCRBD02-01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCGGGAACAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSGTTTGELFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	1	8	3	4	1	5	19	34	40	35	45													Vb 5.1	CASSLSGTTTGELFF+TCRBV05-01+TCRBJ02-02	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGACCCCGCGAATGGCTACACCTTCGGTTCG		Out	VDJ	2	35	4.531800290035219E-4		40	TCRBV05	TCRBV05-01	01				TCRBJ01	TCRBJ01-02	01	0	2	7	6	0	7	19	-1	38	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	X+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCAAGATCTGGGACAGGGAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSQDLGQGVSGNTIYF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	3	0	8	3	19	31	48	39	51													Vb 5.1	CASSQDLGQGVSGNTIYF+TCRBV05-01+TCRBJ01-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGACTAGCGGGAGTTTCCAAGAGACCCAGTACTTCGGGCCA	CASSWTSGSFQETQYF	In	VDJ	3	52	6.732960430909468E-4	8.012943986439634E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	1	2	1	0	3	19	-1	45	32	48													Vb 5.1	CASSWTSGSFQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGTGCAGGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSSVQGVNTEAFF	In	VDJ	3	62	8.027760513776673E-4	9.553894753062639E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	0	5	0	19	32	-1	37	44													Vb 5.1	CASSSVQGVNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAGGGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLQGNSNQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	2	0	0	2	25	-1	46	40	48													Vb 3	CASSLQGNSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTAAGAACACTGAAGCTTTCTTTGGACAA	CASSLSKNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	4	9	1	0	1	25	-1	44	41	45						01,02							Vb 3	CASSLSKNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTACCAGCAGTCAAATATGGGGACTAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CTSSQIWGLTNTGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	9	0	8	1	25	37	52	45	53						01,02							Vb 3	CTSSQIWGLTNTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGTCAGCAGTCCCCGGGACAGGGCCACAGATACGCAGTATTTTGGCCCA	CVSSPRDRATDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	2	4	1	25	37	50	41	51													Vb 3	CVSSPRDRATDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCGGTTTAACTATGGCTACACCTTCGGTTCG	CASSPRFNYGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	5	1	3	2	25	37	43	40	45						01,02							Vb 3	CASSPRFNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATGGCCGGCTGAAGCTTTCTTTGGACAA	CASSLWPAEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	0	8	5	6	2	0	25	42	-1	44	47						01,02							Vb 3	CASSLWPAEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGAGACAGCCGAACACTGAAGCTTTCTTTGGACAA	CASRRQPNTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	2	2	25	36	43	38	45													Vb 3	CASRRQPNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCCCGGGACAGGGATATGGCTACACCTTCGGTTCG	CASSSPGQGYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	5	4	1	25	38	51	42	52													Vb 3	CASSSPGQGYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGACAGCCGCTCTTCACCCCTCCACTTTGGGAAC	CASSLDSRSSPLHF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	5	9	0	6	25	-1	45	39	51													Vb 3	CASSLDSRSSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACCCCTCTATGGCTACACCTTCGGTTCG	CASSLPLYGYTF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	4	10	4	3	0	25	40	-1	43	45						01,02							Vb 3	CASSLPLYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCACGGTGGCAACAGATACGCAGTATTTTGGCCCA	CASSTVATDTQYF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	6	9	0	3	6	1	25	36	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSTVATDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGTCCGGGACTAGGGCAAACGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	38	4.920240314895381E-4		53	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	8	4	6	8	25	39	53	45	61						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGGACAAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	39	5.049720323182101E-4		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	6	17	3	19	25	37	45	40	64													Vb 3	X+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAACCGGACAGGGGGACGGCTACACCTTCGGTTCG	CASRTGQGDGYTF	In	VDJ	5	95	0.001230060078723845	0.001463903228291856	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	1	8	4	2	25	36	50	40	52													Vb 3	CASRTGQGDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTAGGCAGTTGTCCCCCGGCTAAGCCCCAGCATTTTGGTGAT	CASRLGSCPPAKPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV12	TCRBV12-02	01				TCRBJ01	TCRBJ01-05	01	1	4	5	8	1	14	18	34	38	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRLGSCPPAKPQHF+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAACGACCTCTCCGGCAGGGTCTTTGGAAACACCATATATTTTGGAGAG	CANDLSGRVFGNTIYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	12	4	3	3	15	4	18	23	43	38	47														CANDLSGRVFGNTIYF+TCRBV12-02+TCRBJ01-03	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCAAGTCGCTTTCCGGACAAATGAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	1.5537600994406463E-4		44	TCRBV12	TCRBV12-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	6	4	3	4	18	32	40	35	44														X+TCRBV12-02+TCRBJ01-05	TCRBV12-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGTTCGGGACGGTCTAATGAAAAACTGTTTTTTGGCAGT	CASSQEGSGRSNEKLFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-04	01	0	0	7	3	6	3	23	40	51	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGSGRSNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGCAGGGGGCTTGCAAATGAGCAGTTCTTCGGGCCA	CASSQEGRGLANEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	7	3	5	23	40	51	43	56														CASSQEGRGLANEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAAGGGGCAGACCACTATGGCTACACCTTCGGTTCG	CASSQEGADHYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	3	0	6	23	-1	45	40	51														CASSQEGADHYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCAGGGACCCCTCCACTTTGGGAAC	CASSQDQGPLHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	3	12	1	0	23	40	-1	41	46														CASSQDQGPLHF+TCRBV01-01+TCRBJ01-06	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATAACGCTGGCGGACTGTTTTTTGGCAGT	CASSHNAGGLFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	7	5	13	8	0	23	37	-1	45	49						01,02								CASSHNAGGLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCCGCGGGGCGACGGAGACCCAGTACTTCGGGCCA	CASRGATETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	7	3	5	1	5	23	32	39	33	44														CASRGATETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCACGGGGCGGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSPTGRGGETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	7	0	4	7	0	23	36	-1	43	52														CASSPTGRGGETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCGGACAGGCCCACGGGGACCCAGTACTTCGGGCCA	CASSPDRPTGTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	4	7	1	8	23	36	44	37	52														CASSPDRPTGTQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCGGTCTCCGGGACAAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSRSPGQNTGELFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	6	2	7	1	23	36	49	43	50														CASSRSPGQNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATCGTCTTGGGAATCAGCCCCAGCATTTTGGTGAT	CASSQDRLGNQPQHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-05	01	0	0	9	4	7	0	23	40	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRLGNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCATGCGGGGCGCTACAATGAGCAGTTCTTCGGGCCA	CASSHAGRYNEQFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	3	3	1	2	23	37	44	38	46														CASSHAGRYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCTAGGGACAGGCTCAAATCAGCCCCAGCATTTTGGTGAT	CTSSLGTGSNQPQHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	0	4	4	2	4	23	36	46	38	50														CTSSLGTGSNQPQHF+TCRBV01-01+TCRBJ01-05	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGACTAGCGGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CTSSQD*RGYQETQYF	Stop	VDJ	1	19	2.4601201574476903E-4		48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	2	0	0	1	23	-1	50	40	51														CTSSQD*RGYQETQYF+TCRBV01-01+TCRBJ02-05	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCTACAGGGTGCTAACTATGGCTACACCTTCGGTTCG	CASSLQGANYGYTF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	3	0	1	2	23	36	43	37	45														CASSLQGANYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCTGACAGCCTCAATGAAAAACTGTTTTTTGGCAGT	CASSPDSLNEKLFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	5	2	4	23	36	43	38	47														CASSPDSLNEKLFF+TCRBV01-01+TCRBJ01-04	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCGGTTCCCTAGACAGAACACCGGGGAGCTGTTTTTTGGAGAA	CTSSRFPRQNTGELFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-02	01	4	2	6	1	9	0	23	36	-1	45	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSRFPRQNTGELFF+TCRBV01-01+TCRBJ02-02	TCRBV01-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTAGATTTAGGATTTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQVDLGFSYNEQFF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	1	1	8	1	8	3	23	39	50	47	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVDLGFSYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTGTATCTCTGTGCCAGCAGCAACTGGACAGGGACTTATGGCTACACCTTCGGTTCG	CASSNWTGTYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV05	TCRBV05-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	3	5	4	3	19	31	43	35	46													Vb 5.3	CASSNWTGTYGYTF+TCRBV05-05+TCRBJ01-02	TCRBV05-05*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTCCACAGGGCTCGGGACCCAGTACTTCGGGCCA	CASSSTGLGTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	7	2	5	23	36	44	38	49													Vb 14	CASSSTGLGTQYF+TCRBV27-01+TCRBJ02-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTATCGGCGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLSAGATGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	7	2	4	1	1	23	40	48	41	49													Vb 14	CASSLSAGATGELFF+TCRBV27-01+TCRBJ02-02	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTGTTGACAGTAGAGAAGAGACCCAGTACTTCGGGCCA	CASSVDSREETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	5	3	3	5	23	35	43	38	48													Vb 14	CASSVDSREETQYF+TCRBV27-01+TCRBJ02-05	TCRBV27-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTAGGGAAGGGACAGGGGTGGACTGAAGCTTTCTTTGGACAA	CASSLGKGQGWTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	2	5	5	3	23	38	53	43	56													Vb 14	CASSLGKGQGWTEAFF+TCRBV27-01+TCRBJ01-01	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTTTTTGAATTACAATGAGCAGTTCTTCGGGCCA	CASSFLNYNEQFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV27	TCRBV27-01	01				TCRBJ02	TCRBJ02-01	01	3	2	8	4	3	2	23	37	42	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 14	CASSFLNYNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTCGCCCCAGGGGCGCGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRPRGAATNEKLFF	In	VDJ	8	152	0.0019680961259581522	0.0023422451652669696	51	TCRBV27	TCRBV27-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	0	5	5	23	35	46	40	51													Vb 14	CASSRPRGAATNEKLFF+TCRBV27-01+TCRBJ01-04	TCRBV27-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGATAGCGGGGGAGCTAACAATGAGCAGTTCTTCGGGCCA	CSVDSGGANNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	5	3	5	25	33	45	36	50													Vb 4	CSVDSGGANNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACTAAGCTGCCGAACACTGAAGCTTTCTTTGGACAA	CSVTKLPNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	3	9	1	0	7	25	-1	38	34	45						01,02							Vb 4	CSVTKLPNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGCTACGGGCTATGGCTACACCTTCGGTTCG	CSVEGATGYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	4	0	6	25	-1	42	36	48													Vb 4	CSVEGATGYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGGCCGGGACAGGAACTGAAGCTTTCTTTGGACAA	CSVGAGTGTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	4	5	5	1	25	35	48	40	49													Vb 4	CSVGAGTGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTTTGCGCTAGCCTAGGGTCCAATGAGCAGTTTTTCGGGCCA	CSVEDLCASLGSNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02			0	4	7	19	8	21	25	39	52	47	73						01,02		TCRBJ02-01,TCRBJ02-05					Vb 4	CSVEDLCASLGSNEQFF+TCRBV29-01+TCRBJ02-X	TCRBV29-01*01	TCRBD02-01	TCRBJ02	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTAGGCGACGGACTTGGTGGTTATACCTTCGGTTCG	CSVLGDGLGGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	10	14	9	10	25	34	48	43	58						01,02							Vb 4	CSVLGDGLGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTACCATAGGGACCAATTCACCCCTCCACTTTGGGAAC	CSVTIGTNSPLHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	5	0	7	7	6	1	25	34	45	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVTIGTNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCTCAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGSGGTNEKLFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	4	0	2	3	0	25	35	-1	38	46													Vb 4	CSVGSGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGGCAGGAGATACGCAGTATTTTGGCCCA	CSVEGAGDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	6	0	5	0	3	25	-1	42	36	45													Vb 4	CSVEGAGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACTAGCCAAGAGACCCAGTACTTCGGGCCA	CSVGTSQETQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	8	1	0	0	25	-1	-1	35	42						01,02							Vb 4	CSVGTSQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCGGGGTGACACTGAAGCTTTCTTTGGACAA	CSVEDRGDTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	3	1	2	25	39	45	40	47													Vb 4	CSVEDRGDTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTCCCCGGGTCCTGGGGGGCTTTCTTTGGACAA	CSVVPGSWGAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	4	6	1	11	12	0	25	35	-1	47	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVPGSWGAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTAGACAGCACCTACGAGCAGTACGTCGGGCCG	CSVVDSTYEQYV	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-07	01	0	4	5	17	0	17	25	-1	42	39	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVVDSTYEQYV+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCTGGGGCAGGGGAACACACAGATACGCAGTATTTTGGCCCA	CSSGAGEHTDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	2	2	7	4	25	31	44	38	48													Vb 4	CSSGAGEHTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCAATATTGGGACAGGGGGGACTGAAGCTTTCTTTGGACAA	CSVNIGTGGTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	5	7	1	25	33	51	40	52													Vb 4	CSVNIGTGGTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGAAGATAGGGACAGGAATAACTATGGCTACACCTTCGGTTCG	CSVEDRDRNNYGYTF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	4	1	2	2	25	39	49	41	51													Vb 4	CSVEDRDRNNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTACAAGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CSVQGQMNTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	0	4	1	25	33	43	37	44													Vb 4	CSVQGQMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAAACGGACCTGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVQTDLGSGANVLTF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	48	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	5	1	7	0	5	5	25	34	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVQTDLGSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAACTGGACATTAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVQLDINSGANVLTF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	0	5	4	25	34	44	39	48													Vb 4	CSVQLDINSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCTCAACTGGGAATAATTCACCCCTCCACTTTGGGAAC	CSASTGNNSPLHF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	7	0	8	5	8	0	25	32	-1	40	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSASTGNNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGACAGGGCATCGGGGAAACTATGGCTACACCTTCGGTTCG	CSVEGTGHRGNYGYTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	2	0	9	25	-1	46	38	55													Vb 4	CSVEGTGHRGNYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTTAGGCGACGGACTTGGTGGCTACACCTTCGGTTCG	CSVLGDGLGGYTF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	1	10	7	9	3	25	34	48	43	51						01,02							Vb 4	CSVLGDGLGGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCTCAGTACAGGGAAATCCCACAGATACGCAGTATTTTGGCCCA	CSVSVQGNPTDTQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	45	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	2	6	6	25	33	45	39	51													Vb 4	CSVSVQGNPTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAACAGACCACAGATACGCAGTATTTTGGCCCA	CSVEEQTTDTQYF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	5	2	3	2	25	36	43	39	45													Vb 4	CSVEEQTTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACGCGGAAACTGGGGATACGCAGTATTTTGGCCCA	CSVDAETGDTQYF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	7	5	6	1	8	25	36	41	37	49						01,02							Vb 4	CSVDAETGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGCCGGGACAGCCGTCGGCAATGAGCAGTTCTTCGGGCCA	CSGAGTAVGNEQFF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	5	6	5	7	25	32	44	37	51													Vb 4	CSGAGTAVGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCGCCTTTGGGGAGGGGGGTATGGCCGGCAGTTCTTCGGGCCA		Out	VDJ	2	48	6.215040397762585E-4		44	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	9	0	12	8	11	25	33	48	41	59													Vb 4	X+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCTTCGCGCTAGCCTAGGGTCCAATGAGCAGTTCTTCGGGCCA	CSVEDLRASLGSNEQFF	In	VDJ	3	57	7.38036047234307E-4	8.783419369751136E-4	51	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	7	6	8	8	25	39	52	47	60						01,02							Vb 4	CSVEDLRASLGSNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTCCCCTCCGGACAGGGGCAGGAGACCCAGTACTTCGGGCCA	CSVPSGQGQETQYF	In	VDJ	4	80	0.0010358400662937642	0.0012327606132984052	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	2	5	7	3	25	33	49	40	52													Vb 4	CSVPSGQGQETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGCAGGGTTCTGGAAACACCATATATTTTGGAGAG	CSVQGSGNTIYF	In	VDJ	9	178	0.0023047441475036253	0.0027428923645889513	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	1	1	1	25	33	39	34	40													Vb 4	CSVQGSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGCTAGGGGATCAAAACATTCAGTACTTCGGCGCC	CSVGLGDQNIQYF	In	VDJ	13	249	0.0032240522063393413	0.003836967408891286	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	5	2	5	4	3	25	35	44	39	47													Vb 4	CSVGLGDQNIQYF+TCRBV29-01+TCRBJ02-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCCCAGGGAAATAATTCACCCCTCCACTTTGGGAAC	CSVSQGNNSPLHF	In	VDJ	14	265	0.003431220219598094	0.004083519531550967	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	3	5	3	2	25	34	42	37	44													Vb 4	CSVSQGNNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGGACAGGGGGCACTAATGAAAAACTGTTTTTTGGCAGT	CSVGTGGTNEKLFF	In	VDJ	21	404	0.005230992334783509	0.006225441097156946	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	0	2	0	0	25	-1	-1	35	46													Vb 4	CSVGTGGTNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGGACACAGGAAACACCATATATTTTGGAGAG	CSVVDTGNTIYF	In	VDJ	22	420	0.005438160348042263	0.006471993219816627	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	1	6	4	1	2	25	35	41	36	43													Vb 4	CSVVDTGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGAGTGACGGTGAACACTGAAGCTTTCTTTGGACAA	CASRVTVNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-01	01	6	2	7	0	3	2	23	34	40	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASRVTVNTEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAACTAGCGGGGTCCGAGCAGTACGTCGGGCCG	CASSELAGSEQYV	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	17	0	13	23	-1	47	38	60													Vb 22	CASSELAGSEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGCAGGGGACTAGCGGCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	9	1.1653200745804848E-4		46	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	1	5	0	23	34	-1	39	50						01,02							Vb 22	X+TCRBV02-01+TCRBJ02-05	TCRBV02-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAAACCTGGGGAACACCATATATTTTGGAGAG	CASSENLGNTIYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-03	01	2	6	2	7	5	0	23	38	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSENLGNTIYF+TCRBV02-01+TCRBJ01-03	TCRBV02-01*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATTAGGGACGGGGTATATTCACCCCTCCACTTTGGGAAC	CASIRDGVYSPLHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-06	01	7	0	7	8	3	7	23	33	41	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASIRDGVYSPLHF+TCRBV02-01+TCRBJ01-06	TCRBV02-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTACACGGGGCAGGGGGGCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVHGAGGPGANVLTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	54	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	4	1	4	11	4	23	34	52	45	56													Vb 22	CASSVHGAGGPGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCTGGGGCCTTATGGCTACACCTTCGGTTCG	CASSEALGPYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	5	3	2	23	40	48	43	50													Vb 22	CASSEALGPYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATTTCAGCGCGTACAATGAGCAGTTCTTCGGGCCA	CASSDFSAYNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	6	6	4	4	2	23	37	45	41	47						01,02							Vb 22	CASSDFSAYNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAATCGCGGGGGCTCCCCCAATGAGCAGTTCTTCGGGCCA	CASNRGGSPNEQFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	7	2	6	3	6	23	33	43	36	49													Vb 22	CASNRGGSPNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCGGATGGGTTTCAGGGGACAGGGGGCGCAGCACCGGGGAGCTGTTTTTTGGAGAA	CAGWVSGDRGRSTGELFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	54	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	11	0	0	4	13	4	23	29	54	42	58													Vb 22	CAGWVSGDRGRSTGELFF+TCRBV02-01+TCRBJ02-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGGGTACCGGGACAACACAGATACGCAGTATTTTGGCCCA	CGYRDNTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	13	0	6	2	6	1	23	27	39	33	40													Vb 22	CGYRDNTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAAACAGGACAGGGACAACACGAGCAGTACGTCGGGCCG	CASKTGQGQHEQYV	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	17	5	17	23	33	46	38	63													Vb 22	CASKTGQGQHEQYV+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGTAAGAAGCTATGGCTACACCTTCGGTTCG	CASSVRSYGYTF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	36	TCRBV02	TCRBV02-01	01				TCRBJ01	TCRBJ01-02	01	4	2	8	4	3	2	23	36	41	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	CASSVRSYGYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGCGCTTCCGGGGCGAGACCTACGAGCAGTACGTCGGGCCG		Out	VDJ	4	84	0.0010876320696084525		49	TCRBV02	TCRBV02-01	01				TCRBJ02	TCRBJ02-07	01	0	7	0	17	6	19	23	40	51	46	70				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAATGGGACAGTGCCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	4	87	0.0011264760720944686		46	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	5	0	1	3	23	38	46	39	49													Vb 22	X+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACGTACAGGGGACGATTGAAAAACTGTTTTTTGGCAGT	CASSDVQGTIEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	2	7	2	5	28	43	52	45	57			01,02											CASSDVQGTIEKLFF+TCRBV06-04+TCRBJ01-04	TCRBV06-04	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAACTGCCAGGGAAGGAATGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	1.2948000828672053E-4		43	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	4	3	8	5	8	28	38	48	43	56			01,02											X+TCRBV06-04+TCRBJ01-04	TCRBV06-04	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGCAGATGGACTAGCGGGGCGATAGATACGCAGTATTTTGGCCCA	CASSRWTSGAIDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	5	5	4	28	39	56	44	60			01,02											CASSRWTSGAIDTQYF+TCRBV06-04+TCRBJ02-03	TCRBV06-04	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGGAGGGACGGTAATCAGCCCCAGCATTTTGGTGAT	CASRRDGNQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV06	TCRBV06-04					TCRBJ01	TCRBJ01-05	01	6	0	7	4	2	3	28	39	46	41	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRDGNQPQHF+TCRBV06-04+TCRBJ01-05	TCRBV06-04		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGTAGCGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVAGNTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV06	TCRBV06-04		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	5	4	1	0	0	28	-1	-1	41	48			01,02			01,02								CASSVAGNTGELFF+TCRBV06-04+TCRBJ02-02	TCRBV06-04	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCGGGACAGGGTCTGGATCAGCCCCAGCATTTTGGTGAT	CASSPGQGLDQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	3	5	2	5	26	38	49	40	54														CASSPGQGLDQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGACAGGCCGCCAGCTTAACATTCAGTACTTCGGCGCC	CASSYSTGRQLNIQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	2	4	7	0	10	26	-1	49	43	59														CASSYSTGRQLNIQYF+TCRBV06-07+TCRBJ02-04	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAATCCTTTATGGTCGAGGGGGAAGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	7	9.063600580070438E-5		55	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	5	1	2	14	4	26	36	56	50	60														X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCCCCAAGAGACCCAGTACTTCGGGCCA	CASSPQETQYF	In	VJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	5	0	0	1	0	2	26	-1	38	-1	40														CASSPQETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCAGGGACTGGATGGCGGGGAGCTGTTTTTTGGAGAA	CASSQGLDGGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	7	2	6	26	38	46	40	52						01,02								CASSQGLDGGELFF+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTGACCCCCGGACAGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	1.1653200745804848E-4		50	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	1	7	1	26	38	53	45	54														X+TCRBV06-07+TCRBJ02-02	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTTAGGCTTAACCCACTTTGGGAAC	CASSYLGLTHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-06	01	1	5	4	18	1	6	26	42	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGLTHF+TCRBV06-07+TCRBJ01-06	TCRBV06-07*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TTCTGTTTACTTCTGTGCCAGCAGTGAAGGTTCAGGTGCGCCCAGCTCCCGTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGSGAPSSRSYNEQFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	60	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	4	1	7	16	13	25	36	32	52														CASSEGSGAPSSRSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGCATTCGGGGGTGACTAGCGGGGTAAGAGACCCAGTACTTCGGGCCA	CASSIRG*LAG*ETQYF	Stop	VDJ	1	15	1.942200124300808E-4		51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	3	11	1	26	37	59	48	60														CASSIRG*LAG*ETQYF+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCATTCGAAGCGGGGCTTCGAACACTGAAGCTTTCTTTGGACAA	CAIRSGASNTEAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	6	3	1	5	4	26	33	45	38	49														CAIRSGASNTEAFF+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACCCGACTAGCGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSYPTSGATDTQYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	48	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	2	2	1	26	41	54	43	55														CASSYPTSGATDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTATTCTGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	2.3306401491609695E-4		35	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-05	01	3	0	10	5	4	0	26	40	-1	44	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-05	TCRBV06-07*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCAAATGAGCAGTTCTTCGGGCCA	CASSYSNEQFF	In	VJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	33	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-01	01	0	0	0	7	0	1	26	-1	43	-1	44														CASSYSNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCTCGGAGGGACTCCCCACAGATACGCAGTATTTTGGCCCA	CASSEGLPTDTQYF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	42	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	8	0	10	2	5	3	26	35	46	40	49						01,02								CASSEGLPTDTQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGTAGGGTCCTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYVGSFSNQPQHF	In	VDJ	3	60	7.768800497203232E-4	9.245704599738038E-4	48	TCRBV06	TCRBV06-07	01				TCRBJ01	TCRBJ01-05	01	2	5	3	0	2	5	26	41	47	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYVGSFSNQPQHF+TCRBV06-07+TCRBJ01-05	TCRBV06-07*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCAGCCATGTATCGCTGTGCAAGTCGCTTAAACCAGATTTGGGGAACATTCAGTACTTCGGCGCC		Out	VDJ	1	12	1.5537600994406463E-4		44	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-04	01	2	6	2	7	10	0	19	34	-1	44	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-07+TCRBJ02-04	TCRBV07-07*01		TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAAGTACGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSLSTGQETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	8	4	1	4	0	19	34	-1	38	42						01,02								CASSLSTGQETQYF+TCRBV07-07+TCRBJ02-05	TCRBV07-07*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCAGCCATGTATCGCTGTGCCAGCCAACTAGGACAGGGTGATACCGAGGAGCTGTTTTTTGGAGAA	CASQLGQGDTEELFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	3	10	6	9	19	28	42	34	51														CASQLGQGDTEELFF+TCRBV07-07+TCRBJ02-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGGGACAGGGGTTATCTATGGCTACACCTTCGGTTCG		Out	VDJ	3	57	7.38036047234307E-4		46	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	2	4	0	4	19	-1	45	35	49														X+TCRBV07-07+TCRBJ01-02	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCSGCCRTGTATCKCTGTGCCAGCAGCCCCCGGACAGGGGGGTATGGAGAGACCCAGTACTTCGGGCCA	CASSPRTGGYGETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	1	4	4	6	20	32	46	36	52		TCRBV07-06,TCRBV07-08												CASSPRTGGYGETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCCTCCCARACATCTGTGTACTTSTGTGCCAGCACCAAAGCGGGCACAGATACGCAGTATTTTGGCCCA	CASTKAGTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	6	5	1	4	0	23	33	-1	37	42		TCRBV06-02,TCRBV06-03,TCRBV06-08				01,02								CASTKAGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTCTGACAGTGACGTACGAGCAGTACGTCGGGCCG	CASSLTVTYEQYV	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	17	2	18	23	35	42	37	60		TCRBV06-04,TCRBV06-08												CASSLTVTYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGAGGCCATGACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSGGHDSYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	1	0	0	6	26	-1	43	39	49		TCRBV10-01,TCRBV10-02												CASSGGHDSYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTCCGAGGCTGGACAACACACCTTCGGTTCG	CASSSEAGQHTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	12	8	2	26	39	52	47	54		TCRBV06-08,TCRBV06-09												CASSSEAGQHTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGGGCTAGCGGGGGGGAAAGAGACCCAGTACTTCGGGCCA	CASSYGLAGGKETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	4	0	3	3	1	26	41	56	44	57		TCRBV06-05,TCRBV06-06,TCRBV06-07												CASSYGLAGGKETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTAGACAGGGCCTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	6	7.768800497203231E-5		43	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	3	1	0	3	26	-1	47	40	50		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTTCGCAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSFAANTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	5	0	3	0	26	39	-1	42	45		TCRBV06-05,TCRBV06-06,TCRBV06-07												CASSFAANTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCTCGCCTCTTTCACAGGTGGTACTGAAGCTTTCTTTGGACAA	CASLASFTGGTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	4	5	12	4	26	35	52	47	56		TCRBV06-07,TCRBV06-08												CASLASFTGGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCCCGGACAGGACTATGGCTACACCTTTGGTTCG	CASSPGQDYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	20	3	17	18	30	40	33	57		TCRBV07-02,TCRBV07-08												CASSPGQDYGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCAATCCCGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQSRGTNEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	3	1	6	0	18	30	-1	36	41		TCRBV11-01,TCRBV11-03												CASSQSRGTNEKLFF+TCRBV11-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCGGACTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSRTSGSTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	4	0	1	0	18	30	-1	31	42		TCRBV11-01,TCRBV11-03				01,02								CASSRTSGSTDTQYF+TCRBV11-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGACAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLDSSYNSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	1	5	0	0	0	18	-1	-1	32	38		TCRBV11-01,TCRBV11-03												CASSLDSSYNSPLHF+TCRBV11-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCCCACCGGACAGGGGGGGTGAAGCTTTCTTTGGACAA	CASSPPDRGGEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	1	7	5	2	19	31	46	36	48		TCRBV07-07,TCRBV07-08												CASSPPDRGGEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCGCCCGGACTCGTTACAATGAGCAGTTCTTCGGGCCA	CASSARTRYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	4	4	3	19	31	40	35	43		TCRBV07-05,TCRBV07-07				01,02								CASSARTRYNEQFF+TCRBV07-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCMGCCRTGTATCKCTGTGCCAGCAGCTTAGCAGGGGTTGATTCTGGCTACACCTTCGGTTCG	CASSLAGVDSGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	7	0	7	19	-1	41	36	48		TCRBV07-07,TCRBV07-08												CASSLAGVDSGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTACCACCAGGGAGAAGTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	6	7.768800497203231E-5		53	TCRBV05	unresolved					TCRBJ02	TCRBJ02-06	01	2	4	3	1	5	5	19	33	43	38	48		TCRBV05-05,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV05-X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCCCTGGGCCCAGTGGGGGCTACACCTTCGGTTCG	CASSPGPSGGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	8	0	8	3	8	22	34	41	37	49		TCRBV07-01,TCRBV07-04												CASSPGPSGGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYRGCTGTGTATCTCTGTGCCAGCAGCGCCCGACTAGCCGGGGAGCTGTTTTTTGGAGAA	CASSARLAGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	8	6	4	0	22	34	-1	38	44		TCRBV07-01,TCRBV07-04				01,02								CASSARLAGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCARACWTCTGTKTACTTCTGTGCCAGCAGTTACTCCTCCAGTAACACTGAAGCTTTCTTTGGACAA	CASSYSSSNTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	2	3	1	25	42	48	45	49		TCRBV06-02,TCRBV06-03,TCRBV06-07												CASSYSSSNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGGCGTTCTCCACACCTTCGGTTCG	CASSYGVLHTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	33	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	5	9	0	12	3	7	28	40	46	43	53		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVLHTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGAACGGACAGGGAGGGGAGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSERTGRGVAKNIQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	3	0	1	8	24	39	48	40	56		TCRBV06-01,TCRBV06-08												CASSERTGRGVAKNIQYF+TCRBV06-X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTATCGAGACAGGGGGCTTCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	8	1.0358400662937643E-4		52	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	0	3	4	2	23	37	51	41	53		TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCGTATGGACCGGGACAGCAAGATGGCTACACCTTCGGTTCG		Out	VDJ	1	8	1.0358400662937643E-4		40	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	11	0	5	6	9	4	23	29	45	38	49		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAGGAGCGATAGAGACCCAGTACTTCGGGCCA	CASSLGAIETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	6	6	4	1	2	18	34	39	35	41		TCRBV07-02,TCRBV07-08				01,02								CASSLGAIETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCTGGGAGGGTACAGCCCGGCGAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		55	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	17	3	31	18	30	40	33	71		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTATTGCGGGGGAGTAACAATGAGCAGTTCTTCGGGCCA	CASSLLRGSNNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	2	5	2	4	18	33	42	35	46		TCRBV11-01,TCRBV11-03												CASSLLRGSNNEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCGCCGGGACAGGGGAGGAAAAACTGTTTTTTGGCAGT	CASSAGTGEEKLFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	2	8	3	2	19	31	44	34	46		TCRBV07-06,TCRBV07-07												CASSAGTGEEKLFF+TCRBV07-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGCAAGCCACGTTTGGTGGSGACTCRGCYRTGTATCKCTGYGCCAGCAGCTTAACGGGACCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLTGPTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV07	unresolved					TCRBJ02	TCRBJ02-02	01	2	0	7	4	2	1	19	34	41	36	42		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGPTGELFF+TCRBV07-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGGATGAAGTGTCAGGGGAGAACGCCGCTCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	8	1.0358400662937643E-4		61	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	4	2	0	10	9	19	30	46	40	55		TCRBV07-05,TCRBV07-07												X+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCTTCCCTCTACAGGAGACCCAGTACTTCGGGCCA	CASSFPLQETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	5	5	7	0	22	35	-1	42	46		TCRBV07-01,TCRBV07-02												CASSFPLQETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCARACWTCTGTKTACTTCTGTGCCAGCACGGCTAGCGGCATAATAGGGGAGCTGTTTTTTGGAGAA	CASTASGIIGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	4	5	8	3	7	25	35	45	38	52		TCRBV06-02,TCRBV06-03,TCRBV06-07				01,02								CASTASGIIGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCACCGAAGCCCCACAGGGGGCCTCACCCCAGCATTTTGGTGAT	CASTEAPQGASPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	0	10	10	4	28	38	57	48	61		TCRBV06-04,TCRBV06-07												CASTEAPQGASPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGGGCGACAGGGTTAGGCTACACCTTCGGTTCG	CARATGLGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	33	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	2	3	8	3	3	28	36	46	39	49		TCRBV06-04,TCRBV06-07												CARATGLGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGAACCCGACAGGAAGGTCTTCGGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	1.2948000828672053E-4		46	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	4	9	5	11	26	37	48	42	59		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCCGCGGACAGGGATCAGGGGAGCTGTTTTTTGGAGAA	CASSRGQGSGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	3	8	3	4	19	31	42	34	46		TCRBV07-02,TCRBV07-05												CASSRGQGSGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGGGGACAGGGGTGGGGCTACACCTTCGGTTCG		Out	VDJ	1	10	1.2948000828672053E-4		41	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	8	1	3	26	41	52	42	55		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACTCGGGACAGCCTAATGGCTACACCTTCGGTTCG	CASSYSGQPNGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	5	6	0	4	26	-1	50	43	54		TCRBV06-07,TCRBV06-08												CASSYSGQPNGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCCAAGGGGGTAGGGAGACCCAGTACTTCGGGCCA	CASQGGRETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	5	1	5	2	4	26	35	43	37	47		TCRBV06-07,TCRBV06-08												CASQGGRETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTATCTTCGGGGGTCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	10	1.2948000828672053E-4		46	TCRBV07	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	2	2	4	1	18	33	43	37	44		TCRBV07-02,TCRBV07-06												X+TCRBV07-X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCATCCGGGACAGGGTTTTTTTGGGGGAGACCCAGTACTTCGGGCCA	CASSIRDRVFLGETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	51	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	4	11	18	30	43	34	54		TCRBV07-02,TCRBV07-05												CASSIRDRVFLGETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCYGTGTATSTCTGTGCCAGCAGTTTAGCGTAGGTTGGACAAGTCCCGGGTAATAGCAATCAGCTCCAGCATTTTGGTGAT	CASSLA*VGQVPGNSNQLQHF	Stop	VDJ	1	10	1.2948000828672053E-4		63	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	6	12	7	24	18	35	47	42	71		TCRBV07-02,TCRBV07-04												CASSLA*VGQVPGNSNQLQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAAACCGGATTAATGAAAAACTGTTTTTTGGCAGT	CASSLNRINEKLFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV07	unresolved					TCRBJ01	TCRBJ01-04	01	2	1	8	4	4	1	19	34	41	38	42		TCRBV07-06,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNRINEKLFF+TCRBV07-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCGGGKCGAGACAGGGTGATGGCTACACCTTCGGTTCG	CASSGXRQGDGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	3	6	7	2	19	31	45	38	47		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSGXRQGDGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCGGACGGGCCTTACTTGGTTCACCCCTCCACTTTGGGAAC	CASGRALLGSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV05	unresolved					TCRBJ01	TCRBJ01-06	01	7	1	7	9	0	13	19	-1	32	28	45		TCRBV05-05,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGRALLGSPLHF+TCRBV05-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGACCCTTCAGGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSDPSGGNTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	2	5	1	26	40	52	45	53		TCRBV10-01,TCRBV10-02												CASSDPSGGNTEAFF+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGACTTCGACAGGGCATGGCTACACCTTCGGTTCG	CASRTSTGHGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	6	6	1	23	34	47	40	48		TCRBV06-04,TCRBV06-08												CASRTSTGHGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAAGGGAGGGTCCTACGAGCAGTACGTCGGGCCG	CASSKGGSYEQYV	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	9	0	17	2	16	23	35	44	37	60		TCRBV06-07,TCRBV06-08												CASSKGGSYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCCGGGGACATAAATTCACCCCTCCACTTTGGGAAC	CASSPGDINSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	7	4	2	19	31	41	35	43		TCRBV07-05,TCRBV07-07												CASSPGDINSPLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGTTTGACAGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSLTGMNTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	0	3	1	19	30	40	33	41		TCRBV11-01,TCRBV11-03												CASSLTGMNTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTATCGATAGCGGAACTATGGCTACACCTTCGGTTCG	CASSYR*RNYGYTF	Stop	VDJ	1	12	1.5537600994406463E-4		42	TCRBV05	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	5	5	2	5	0	19	32	-1	37	43		TCRBV05-05,TCRBV05-06,TCRBV05-07				01,02								CASSYR*RNYGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTAGACTCGACGTACAATGAGCAGTTCTTCGGGCCA	CASSLDSTYNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV11	unresolved					TCRBJ02	TCRBJ02-01	01	0	2	7	4	3	1	19	36	42	39	43		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDSTYNEQFF+TCRBV11-X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCAACAGGGGGCGGATGGCTACACCTTCGGTTCG	CASSQQGADGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	0	6	2	2	22	34	45	36	47		TCRBV07-01,TCRBV07-02												CASSQQGADGYTF+TCRBV07-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCCTCCCARACATCTGTGTACTTSTGTGCCAGCAGCGCCCCCGGGACTGGAAATGAGCAGTTCTTCGGGCCA	CASSAPGTGNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	7	7	3	25	36	49	43	52		TCRBV06-02,TCRBV06-03,TCRBV06-08				01,02								CASSAPGTGNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCTGTKTACTTSTGTGCCAGCAGTGAAGTGCCCGAAATGGGGTCGGCAGGGACCTTCGGCACTGAAGCTTTCTTTGGACAA	CASSEVPEMGSAGTFGTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	63	TCRBV06	unresolved					TCRBJ01	TCRBJ01-01	01	5	0	7	4	24	6	8	20	49	44	55		TCRBV06-01,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEVPEMGSAGTFGTEAFF+TCRBV06-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCTCGGCAGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGRTSTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	1	10	0	7	0	26	38	-1	45	50		TCRBV06-07,TCRBV06-08				01,02								CASSLGRTSTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCTCCTCGGGGGCAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLLGGRSNQPQHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	TCRBV05	unresolved					TCRBJ01	TCRBJ01-05	01	4	6	0	1	6	3	19	31	43	37	46		TCRBV05-05,TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLGGRSNQPQHF+TCRBV05-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTACTCCCAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSLLPGGTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	1	4	5	0	19	33	-1	38	45		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSLLPGGTEAFF+TCRBV05-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGTACATACCGGGACAGGGGAAATTCACCCCTCCACTTTGGGAAC	CASTYRDRGNSPLHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	0	2	7	8	1	23	31	49	39	50		TCRBV06-07,TCRBV06-08												CASTYRDRGNSPLHF+TCRBV06-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACTCTACAGGGGTGGGTAGCTTTCTTTGGACAA	CASTLQGWVAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	2	10	4	5	26	36	47	40	52		TCRBV06-07,TCRBV06-08												CASTLQGWVAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGACCCGGGACAAAATATGGCTACACCTTCGGTTCG	CASRPGTKYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	6	5	4	3	23	34	44	38	47		TCRBV06-07,TCRBV06-08												CASRPGTKYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCGTAAGGGACCTGAATTCACCCCTCCACTTTGGGAAC	CASSVRDLNSPLHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV07	unresolved					TCRBJ01	TCRBJ01-06	01	5	0	7	7	4	3	19	31	40	35	43		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVRDLNSPLHF+TCRBV07-X+TCRBJ01-06	unresolved		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTACCGTGACAGGGGGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSYRDRGFSGANVLTF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	54	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	2	1	0	3	2	23	38	50	41	52		TCRBV06-08,TCRBV06-09												CASSYRDRGFSGANVLTF+TCRBV06-X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGATCCTCTGGACAGGAGAACACTGAAGCTTTCTTTGGACAA	CASRSSGQENTEAFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	1	7	1	18	29	43	36	44		TCRBV11-01,TCRBV11-03												CASRSSGQENTEAFF+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGTTACCGGAAATTCACCGGGGAGCTGTTTTTTGGAGAA	CASSYRKFTGELFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV06	unresolved					TCRBJ02	TCRBJ02-02	01	5	1	8	4	4	4	28	40	47	44	51		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRKFTGELFF+TCRBV06-X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTCCATGACGGGGACTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	2.4601201574476903E-4		41	TCRBV06	unresolved					TCRBJ01	TCRBJ01-04	01	5	0	7	7	8	0	26	38	-1	46	51		TCRBV06-04,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGGGTCCTAATCAGCCCCAGCATTTTGGTGAT	CASRGPNQPQHF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV06	unresolved					TCRBJ01	TCRBJ01-05	01	6	0	9	4	0	4	23	-1	37	34	41		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGPNQPQHF+TCRBV06-X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCGCTGTGCCAGAAGCCTGGGCCAAAGGACAGGGCCCGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	20	2.5896001657344105E-4		50	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	5	10	5	18	30	48	40	53		TCRBV07-06,TCRBV07-07												X+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTAGATCTAGGACAGGGACCTACGAGCAGTACGTCGGGCCG	CASSRSRTGTYEQYV	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	17	7	16	26	38	53	45	69		TCRBV06-07,TCRBV06-08												CASSRSRTGTYEQYV+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGATGTGGGACAGGGGGCTGGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	2.8485601823078515E-4		52	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	0	5	6	5	20	34	52	40	57		TCRBV05-06,TCRBV05-07,TCRBV05-08												X+TCRBV05-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACGCCAGTAACTATGGCTACACCTTCGGTTCG	CASSYASNYGYTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	1	2	0	24	39	-1	41	44		TCRBV06-05,TCRBV06-06,TCRBV06-07												CASSYASNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGATTTGTAGGGGAGAGCAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	25	3.2370002071680133E-4		53	TCRBV06	unresolved					TCRBJ02	TCRBJ02-03	01	1	5	2	0	6	5	23	39	50	45	55		TCRBV06-01,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACTCGAACCGGGATCAGCCCCAGCATTTTGGTGAT	CASSYSNRDQPQHF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	8	4	5	4	0	26	43	-1	47	51		TCRBV06-05,TCRBV06-06,TCRBV06-07				01,02								CASSYSNRDQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCARACWTCTGTKTACTTCTGTGCCAGCAGTGAAAGTCCGAATAACTATGGCTACACCTTCGGTTCG	CASSESPNNYGYTF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	2	2	8	1	5	1	25	40	47	45	48		TCRBV06-01,TCRBV06-02,TCRBV06-03,TCRBV06-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSESPNNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCCAACAGGGGGCGACAGATACGCAGTATTTTGGCCCA	CASSQQGATDTQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	3	2	1	19	31	42	33	43		TCRBV07-02,TCRBV07-07												CASSQQGATDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCGAACCCGACGGGCGGGGCGGCTACACCTTCGGTTCG	CASSEPDGRGGYTF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	42	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	4	7	3	8	11	1	19	31	48	42	49		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSEPDGRGGYTF+TCRBV05-X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTCCGGGTCCCTTGAGGACAGCTGAAGCTTTCTTTGGACAA		Out	VDJ	2	32	4.143360265175057E-4		46	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	6	13	0	18	31	-1	44	50		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGATACAGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSDTATGELFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	39	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	3	5	4	1	1	23	37	42	38	43		TCRBV10-01,TCRBV10-02												CASSDTATGELFF+TCRBV10-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCGGGAAGGGGTGGGTAACTATGGCTACACCTTCGGTTCG	CASSREGVGNYGYTF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	45	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	5	5	2	1	5	4	23	35	45	40	49		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSREGVGNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTGGGGACTAGCGGAAACAGATACGCAGTATTTTGGCCCA	CASSEWGLAETDTQYF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	48	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	5	3	1	2	26	42	54	43	56		TCRBV10-01,TCRBV10-02				01,02								CASSEWGLAETDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAAACCAGGGGAAGGGCTACACCTTCGGTTCG	CASSENQGKGYTF	In	VDJ	2	43	5.567640356328983E-4	6.626088296478928E-4	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	8	3	3	23	38	47	41	50		TCRBV06-01,TCRBV06-07,TCRBV06-08												CASSENQGKGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGAGTCTCGGACTAGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSESRTSGGYNEQFF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	51	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	1	2	4	2	1	23	40	55	42	56		TCRBV10-01,TCRBV10-02												CASSESRTSGGYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYRTGTATCKCTGTGCCAGCAGCTTAGAGCGGTTCACAGATACGCAGTATTTTGGCCCA	CASSLERFTDTQYF	In	VDJ	3	49	6.344520406049306E-4	7.550658756452732E-4	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	6	5	2	0	2	19	-1	40	35	42		TCRBV07-05,TCRBV07-06				01,02								CASSLERFTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAGACATCTGTGTACTTSTGTGCCAGCAGTGATGGGCCTATGGGGACTAGCGGGGAGCAATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	62	8.027760513776673E-4		61	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	4	12	6	20	32	57	44	63		TCRBV06-04,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCTTTTCGGGACAGGGGGCGTACTATGGCTACACCTTCGGTTCG	CASSFSGQGAYYGYTF	In	VDJ	5	99	0.0012818520820385333	0.0015255412589567764	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	0	3	6	2	26	37	55	43	57		TCRBV06-07,TCRBV06-08												CASSFSGQGAYYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTGGGGTACTAGACCAGAATGAGCAGTTCTTCGGGCCA	CASSGVLDQNEQFF	In	VDJ	7	129	0.0016702921068986948	0.0019878264889436783	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	8	7	4	5	23	36	45	40	50		TCRBV10-01,TCRBV10-02				01,02								CASSGVLDQNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAAGGTGTTGGCGGGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSEGVGGGAETQYF	In	VDJ	7	134	0.0017350321110420552	0.0020648740272748286	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	0	4	6	1	23	39	54	45	55		TCRBV06-01,TCRBV06-07												CASSEGVGGGAETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCACCAGTGTCCCCACGGGGTCGGCAGATACGCAGTATTTTGGCCCA	CATSVPTGSADTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV22	TCRBV22-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	13	8	3	4	16	4	25	28	49	44	53														CATSVPTGSADTQYF+TCRBV22-01+TCRBJ02-03	TCRBV22-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCAGCAGGGTAGGAGGCGTGAACACTGAAGCTTTCTTTGGACAA	CASRVGGVNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-01	01	13	4	3	0	5	9	25	28	38	33	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVGGVNTEAFF+TCRBV22-01+TCRBJ01-01	TCRBV22-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCGCAGACAGAAACCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	10	1.2948000828672053E-4		44	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	17	3	20	22	36	44	39	64														X+TCRBV07-01+TCRBJ02-07	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGATCCTGTCACAAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLAILSQGSGNTIYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	54	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-03	01	0	3	6	0	9	3	22	39	51	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAILSQGSGNTIYF+TCRBV07-01+TCRBJ01-03	TCRBV07-01*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCACCCCAACCGACCTTTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	33	4.2728402734617773E-4		44	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-06	01	5	2	7	9	11	2	22	34	48	45	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-01+TCRBJ01-06	TCRBV07-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGCTAAGGACAGGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	71	9.193080588357158E-4		47	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	3	5	5	0	22	39	-1	44	52														X+TCRBV07-01+TCRBJ02-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGCTTGGTCGGCGGCAACTCTGGAAACACCATATATTTTGGAGAG	CASSLVGGNSGNTIYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV07	TCRBV07-08		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	7	5	0	5	3	20	34	43	39	46			01,02			01,02								CASSLVGGNSGNTIYF+TCRBV07-08+TCRBJ01-03	TCRBV07-08	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCAGGCCGTCGTGGGGGTACGGCTACACCTTCGGTTCG	CASRPSWGYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV07	TCRBV07-08					TCRBJ01	TCRBJ01-02	01	6	6	1	8	8	3	20	31	44	39	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPSWGYGYTF+TCRBV07-08+TCRBJ01-02	TCRBV07-08		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGCTAGCGGGGGGAACAGATACGCAGTATTTTGGCCCA	CASSESLAGGTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	1	3	1	1	23	40	52	41	53													Vb 12	CASSESLAGGTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGGGGACTAGCGGGGGTTCTTCGTACGAGCAGTACGTCGGGCCG	CASRGTSGGSSYEQYV	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	17	1	20	23	34	49	35	69													Vb 12	CASRGTSGGSSYEQYV+TCRBV10-02+TCRBJ02-07	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCCACAGGGCCCGGGGAGCTGTTTTTTGGAGAA	CASSATGPGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	6	2	1	23	36	44	38	45													Vb 12	CASSATGPGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCATTGGGACCGCCCGAACACTGAAGCTTTCTTTGGACAA	CASHWDRPNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-01	01	8	0	7	1	4	5	23	32	41	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASHWDRPNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCCGAAAAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASRKGVNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	5	2	0	5	0	23	32	-1	37	42													Vb 12	CASRKGVNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACAGGGGGATCAGCCCCAGCATTTTGGTGAT	CASRQGDQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	1	5	0	0	23	-1	-1	34	42													Vb 12	CASRQGDQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGACAGTACCCCCCAAGAGACCCAGTACTTCGGGCCA	CASSEDSTPQETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	5	1	1	6	23	37	43	38	49													Vb 12	CASSEDSTPQETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACAGGGTTGGGGAGACCCAGTACTTCGGGCCA	CASSDRVGETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	3	5	0	5	23	-1	42	37	47													Vb 12	CASSDRVGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGCTCCGGGAGCGGCAATGAGCAGTTCTTCGGGCCA	CASGSGSGNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	8	2	6	5	3	23	32	43	37	46													Vb 12	CASGSGSGNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAACGCACTTAACCCAGGGGTTGAGCAGTTCTTCGGGCCA	CASNALNPGVEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	9	12	1	23	33	51	45	52													Vb 12	CASNALNPGVEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAAGGACAGGGGGACCCGAGCCCCAGCATTTTGGTGAT	CASSERTGGPEPQHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	1	8	2	5	23	37	49	39	54													Vb 12	CASSERTGGPEPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCACCTCACAGGGGGTGAACTATGGCTACACCTTCGGTTCG	CASTSQGVNYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	1	2	4	2	23	33	45	37	47													Vb 12	CASTSQGVNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGACTGGGAGCGAGCGGGGAGCTGTTTTTTGGAGAA	CASRLGASGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	9	2	7	3	4	23	34	42	37	46													Vb 12	CASRLGASGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGAGCGATAGCGGGTGAGCAGTTCTTCGGGCCA	CASSGAIAGEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	5	4	9	6	0	23	36	-1	42	49						01,02							Vb 12	CASSGAIAGEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCATGGGACAGGGGAGTGCTAACTATGGCTACACCTTCGGTTCG	CASMGQGSANYGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	2	0	1	4	23	33	44	34	48													Vb 12	CASMGQGSANYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGGAGTTCTCTAGGGGGGCAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	11	1.4242800911539258E-4		47	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-04	01	5	5	1	0	5	2	23	35	46	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01		TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACCCTAATCAGCCCCAGCATTTTGGTGAT	CASSDPNQPQHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	4	10	4	2	0	23	37	-1	39	41						01,02							Vb 12	CASSDPNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGTTAGGGACAGGGACTCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSRLGTGTRTGELFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	51	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	5	6	6	23	35	50	41	56													Vb 12	CASSRLGTGTRTGELFF+TCRBV10-02+TCRBJ02-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGGGTTCCCAGGGAAACATTCAGTACTTCGGCGCC	CASSESGSQGNIQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	4	3	6	7	0	23	40	-1	47	52													Vb 12	CASSESGSQGNIQYF+TCRBV10-02+TCRBJ02-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATGGCAGGGGGCTTAACACTGAAGCTTTCTTTGGACAA	CASSDGRGLNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	0	2	3	2	23	37	48	40	50													Vb 12	CASSDGRGLNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCGAGATCGGGGAAAACAGGGGCCCTAACAATGAGCAGTTCTTCGGGCCA	CASSEIGENRGPNNEQFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	54	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	2	5	10	5	23	38	55	48	60													Vb 12	CASSEIGENRGPNNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTACGTTTACTGGAAACACCATATATTTTGGAGAG	CASSTFTGNTIYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	5	3	7	2	0	5	23	-1	37	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSTFTGNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGACTGGGGGACTCCAAAGATACGCAGTATTTTGGCCCA	CASSRLGDSKDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	5	7	4	23	35	48	42	52						01,02							Vb 12	CASSRLGDSKDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGCCGCGAAACACCATATATTTTGGAGAG	CASSEPRNTIYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-03	01	2	10	0	5	2	0	23	38	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEPRNTIYF+TCRBV10-02+TCRBJ01-03	TCRBV10-02*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCGTCTAGCGGGGTAAAAGGGACCCAGTACTTCGGGCCA	CASSESSSGVKGTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	7	2	7	23	40	51	42	58													Vb 12	CASSESSSGVKGTQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGAAACGACCGGGACAGGTCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	2.201160140874249E-4		46	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	0	4	3	9	1	23	32	49	41	50													Vb 12	X+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTAAAGGGGCTAGCGGGGAGGCAGAGACCCAGTACTTCGGGCCA	CASSKGASGEAETQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	4	7	4	23	35	51	42	55													Vb 12	CASSKGASGEAETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGGGCGGGGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSEGRGGPDTQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	4	3	2	23	37	49	40	51													Vb 12	CASSEGRGGPDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGACTCCGGGACGGCGGATACGCAGTATTTTGGCCCA	CASSDSGTADTQYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	42	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-03	01	3	0	7	6	4	4	23	37	46	41	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSDSGTADTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTCGGACAGGGGAGATGAACACTGAAGCTTTCTTTGGACAA	CASSRTGEMNTEAFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	2	0	1	3	23	35	45	36	48													Vb 12	CASSRTGEMNTEAFF+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAAGGCGCTAGCGGGGGCCGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSEGASGGRSSYNEQFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	57	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	4	2	0	5	6	23	37	52	42	58													Vb 12	CASSEGASGGRSSYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTTCAGGGCCGATCGAATGAGCAGTTCTTCGGGCCA	CASSEVQGRSNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	7	3	7	23	38	46	41	53													Vb 12	CASSEVQGRSNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGGTCCTAGGAAAAAATCAGCCCCAGCATTTTGGTGAT	CASSEVLGKNQPQHF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	4	8	4	3	5	23	38	45	41	50						01,02							Vb 12	CASSEVLGKNQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCACTCAGGCAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CATQAATNEKLFF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	4	4	0	2	3	23	30	36	32	39													Vb 12	CATQAATNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCGGCCTAGCGGGGGCCGACACAGATACGCAGTATTTTGGCCCA	CASGLAGADTDTQYF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	4	2	2	3	4	23	32	45	35	49													Vb 12	CASGLAGADTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTACGGGACCCCCGGAGTCGAGGAGACCCAGTACTTCGGGCCA	CASSYGTPGVEETQYF	In	VDJ	2	47	6.085560389475865E-4	7.24246860312813E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	5	0	7	5	3	13	23	35	43	38	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSYGTPGVEETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGGCACGGCGGGGGGCCGTGACAGTGAGCAGTTCTTCGGGCCA	CASSGTAGGRDSEQFF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	48	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	1	9	5	9	23	36	49	41	58													Vb 12	CASSGTAGGRDSEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGAACAGGGGGCGAAGCTTTCTTTGGACAA		Out	VDJ	3	54	6.991920447482909E-4		37	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	0	8	1	0	23	38	-1	39	48													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCGAAGAAAGTGGATGAGCAGTTCTTCGGGCCA	CAISESKKVDEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	0	0	10	8	9	0	23	40	-1	49	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISESKKVDEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGAGATACGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSEIRANTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-01	01	2	8	0	1	4	0	24	39	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSEIRANTEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGGGACAGGGGGCCGCACAGATACGCAGTATTTTGGCCCA	CAISGTGGRTDTQYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	0	1	0	1	24	-1	48	37	49													Vb 12	CAISGTGGRTDTQYF+TCRBV10-03+TCRBJ02-03	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCTGAGGGCCACTGAAGCTTTCTTTGGACAA	CAISELRATEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	0	4	2	1	23	38	45	40	46													Vb 12	CAISELRATEAFF+TCRBV10-03+TCRBJ01-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTCCCCCGACAGGGTGGATGGCTACACCTTCGGTTCG	CAISESPDRVDGYTF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	6	4	3	23	40	51	44	54													Vb 12	CAISESPDRVDGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCGATCCAGGGGCGACAATGAGCAGTTCTTCGGGCCA	CAISERSRGDNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	5	5	2	23	38	49	43	51													Vb 12	CAISERSRGDNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCAAAAGGACTAGCGGGGGTGATGAGCAGTTCTTCGGGCCA	CATKRTSGGDEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	1	2	8	6	2	27	34	53	40	55			01,02										Vb 17	CATKRTSGGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCGTCGCGATAACTATGGCTACACCTTCGGTTCG	CASTRRDNYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	7	6	1	6	1	27	37	46	43	47			01,02			01,02							Vb 17	CASTRRDNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACGTAGCGGGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSIRSGGTQETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	1	2	2	27	42	54	44	56			01,02										Vb 17	CASSIRSGGTQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCAGCTACGCCTTGAATGAGCAGTTCTTCGGGCCA	CASSIGSYALNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	4	5	7	3	10	27	41	47	44	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGSYALNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCACAGGGGTTGGCAGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSIHRGWQGGTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	1	2	11	27	41	50	43	61			01,02										Vb 17	CASSIHRGWQGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGTCCGAGGGTCGGCGGCGGGGAGCTGTTTTTGGAGAA	CASSQSEGRRRGAVF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	3	18	17	5	27	39	62	56	67			01,02										Vb 17	CASSQSEGRRRGAVF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTCCTCGTAGATAGCACAGATACGCAGTATTTTGGCCCA	CASSLLVDSTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	5	8	0	7	2	27	39	49	46	51			01,02			01,02							Vb 17	CASSLLVDSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGCGCCGGCGGTCAGGGGTCAGAGACCCAGTACTTCGGGCCA	CASAGGQGSETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	12	4	2	4	13	2	27	32	51	45	53			01,02										Vb 17	CASAGGQGSETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAAACCGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASTPNRDTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	7	8	4	3	8	0	27	37	-1	45	49			01,02			01,02							Vb 17	CASTPNRDTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAAGGCCGGGTCTGATACGCAGTATTTTGGCCCA	CASRKAGSDTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	8	4	6	6	3	27	38	48	44	51			01,02			01,02							Vb 17	CASRKAGSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCAGGAAATGAAAAACTGTTTTTTGGCAGT	CASSIPGNEKLFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	4	5	2	1	27	41	47	43	48			01,02										Vb 17	CASSIPGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTACGGCACCAACACTGAAGCTTTCTTTGGACAA	CASSIYGTNTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	3	9	0	2	4	3	27	41	48	45	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIYGTNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACAGGGGCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGQGLSNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	2	0	0	2	27	-1	48	39	50			01,02										Vb 17	CASSGQGLSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGGACAGGGTTTGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTGFGNTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	1	3	2	1	6	27	36	45	37	51			01,02										Vb 17	CASRTGFGNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTCTACTCTGTGCCAGTAGTACAACTAGCGGGAGTTTTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	7	9.063600580070438E-5		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	21	3	2	7	18	4	37	33	62	51	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAAGATTTACGGGACAATCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIKIYGTISGANVLTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	6	0	9	2	24	39	54	48	56			01,02										Vb 17	CASSIKIYGTISGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCATCGGGGGGGGTGTCACTGAAGCTTTCTTTGGACAA	CASTIGGGVTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	4	4	4	27	37	49	41	53			01,02										Vb 17	CASTIGGGVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGGACAGGGGGCAGGGCGACACTGAAGCTTTCTTTGGACAA	CASRDRGQGDTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	0	3	0	6	27	-1	49	38	55			01,02										Vb 17	CASRDRGQGDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGCCAGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSIVGQGAYNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	2	5	0	27	43	-1	48	55			01,02										Vb 17	CASSIVGQGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAAGTGGGGGATTGTATCAGCCCCAGCATTTTGGTGAT	CASSIGSGGLYQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	6	1	5	7	5	27	41	53	48	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGSGGLYQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCAGACTAGCGGGGATTACAATGAGCAGTTCTTCGGGCCA	CASSQTSGDYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	4	3	2	27	38	52	41	54			01,02										Vb 17	CASSQTSGDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGACCGGGACAGGGGTGGGTGAAGCTTTCTTTGGACAA	CASRTGTGVGEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	2	7	4	4	27	38	52	42	56			01,02										Vb 17	CASRTGTGVGEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCTAACCAAGAGACCCAGTACTTCGGGCCA	CASSIANQETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	1	4	9	0	0	0	27	-1	-1	43	46			01,02			01,02							Vb 17	CASSIANQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTCTCTCGGGACCCAGTACTTCGGGCCA	CASSISLGTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	8	5	7	6	0	27	41	-1	47	50			01,02			01,02							Vb 17	CASSISLGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGTGGCTCTGGAAACACCATATATTTTGGAGAG	CASSMSGSGNTIYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	11	2	0	0	3	27	-1	44	41	47			01,02										Vb 17	CASSMSGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGTGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	9	1.1653200745804848E-4		35	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	0	10	8	4	0	27	41	-1	45	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGCGCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSKRGTGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	7	4	5	3	0	27	40	-1	43	48			01,02			01,02							Vb 17	CASSKRGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGGGACATCAACTGGGACACTGAAGCTTTCTTTGGACAA	CASSIRDINWDTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	6	3	2	9	27	41	49	43	58			01,02										Vb 17	CASSIRDINWDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGTAACCGGGACAGGGGTAAGGACCCAGTACTTCGGGCCA	CASSIVTGTGVRTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	2	7	7	4	27	41	58	48	62			01,02										Vb 17	CASSIVTGTGVRTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCGGGGACTAGCAGGGGGCGCAGATACGCAGTATTTTGGCCCA	CASSIRGLAGGADTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	7	4	3	8	27	41	53	44	61			01,02			01,02							Vb 17	CASSIRGLAGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCGGGGGACAGATTCGGTTCACCCCTCCACTTTGGGAAC	CASSPSGDRFGSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	5	9	7	6	27	39	53	46	59			01,02										Vb 17	CASSPSGDRFGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGGGAGGACCCCTCCACTTTGGGAAC	CASSPGGPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	8	1	12	1	0	27	39	-1	40	47			01,02										Vb 17	CASSPGGPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGACAGAGGGCGTCATGAGCTATGGCTACACCTTCGGTTCG	CASGTEGVMSYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	5	4	0	13	27	-1	43	36	56			01,02										Vb 17	CASGTEGVMSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.2948000828672053E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	24	2	0	4	20	0	37	30	-1	50	64			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACCTCTTTCGGACAGGGACTTGACTACACCTTCGGTTCG	CASRTSFGQGLDYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	10	10	6	27	38	56	48	62			01,02										Vb 17	CASRTSFGQGLDYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTATTGGGAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIVLGSNQPQHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	8	1	4	0	27	43	-1	47	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVLGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTGGGGGCTCCGCTGGTGGGTTCTACACCTTCGGTTCG	CASSIGGGSAGGFYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	6	0	10	4	14	27	41	51	45	65			01,02										Vb 17	CASSIGGGSAGGFYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGTTTAAATGGCTACACCTTCGGTTCG	CASSIGLNGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	8	5	6	0	5	27	-1	44	41	49			01,02			01,02							Vb 17	CASSIGLNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCCGGGCTCCCAGCGGCCCAGTACTTCGGGCCA	CASSIPGLPAAQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	6	5	9	12	0	27	41	-1	53	58			01,02			01,02							Vb 17	CASSIPGLPAAQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTTCGAAGCACAGATACGCAGTATTTTGGCCCA	CASSFRSTDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	6	2	8	0	5	0	27	38	-1	43	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCGGGGTAAACTATGGCTACACCTTCGGTTCG	CASSFGVNYGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	8	3	2	2	2	27	39	46	41	48			01,02										Vb 17	CASSFGVNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGTTTGGTGCCAAAAGAACCCGACAGCTTTTATCTCTGTGCCAGTAGTACAACTAGCGGGAGTTTTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	1.5537600994406463E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	24	3	2	7	21	4	37	30	62	51	66			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGGACAGGGACAACACTGAAGCTTTCTTTGGACAA	CASSMDRDNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	2	3	2	27	38	49	41	51			01,02										Vb 17	CASSMDRDNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCGAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPEGNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	11	0	1	4	0	27	38	-1	42	47			01,02										Vb 17	CASSPEGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGTTTTCTCAGCCCTAGCATTTTGGTGAT	CASSIGFSQP*HF	Stop	VDJ	1	13	1.683240107727367E-4		39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	0	9	14	1	13	27	41	45	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGFSQP*HF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGACACGGGACGACAGCCCCAGCATTTTGGTGAT	CASSPDTGRQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	0	7	7	8	2	27	39	52	47	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPDTGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCTAGACAGGTCCGAGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.8127201160140875E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	4	6	4	9	27	37	47	41	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAATCAAAGGGGGAACACTGAAGCTTTCTTTGGACAA	CASNQRGNTEAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	1	5	0	27	37	-1	42	47			01,02										Vb 17	CASNQRGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGCGGTGACTTCCTACAATGAGCAGTTCTTCGGGCCA	CASRAVTSYNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	6	5	1	0	5	27	-1	43	38	48			01,02			01,02							Vb 17	CASRAVTSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGTTGACAGGGACCAACTATGGCTACACCTTCGGTTCG	CASSLLTGTNYGYTF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	2	6	3	27	38	51	44	54			01,02										Vb 17	CASSLLTGTNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGGACTAGCACGCACAGATACGCAGTATTTTGGCCCA	CASSKGLARTDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	7	1	1	2	27	40	50	41	52			01,02			01,02							Vb 17	CASSKGLARTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCAGGGGGCCGATATGGCTACACCTTCGGTTCG	CASSIPGGRYGYTF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	0	5	1	3	27	42	51	43	54			01,02										Vb 17	CASSIPGGRYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAAGCTGGAAACACCATATATTTTGGAGAG	CASSIEAGNTIYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	0	5	5	2	0	0	27	-1	-1	44	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIEAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAGGACAGAAATAGCTGAAGCTTTCTTTGGACAA	CASRRTEIAEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	6	2	6	27	38	46	40	52			01,02										Vb 17	CASRRTEIAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCCAGGGGAGGAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSPRGGGSGNTIYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	4	2	0	3	6	27	38	47	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPRGGGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGGGCCTCTTCTGGAAACACCATATATTTTGGAGAG	CASSIRGASSGNTIYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	2	5	2	1	2	5	27	42	49	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRGASSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGACAACGACCATATATTTTGGAGAG	CASSIGTTTIYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	6	10	0	3	27	-1	48	43	51			01,02										Vb 17	CASSIGTTTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGTTAGCACTGAAGCTTTCTTTGGACAA	CASSIGVSTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	0	9	4	0	4	27	-1	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCTGGAAACACCATATATTTTGGAGAG	CASSIPGNTIYF	In	VJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	3	0	0	2	0	2	27	-1	41	-1	43			01,02										Vb 17	CASSIPGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGACCCCAAGAGACCCAGTACTTCGGGCCA	CASSIRPQETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	2	7	1	2	1	27	41	46	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRPQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCAGACAGGGATTCCCAGGGCAAGATACGCAGTATTTTGGCCCA	CASSPRQGFPGQDTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	5	4	12	27	39	50	43	62			01,02										Vb 17	CASSPRQGFPGQDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGCCGGGGGGGAGCCTCTGGAAACACCATATATTTTGGAGAG	CASSGRGGASGNTIYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	5	8	0	0	3	3	27	39	50	42	53			01,02										Vb 17	CASSGRGGASGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	2.201160140874249E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	3	1	27	38	55	41	56			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGGACGACGGCTACACCTTCGGTTCG	CASRRDDGYTF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	33	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	0	7	8	2	3	27	38	45	40	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRRDDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTTACAGGGTTCACCCCTCCACTTTGGGAAC	CASRLQGSPLHF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	3	9	3	0	27	38	-1	41	47			01,02										Vb 17	CASRLQGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATTGGACAGGAAATTCACCCCTCCACTTTGGGAAC	CASSIDWTGNSPLHF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	4	7	2	1	27	44	53	46	54			01,02										Vb 17	CASSIDWTGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCTTAATGGCTACACCTTCGGTTCG	CASSIGLNGYTF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	1	4	10	6	2	2	27	43	47	45	49			01,02			01,02							Vb 17	CASSIGLNGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTTGGCCTGGGACAGACCTTAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.3306401491609695E-4		50	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	5	2	8	5	27	39	54	47	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCTTGAATAGGACAGGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.3306401491609695E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	3	0	9	0	27	36	-1	45	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGTTTGGTGCCAAAAGAACCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSMTSGGADTQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	3	0	36	47	-1	50	64			01,02										Vb 17	CASSMTSGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCACAGGTTCCTATGGCTACACCTTCGGTTCG	CASSTGSYGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	4	4	1	3	27	38	44	39	47			01,02										Vb 17	CASSTGSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATATGGAGGGATCGATGGCTACACCTTCGGTTCG	CASSIYGGIDGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	10	0	6	3	4	27	42	51	45	55			01,02										Vb 17	CASSIYGGIDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCGGCAGGGGGCTATGGCTACACCTTCGGTTCG	CASSIAAGGYGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	4	5	0	27	41	-1	46	53			01,02										Vb 17	CASSIAAGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGCCCCCGAACACTGAAGCTTTCTTTGGACAA	CASSGPPNTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	8	0	1	0	4	27	-1	43	39	47			01,02										Vb 17	CASSGPPNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCTACTCGGGGGGGTTCACTGAAGCTTTCTTTGGACAA	CASYSGGFTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	9	8	0	4	5	2	27	35	48	40	50			01,02										Vb 17	CASYSGGFTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGGACACAATAATTCACCCCTCCACTTTGGGAAC	CASTGHNNSPLHF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	0	6	5	1	2	27	37	44	38	46			01,02										Vb 17	CASTGHNNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCGGATTTCCCCTACAATGAGCAGTTCTTCGGGCCA	CASSMADFPYNEQFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	7	5	2	1	6	27	41	46	42	52			01,02			01,02							Vb 17	CASSMADFPYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGCAGGGCTATGGCTACACCTTCGGTTCG	CASSLQGYGYTF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	4	3	0	27	39	-1	42	47			01,02										Vb 17	CASSLQGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCGGACAGGTTGAAGCTTTCTTTGGACAA	CASSSGQVEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	7	3	1	27	39	49	42	50			01,02										Vb 17	CASSSGQVEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATAAACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSNKQMNTEAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	5	0	4	1	27	40	48	44	49			01,02										Vb 17	CASSNKQMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCAGTCAGGGTTGGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	2.7190801740211313E-4		49	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	5	5	6	27	43	53	48	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCAGGAGCACAGATACGCAGTATTTTGGCCCA	CASSPRSTDTQYF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	4	4	0	2	0	27	39	-1	41	45			01,02										Vb 17	CASSPRSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGTGCCAGGGAGCACTGAAGCTTTCTTTGGACAA	CASSSVPGSTEAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	3	4	7	2	27	39	51	46	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSSVPGSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTCAGGGTGGGAGCTAACTATGGCTACACCTTCGGTTCG	CASSFRVGANYGYTF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	4	3	0	2	6	27	39	46	41	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFRVGANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCTTTTCGGCACTGAAGCTTTCTTTGGACAA	CATLFGTEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	10	8	5	4	7	0	27	34	-1	41	44			01,02			01,02							Vb 17	CATLFGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGGAGTACAATGAGCAGTTCTTCGGGCCA	CASTEYNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	10	2	4	1	0	27	37	-1	38	42			01,02										Vb 17	CASTEYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGAACTCTACGAGCAGTACGTCGGGCCG	CASSTELYEQYV	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	4	1	8	17	1	17	27	40	44	41	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTELYEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCGGGACAATGAAGCTTTCTTTGGACAA	CASSIVRDNEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	6	7	3	1	27	43	52	46	53			01,02										Vb 17	CASSIVRDNEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCTAGTAAACCCTCCGCGGTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	22	2.8485601823078515E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	7	5	17	8	16	27	37	49	45	65			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGCAGTAGTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CATRSSSGANVLTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	10	4	5	1	4	4	27	34	41	38	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CATRSSSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGTACAGGGCTGGTAGGGTGGCTACACCTTCGGTTCG		Out	VDJ	1	23	2.9780401905945723E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	2	9	27	38	46	40	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCAACGGGTTCGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSIATGSGTGELFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	8	4	4	3	6	27	43	50	46	56			01,02			01,02							Vb 17	CASSIATGSGTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCATTGAGTGAAAAACTGTTTTTTGGCAGT	CASSPLSEKLFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	7	5	0	27	39	-1	44	47			01,02										Vb 17	CASSPLSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCGTCGGAATCGGACTGAAGCTTTCTTTGGACAA	CASSIDRRNRTEAFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	1	8	5	5	5	27	44	52	49	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDRRNRTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCCGGGGAGCATCAGCCCCAGCATTTTGGTGAT	CASSIPGEHQPQHF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	3	5	3	3	27	41	49	44	52			01,02			01,02							Vb 17	CASSIPGEHQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTGGGTGATTCACCCCTCCACTTTGGGAAC	CASSIVGDSPLHF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	0	9	8	3	2	27	41	47	44	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVGDSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCCTGGGACGGTATCCGGCGATACGCAGTATTTTGGCCCA	CASSAPGTVSGDTQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	0	7	6	6	10	27	39	50	45	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAPGTVSGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGAGGAGAGCGGAGTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	25	3.2370002071680133E-4		49	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	6	5	2	8	3	27	39	52	47	55			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCGGGACAGGGGTCGACTATGGCTACACCTTCGGTTCG	CASSVGTGVDYGYTF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	3	3	3	27	39	52	42	55			01,02										Vb 17	CASSVGTGVDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCCGCGGGGGGGCTGAAGCTTTCTTTGGACAA	CASSRGGAEAFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	8	7	0	6	4	0	27	36	-1	40	49			01,02										Vb 17	CASSRGGAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCAAGGGACACTGAAGCTTTCTTTGGACAA	CASTPRDTEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	5	3	3	5	0	27	37	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACAGGGGAGCATGAAGCTTTCTTTGGACAA	CASSMTGEHEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	7	0	4	27	-1	49	41	53			01,02										Vb 17	CASSMTGEHEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTGGGCGACCCGATATCCTACAATGAGCAGTTCTTCGGGCCA	CASTLGDPISYNEQFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	8	0	1	4	9	27	37	45	41	54			01,02										Vb 17	CASTLGDPISYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCAGGGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	3.4959602237414543E-4		40	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	3	2	0	27	43	-1	45	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGGTTAGGGCCCTACACCTTCGGTTCG	CASSMGLGPYTF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	5	3	10	6	2	27	41	51	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGLGPYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTCTTTAAACACCATATATTTTGGAGAG	CASSISLNTIYF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	3	4	10	6	2	2	27	41	45	43	47			01,02			01,02							Vb 17	CASSISLNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSVGNQPQHF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	0	10	2	2	0	27	39	-1	41	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCCGGGACAGCGAGGGTGCGAGCAGTACGTCGGGCCG	CATPGQRGCEQYV	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	0	5	17	4	19	27	34	45	38	64			01,02										Vb 17	CATPGQRGCEQYV+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGAGGGGTATCTGAAGCTTTCTTTGGACAA	CASSIRGVSEAFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	5	2	6	2	3	27	42	49	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRGVSEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGTTTGGTGCCAAAAGAACCCGACAGTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSMTSGGADTQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	3	0	36	47	-1	50	64			01,02										Vb 17	CASSMTSGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTTCTCAAGGACAGGGGGAGAAGACCCAGTACTTCGGGCCA	CASTSQGQGEKTQYF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	1	6	8	3	27	37	55	45	58			01,02										Vb 17	CASTSQGQGEKTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCCGCTGGGAGGGGTCCTCCTTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	29	3.7549202403148953E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	11	9	0	17	4	24	27	33	44	37	68			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAAGAACCCGACAGCTTTCTATCTCTGTGCGACGACCTGAGATTGAGGGCCTCCCATTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	30	3.884400248601616E-4		56	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	12	11	0	0	14	10	25	30	49	44	59			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCACAGGGGCCCCCACAGATACGCAGTATTTTGGCCCA	CASSITGAPTDTQYF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	2	2	1	4	27	41	49	42	53			01,02										Vb 17	CASSITGAPTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGGCGGGCACAGATACGCAGTATTTTGGCCCA	CASSWAGTDTQYF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	5	8	0	1	1	2	27	39	44	40	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSWAGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGACAGGGGCCTATAATTCACCCCTCCACTTTGGGAAC	CASSPTGAYNSPLHF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	2	2	2	3	0	27	38	-1	41	49			01,02										Vb 17	CASSPTGAYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACTAGCGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASSMTSGGYNEQFF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	2	4	0	1	27	-1	53	41	54			01,02										Vb 17	CASSMTSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGCCTAACTAGCGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASRLTSGGYNEQFF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	3	2	4	6	1	27	36	53	42	54			01,02										Vb 17	CASRLTSGGYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGCTCCTAGCTCTGGCACAGATACGCAGTATTTTGGCCCA	CASKAPSSGTDTQYF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	4	7	1	6	4	27	37	48	43	52			01,02			01,02							Vb 17	CASKAPSSGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTAGACTGGATGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	32	4.143360265175057E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	2	10	6	5	5	27	37	46	42	51			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTGGGGGTAGCAATGAGCAGTTCTTCGGGCCA	CASSLGGSNEQFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	6	6	1	6	4	3	27	38	47	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLGGSNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSIPGANVLTF	In	VJ	2	32	4.143360265175057E-4	4.93104245319362E-4	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	3	0	0	2	0	2	27	-1	41	-1	43			01,02										Vb 17	CASSIPGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATTGACAGGGGGATCACCGGGGAGCTGTTTTTTGGAGAA	CASIDRGITGELFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	1	4	2	2	27	37	48	39	50			01,02										Vb 17	CASIDRGITGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCTCAGTCTGGGGGCGCGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	32	4.143360265175057E-4		50	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	8	6	0	1	9	6	27	36	51	45	57			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCGGGACAGAGAAATGAAAAACTGTTTTTTGGCAGT	CASRPGQRNEKLFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	5	3	3	27	38	48	41	51			01,02										Vb 17	CASRPGQRNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACAGGGCAAGGGGAGACCCAGTACTTCGGGCCA	CASSMTGQGETQYF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	5	3	6	27	38	48	41	54			01,02										Vb 17	CASSMTGQGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSIGQGYSNQPQHF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	2	0	1	2	27	41	51	42	53			01,02										Vb 17	CASSIGQGYSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCGGGACAAGGCACAGATACGCAGTATTTTGGCCCA	CASSIAGQGTDTQYF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	0	6	1	3	2	27	41	50	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIAGQGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAGAAGGGACAGGGGCGGGAAAACTGTTTTTTGGCAGT	CASREGTGAGKLFF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	2	10	4	4	27	38	52	42	56			01,02										Vb 17	CASREGTGAGKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGCAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	35	4.531800290035219E-4		44	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	1	4	3	0	27	38	-1	41	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTCAGGGATAGCAACTATGGCTACACCTTCGGTTCG	CASSVRDSNYGYTF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	2	2	5	27	39	46	41	51			01,02										Vb 17	CASSVRDSNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGATACAGGGGGTGAGAAACACCATATATTTTGGAGAG	CASRIQGVRNTIYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	1	5	0	3	27	-1	49	42	52			01,02										Vb 17	CASRIQGVRNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGGGATGAACACTGAAGCTTTCTTTGGACAA	CASSGMNTEAFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	3	0	0	0	27	-1	-1	38	43			01,02										Vb 17	CASSGMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCCCCGGGGCACCATATATTTTGGAGAG		Out	VDJ	2	37	4.79076030660866E-4		38	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	3	8	3	9	6	0	27	41	-1	47	52			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTAGCGGGGGGTGGCACAGATACGCAGTATTTTGGCCCA	CASSLAGGGTDTQYF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	1	1	0	2	27	-1	50	43	52			01,02										Vb 17	CASSLAGGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCCAGGACAGGAAATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	38	4.920240314895381E-4		41	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	1	4	5	3	2	27	36	46	39	48			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCTAGGCCGGGACAGAAAAATGAAAAACTGTTTTTTGGCAGT	CASRPGQKNEKLFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	0	5	5	8	3	27	33	48	41	51			01,02										Vb 17	CASRPGQKNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGATTGACTAGCGGGGCTTACAATGAGCAGTTCTTCGGGCCA	CASRLTSGAYNEQFF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	2	3	4	3	2	27	38	52	41	54			01,02										Vb 17	CASRLTSGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTCGGGTACAATCAGCCCCAGCATTTTGGTGAT	CASSILGYNQPQHF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	8	4	3	2	2	27	42	48	44	50			01,02			01,02							Vb 17	CASSILGYNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTCTCACAACCTACACCTTCGGTTCG	CASSIGLTTYTF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	3	6	10	5	2	27	43	51	48	53			01,02										Vb 17	CASSIGLTTYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGACAGGGGGTTAATGAGCAGTTCTTCGGGCCA	CASSGQGVNEQFF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	7	0	2	27	-1	49	39	51			01,02										Vb 17	CASSGQGVNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCGATCGGAGTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	43	5.567640356328983E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	2	17	6	16	27	39	49	45	65			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGAGGGAAGGGATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	43	5.567640356328983E-4		40	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	5	1	5	27	39	45	40	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGAGGACAGGGAAAAACATTCAGTACTTCGGCGCC	CASSIRRTGKNIQYF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	1	3	4	4	0	27	42	-1	46	54			01,02										Vb 17	CASSIRRTGKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTTGGACAGGAACACTGAAGCTTTCTTTGGACAA	CASLDRNTEAFF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	5	1	2	0	27	36	-1	38	44			01,02										Vb 17	CASLDRNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGTCAGCTGGAAACACCATATATTTTGGAGAG	CASSTGSAGNTIYF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	2	0	4	27	-1	45	40	49			01,02										Vb 17	CASSTGSAGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGCCGGGACAGGGGTTGAGCAGTTCTTCGGGCCA	CAAGTGVEQFF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	11	0	2	9	3	1	27	33	46	36	47			01,02										Vb 17	CAAGTGVEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTACCAGGGAGAGTTGATCAGCCCCAGCATTTTGGTGAT	CASSVPGRVDQPQHF	In	VDJ	3	49	6.344520406049306E-4	7.550658756452732E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	4	3	5	4	7	27	39	48	43	55			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVPGRVDQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCTGCTGGGCGGGGGGTTAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLLGGGLSNQPQHF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	1	1	7	3	27	39	54	46	57			01,02										Vb 17	CASSLLGGGLSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATTCGCAAGGGCGTGGTGAGCAGTTCTTCGGGCCA	CASSNSQGRGEQFF	In	VDJ	3	52	6.732960430909468E-4	8.012943986439634E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	4	5	3	9	7	5	27	40	51	47	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSNSQGRGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACTAGCGGGGCCTTCGATGAGCAGTTCTTCGGGCCA	CASSMTSGAFDEQFF	In	VDJ	3	53	6.862440439196188E-4	8.167039063101933E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	2	3	8	0	6	27	-1	52	41	58			01,02										Vb 17	CASSMTSGAFDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAAGGGAAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSIREVYNEQFF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	0	8	3	1	3	27	42	47	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIREVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGATGACAGGGGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	57	7.38036047234307E-4		35	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	2	2	7	2	2	27	35	45	37	47			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTTCAGGGGCGTCTAATGAAAAACTGTTTTTTGGCAGT	CATSGASNEKLFF	In	VDJ	3	58	7.509840480629791E-4	8.937514446413437E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	10	4	2	3	3	3	27	34	43	37	46			01,02										Vb 17	CATSGASNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGCCGGACAGTGAATGAAAAACTGTTTTTTGGCAGT	CASGRTVNEKLFF	In	VDJ	3	60	7.768800497203232E-4	9.245704599738038E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	5	5	4	2	27	36	46	40	48			01,02										Vb 17	CASGRTVNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACTGAGGACAGAGGGAATTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASRLRTEGIATNEKLFF	In	VDJ	3	62	8.027760513776673E-4	9.553894753062639E-4	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	5	0	5	9	27	38	49	43	58			01,02										Vb 17	CASRLRTEGIATNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACCCACGGACGGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	68	8.804640563496996E-4		44	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	2	1	7	4	5	2	27	42	51	47	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTGGACTAGGGGTAATGAGCAGTTCTTCGGGCCA	CASSWTRGNEQFF	In	VDJ	4	72	9.322560596643878E-4	0.0011094845519685646	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	8	7	1	4	27	39	47	40	51			01,02			01,02							Vb 17	CASSWTRGNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACAGGGCCTTGGCTACACCTTCGGTTCG	CASRQGLGYTF	In	VDJ	5	94	0.001217112077895173	0.001448493720625626	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	7	0	3	27	-1	44	38	47			01,02										Vb 17	CASRQGLGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACAGGCGGAGGGTTAAACATTCAGTACTTCGGCGCC	CASSIGTGGGLNIQYF	In	VDJ	5	106	0.0013724880878392377	0.0016334078126203867	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	4	6	1	9	27	41	50	42	59			01,02										Vb 17	CASSIGTGGGLNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGAGGAGAACAGCCCCAGCATTTTGGTGAT	CASSIGGEQPQHF	In	VDJ	6	109	0.0014113320903252537	0.001679636335619077	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	1	10	2	7	2	2	27	43	49	45	51			01,02										Vb 17	CASSIGGEQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCGCCCCCAAGAGACCCAGTACTTCGGGCCA	CASSIRPQETQYF	In	VDJ	6	111	0.0014372280919825978	0.0017104553509515372	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	10	0	1	2	2	27	41	45	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIRPQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACCCCTTGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASNPLTGNTEAFF	In	VDJ	6	120	0.0015537600994406464	0.0018491409199476077	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	4	1	7	0	27	37	-1	44	50			01,02										Vb 17	CASNPLTGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCACTCGGGGGCTACACCTTCGGTTCG	CASSISLGGYTF	In	VDJ	6	125	0.0016185001035840065	0.001926188458278758	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	8	4	8	5	0	27	42	-1	47	51			01,02			01,02							Vb 17	CASSISLGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGGTCGGCAGGGACACTGAAGCTTTCTTTGGACAA	CASSIGVGRDTEAFF	In	VDJ	7	138	0.0017868241143567433	0.002126512057939749	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	3	9	0	27	41	-1	50	55			01,02										Vb 17	CASSIGVGRDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCGCGGGGGCAGACAAAAACATTCAGTACTTCGGCGCC	CATAGADKNIQYF	In	VDJ	7	144	0.0018645121193287756	0.002218969103937129	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	10	7	2	3	2	4	27	34	43	36	47			01,02										Vb 17	CATAGADKNIQYF+TCRBV19-01+TCRBJ02-04	TCRBV19-01	TCRBD02-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGACAGGGAAAAACTGTTTTTTGGCAGT	CASSIDREKLFF	In	VDJ	8	163	0.0021105241350735447	0.0025117497495955004	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	4	8	1	0	27	41	-1	42	48			01,02										Vb 17	CASSIDREKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGACCCCGGGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDPGVSYNEQFF	In	VDJ	8	163	0.0021105241350735447	0.0025117497495955004	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	0	5	1	27	39	49	44	50			01,02										Vb 17	CASSDPGVSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGTCCGACGGGGACCTATGGCTACACCTTCGGTTCG	CASSISPTGTYGYTF	In	VDJ	9	167	0.002162316138388233	0.002573387780260421	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	3	0	7	4	10	0	27	41	-1	51	56			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSISPTGTYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTCGTTGGGGACCCAGTACTTCGGGCCA	CASSMSLGTQYF	In	VDJ	9	170	0.002201160140874249	0.002619616303259111	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	3	0	9	7	6	0	27	41	-1	47	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMSLGTQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGTTTTCTCAGCCCCAGCATTTTGGTGAT	CASSIGFSQPQHF	In	VDJ	9	171	0.002214108141702921	0.002635025810925341	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	3	0	9	6	1	5	27	41	45	42	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGFSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCAGGACAGCCTACCTATGAACACTGAAGCTTTCTTTGGACAA	CASQDSLPMNTEAFF	In	VDJ	9	175	0.0022659001450176094	0.002696663841590261	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	1	5	0	2	8	27	36	44	38	52			01,02										Vb 17	CASQDSLPMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCAGTCCGAGGGTCGGCGGCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	12	227	0.002939196188108556		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	11	0	7	6	7	27	39	50	45	57			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGACTCTCACAGCAGTTCTTCGGGCCA	CASSMGLSQQFF	In	VDJ	16	317	0.0041045162626890406	0.004884813930194931	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	0	10	11	0	5	27	-1	47	41	52			01,02			01,02							Vb 17	CASSMGLSQQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAACCCGTACTGGAAACACCATATATTTTGGAGAG	CASRTRTGNTIYF	In	VDJ	17	337	0.004363476279262482	0.005193004083519532	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-03	01	6	3	7	2	1	5	27	38	41	39	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRTRTGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCTACGGGGGGACCATGAACACTGAAGCTTTCTTTGGACAA	CASSIYGGTMNTEAFF	In	VDJ	18	348	0.004505904288377874	0.005362508667848063	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	0	3	4	27	41	51	44	55			01,02										Vb 17	CASSIYGGTMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACTAGCGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSITSGGSTDTQYF	In	VDJ	19	363	0.004700124300807955	0.005593651282841513	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	2	0	0	1	27	-1	53	42	54			01,02										Vb 17	CASSITSGGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGACTGAATGAGCAGTTCTTCGGGCCA	CASSIGLNEQFF	In	VDJ	19	365	0.004726020302465299	0.005624470298173974	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	10	7	0	1	27	-1	47	43	48			01,02			01,02							Vb 17	CASSIGLNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGGGACAGGGCGAGGAGCTTTCTTTGGACAA	CASSIGTGRGAFF	In	VDJ	50	979	0.01267609281126994	0.015085908005239233	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	10	1	5	27	41	51	42	56			01,02										Vb 17	CASSIGTGRGAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAGGGGTTGCTCAGCCCCAGCATTTTGGTGAT	CASSVGVAQPQHF	In	VDJ	58	1133	0.014670084938885436	0.017458972185838664	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	9	6	0	4	27	-1	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSVGVAQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAACTAGCGGGAGTTTTAATGAGCAGTTCTTCGGGCCA	CASSTTSGSFNEQFF	In	VDJ	67	1300	0.01683240107727367	0.020032359966099082	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	3	2	7	2	4	27	40	53	42	57			01,02										Vb 17	CASSTTSGSFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATGACTAGCGGGGGGGCAGATACGCAGTATTTTGGCCCA	CASSMTSGGADTQYF	In	VDJ	185	3602	0.046638698984876735	0.05550504661376069	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	4	3	0	27	38	-1	41	55			01,02										Vb 17	CASSMTSGGADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGATCCACGAGGGCGGGAAGATGAAAAACTGTTTTTTGGCAGT	CASSDPRGREDEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	3	7	3	6	9	2	23	37	52	46	54													Vb 11	CASSDPRGREDEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCATGTCAGGGGGCGCGGGAACTGAAGCTTTCTTTGGACAA	CASMSGGAGTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	0	5	3	6	23	33	44	36	50													Vb 11	CASMSGGAGTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGGAGGGGGGCGGAAGCACTGAAGCTTTCTTTGGACAA	CASSEWEGGGSTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	9	0	4	0	9	23	-1	46	39	55													Vb 11	CASSEWEGGGSTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACAGGGCCACTGAAGCTTTCTTTGGACAA	CASSDRATEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	4	0	1	23	-1	42	37	43													Vb 11	CASSDRATEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACCCGGGAGCCCCGGGGAGCTGTTTTTTGGAGAA	CASSEPGSPGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	2	6	2	2	23	38	46	40	48													Vb 11	CASSEPGSPGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAGGAGGGGTTTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSEEGFYTGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	0	3	0	5	23	-1	43	37	48													Vb 11	CASSEEGFYTGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATAGTGTGTTTACCAACGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.2948000828672053E-4		50	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	0	3	7	1	8	4	23	40	50	48	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	X+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCGGAAGGAATCCTAGCTTTCTTTGGACAA	CASSESEGILAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	1	8	10	1	9	23	39	43	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESEGILAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATATGACAGGGAAAGGGCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	11	1.4242800911539258E-4		47	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	3	7	1	7	23	40	48	41	55													Vb 11	X+TCRBV25-01+TCRBJ01-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATCCTGGGATACAACTGAAGCTTTCTTTGGACAA	CASSESWDTTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-01	01	1	0	8	5	3	4	23	39	46	42	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSESWDTTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGGCAGGGAATTTTTTTCGGCTTTCTTTGGACAA	CASSGREFFSAFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	11	1	11	23	36	42	37	53													Vb 11	CASSGREFFSAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAACGAAGGGGTTCAAGAGACCCAGTACTTCGGGCCA	CASNEGVQETQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	5	2	2	4	2	23	33	42	37	44													Vb 11	CASNEGVQETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGCGGGGCTTTCAGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGAFRTGANVLTF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	48	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-06	01	6	7	0	2	1	8	23	34	40	35	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSGAFRTGANVLTF+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGCACCAACGACGGGTGGTTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	26	3.366480215454734E-4		53	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	8	4	0	9	5	23	36	49	45	54						01,02							Vb 11	X+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD02-01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASGGSTDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	9	1	0	0	0	23	-1	-1	32	38													Vb 11	CASGGSTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGTCAGCAAATGGGAGGGACTCACAGATACGCAGTATTTTGGCCCA	CVSKWEGLTDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	42	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	9	0	2	3	3	23	33	43	36	46													Vb 11	CVSKWEGLTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCGACAGACTTTGGCGGAGCTTTCTTTGGACAA	CASSPTDFGGAFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	5	10	2	10	23	35	42	37	52													Vb 11	CASSPTDFGGAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCCTCCTTTGTACCGGGCGGGACAGGGGAATACAATGAGCAGTTCTTCGGGCCA	CASSPSFVPGGTGEYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	60	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	4	17	2	21	34	61	51	63													Vb 7.1	CASSPSFVPGGTGEYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGTTAGCGGGCGGGTTACAATGAGCAGTTCTTCGGGCCA	CASSQG*RAGYNEQFF	Stop	VDJ	1	7	9.063600580070438E-5		48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	5	4	4	2	5	23	39	48	41	53						01,02							Vb 7.1	CASSQG*RAGYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCGGATATGACAGGGTGGTTGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSGYDRVVGSGANVLTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	57	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	3	1	6	8	23	35	48	41	56													Vb 7.1	CASSGYDRVVGSGANVLTF+TCRBV04-01+TCRBJ02-06	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCATGGAAGAAGGCCGGGAGTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	9	1.1653200745804848E-4		53	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	8	2	2	11	1	23	37	54	48	55													Vb 7.1	X+TCRBV04-01+TCRBJ02-02	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGCCGACTGGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	9	1.1653200745804848E-4		41	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	2	10	17	3	19	23	36	43	39	62						01,02							Vb 7.1	X+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGCGAGACAGGGCTATCAGCCCCAGCATTTTGGTGAT	CASSQDARQGYQPQHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	3	5	5	2	23	40	52	45	54													Vb 7.1	CASSQDARQGYQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCAGGTCGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQGRSSYNEQFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	4	1	1	3	23	39	44	40	47													Vb 7.1	CASSQGRSSYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAAGGACTGTGTACAATGAGCAGTTCTTCGGGCCA	CASSQRTVYNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	10	4	1	3	23	38	44	39	47						01,02							Vb 7.1	CASSQRTVYNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCTGGGACAGTTTGAAAAACTGTTTTTTGGCAGT	CASSLGQFEKLFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	7	1	2	23	36	44	37	46													Vb 7.1	CASSLGQFEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGATCTAGTTAGCGGGGGAGATAATGAGCAGTTCTTCGGGCCA	XASSQDLVSGGDNEQFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	5	2	7	6	4	22	39	54	45	58													Vb 7.1	XASSQDLVSGGDNEQFF+TCRBV04-01+TCRBJ02-01	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGCAGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQGRGNQPQHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	2	1	0	23	39	-1	40	45													Vb 7.1	CASSQGRGNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATCCTAGCGGGGTACAAGAGACCCAGTACTTCGGGCCA	CASSQDPSGVQETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	4	3	2	2	2	23	40	51	42	53													Vb 7.1	CASSQDPSGVQETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAAAGGGCGGACTTGCTTAAATGGGCCA		Out	VDJ	1	16	2.0716801325875285E-4		37	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01		TCRBJ02			0	1	10	22	6	9	23	40	51	46	60						01,02		TCRBJ02-01,TCRBJ02-05					Vb 7.1	X+TCRBV04-01+TCRBJ02-X	TCRBV04-01*01	TCRBD02-01	TCRBJ02	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATGGCTGGGCAACTAACTATGGCTACACCTTCGGTTCG	CASSQDGWATNYGYTF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	8	0	0	5	2	23	40	49	45	51													Vb 7.1	CASSQDGWATNYGYTF+TCRBV04-01+TCRBJ01-02	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGGGACAGCCCGAAACACCATATATTTTGGAGAG	YASSQGTARNTIYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	42	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	5	5	0	3	22	-1	44	38	47													Vb 7.1	YASSQGTARNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAATATCAGGCAAACACTGAAGCTTTCTTTGGACAA	CASSQEYQANTEAFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	2	4	2	23	40	48	44	50													Vb 7.1	CASSQEYQANTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCACCGGGACCACCCTCAATGAGCAGTTCTTCGGGCCA	CASSTGTTLNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV06	TCRBV06-09	01				TCRBJ02	TCRBJ02-01	01	6	0	7	6	4	6	26	37	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSTGTTLNEQFF+TCRBV06-09+TCRBJ02-01	TCRBV06-09*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCGCCGGGACAGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSAGTGSYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	4	0	4	0	26	37	-1	41	49													Vb 13.1	CASSAGTGSYNEQFF+TCRBV06-09+TCRBJ02-01	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGTTCCAGGTTTGGGGAGACCCAGTACTTCGGGCCA	CASSSRFGETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV06	TCRBV06-09	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	4	4	5	1	6	26	39	44	40	50													Vb 13.1	CASSSRFGETQYF+TCRBV06-09+TCRBJ02-05	TCRBV06-09*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAACCATACTCCGCCGCCGATTGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		41	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-07	01	10	4	5	17	25	4	26	33	61	58	65			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGGGTCGACGGAGGTTTGCATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	8	1.0358400662937643E-4		46	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	1	8	7	5	26	41	53	48	58			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGGGGGACTAGCGGGGGTCGATGAGCAGTTCTTCGGGCCA	CASSGGLAGVDEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	2	8	1	3	26	39	54	40	57			01,02										Vb 12	CASSGGLAGVDEQFF+TCRBV10-01+TCRBJ02-01	TCRBV10-01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAGTCGGCAGCGAACACTGAAGCTTTCTTTGGACAA	CASSESAANTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-01	01	0	4	5	1	2	1	26	43	48	45	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESAANTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCTGGGGGGCTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	9	1.1653200745804848E-4		35	TCRBV10	TCRBV10-01					TCRBJ01	TCRBJ01-02	01	8	6	0	4	2	2	26	35	43	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ01-02	TCRBV10-01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCGGACAGCTTTCTGGAAACACCATATATTTTGGAGAG	CASSGQLSGNTIYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	1	1	3	26	37	44	38	47			01,02										Vb 12	CASSGQLSGNTIYF+TCRBV10-01+TCRBJ01-03	TCRBV10-01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGTGAAAGACAGGACGGGAACACTGAAGCTTTCTTTGGACAA	CASSERQDGNTEAFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	1	2	4	26	40	48	42	52			01,02										Vb 12	CASSERQDGNTEAFF+TCRBV10-01+TCRBJ01-01	TCRBV10-01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGACCAGGGGGTCAGGGTGGTTAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	2.7190801740211313E-4		52	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	1	0	2	10	26	37	46	39	56			01,02										Vb 12	X+TCRBV10-01+TCRBJ01-05	TCRBV10-01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTATATTTCTGCGCCAGCCTCCCCGTCTCAACGTTCCAGGGGGCATAAGTTGGGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	23	2.9780401905945723E-4		62	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	0	6	18	10	10	19	45	37	55			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGGGAGGGAGGGAACGACCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	31	4.0138802568883363E-4		46	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	10	0	1	0	6	26	-1	47	41	53			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-05	TCRBV10-01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTAACCCGTACCGGGGGTTACCCACCTTCAATACGAGCAGTACGTCGGGCCG		Out	VDJ	1	6	7.768800497203231E-5		58	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	2	17	9	27	22	36	51	45	78														X+TCRBV12-01+TCRBJ02-07	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGTCTCGGGACAGGGGGCTATGAAAAACTGTTTTTTGGCAGT	CATSLGTGGYEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	0	6	4	1	18	29	45	33	46														CATSLGTGGYEKLFF+TCRBV15-01+TCRBJ01-04	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGTGGGCCCACTGAAGCTTTCTTTGGACAA	CATSRDRGPTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	8	0	4	4	1	18	35	43	39	44														CATSRDRGPTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGAGGGCCCTAACTATGGCTACACCTTCGGTTCG	CATSREGPNYGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	10	0	0	0	2	18	-1	38	32	40														CATSREGPNYGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAAACTGGGACAGGGGGCGTACAATGAGCAGTTCTTCGGGCCA	CATSKLGQGAYNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	0	4	4	1	18	31	47	35	48														CATSKLGQGAYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCGCTCGGAGAGGGATCAGCCCCAGCATTTTGGTGAT	CATSRSERDQPQHF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	11	0	5	8	0	18	30	-1	38	43														CATSRSERDQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGGAAACAAGTGTGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	3.4959602237414543E-4		55	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-06	01	5	0	8	5	1	18	18	30	35	31	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV15-01+TCRBJ02-06	TCRBV15-01*01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCTAGGTGGGGCTAACACCGGGGAGCTGTTTTTTGGAGAA	CATSRDLGGANTGELFF	In	VDJ	3	53	6.862440439196188E-4	8.167039063101933E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	7	0	2	7	1	18	35	47	42	48														CATSRDLGGANTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGGCCCGGGCGGATCTAGCACAGATACGCAGTATTTTGGCCCA	CATSRGPGGSSTDTQYF	In	VDJ	4	79	0.0010228920654650922	0.001217351105632175	51	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	8	0	0	4	6	18	34	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRGPGGSSTDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATAGGTCTTGAGGTGAACCCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	122	0.0015796561010979905		56	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	1	1	10	6	18	35	49	45	55														X+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATTGGACAGGGTCGGGCGGGGAGCTGTTTTTTGGAGAA	CATSRDWTGSGGELFF	In	VDJ	9	181	0.0023435881499896415	0.0027891208875876414	48	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	7	2	5	18	35	45	37	50														CATSRDWTGSGGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGCACAGGGACACCATATATTTTGGAGAG	CASSLGHRDTIYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	3	3	8	3	0	18	34	-1	37	43														CASSLGHRDTIYF+TCRBV07-02+TCRBJ01-03	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCGAGGGACCCCCAGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSEGPPGTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-02	01	5	0	7	5	2	8	18	30	37	32	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEGPPGTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCAGGACTAGCGGGGGGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.2948000828672053E-4		50	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	1	3	0	18	31	-1	34	48														X+TCRBV07-02+TCRBJ02-03	TCRBV07-02*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCGGGACGGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTGYTGELFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV07	TCRBV07-02	01				TCRBJ02	TCRBJ02-02	01	4	0	7	3	2	5	18	31	38	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSGTGYTGELFF+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCTACGGCGACCGTTCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	16	2.0716801325875285E-4		44	TCRBV07	TCRBV07-02	01				TCRBJ01	TCRBJ01-02	01	4	2	7	4	8	4	18	31	42	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGGGACAGCCGTCGAAGCTTTCTTTGGACAA	CASSLGTAVEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	5	8	0	5	18	-1	40	34	45														CASSLGTAVEAFF+TCRBV07-02+TCRBJ01-01	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGCGTAGGTTGGACAAGTCCCGGGTAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLA*VGQVPGNSNQPQHF	Stop	VDJ	3	50	6.474000414336027E-4		63	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	6	0	7	12	18	35	47	42	59														CASSLA*VGQVPGNSNQPQHF+TCRBV07-02+TCRBJ01-05	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGATACAGGGGAGAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	6	7.768800497203231E-5		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	2	1	4	2	18	30	41	34	43														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTAGGGACAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	6	7.768800497203231E-5		41	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-04	01	4	0	7	0	1	0	18	31	-1	32	37				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01		TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCCCGGGGACAGAGAAACAATGAGCAGTTCTTCGGGCCA	CASSSPRGQRNNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	5	5	7	4	18	31	45	38	49														CASSSPRGQRNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGACAGGGGAACGCAGATACGCAGTATTTTGGCCCA	CASSLGQGNADTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	2	2	4	0	4	18	-1	42	34	46														CASSLGQGNADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCCTCAGGGGGCGGACCTGAATCGGAGCAGTACGTCGGGCCG		Out	VDJ	1	6	7.768800497203231E-5		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	4	0	17	2	22	18	27	37	29	59														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCCTCGTGGGACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLLVGLAGYNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	4	8	0	18	30	-1	38	51														CASSLLVGLAGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTGATGGGACAGGGGACACTGAAGCTTTCTTTGGACAA	CASSLDGTGDTEAFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	3	6	0	18	30	-1	36	46														CASSLDGTGDTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAACCGGGACCGGGGAAACACCATATATTTTGGAGAG	CASSGNRDRGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	7	4	7	3	18	30	42	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGNRDRGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGGAGACAGGGCAGAATGAGCAGTTCTTCGGGCCA	CASSWETGQNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	3	7	4	3	18	31	42	35	45														CASSWETGQNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAACTAGCGGGGGCCCACAATGAGCAGTTCTTCGGGCCA	CASSLELAGAHNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	5	0	3	18	-1	46	35	49														CASSLELAGAHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCACGGGCAGGGGGGGGAGAGACCCAGTACTTCGGGCCA	CASSPRAGGGETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	4	1	4	7	3	18	30	44	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRAGGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTTCACAGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLHRAGANVLTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	3	2	4	0	18	30	-1	34	40														CASSLHRAGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGACCCGGGACAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	8	1.0358400662937643E-4		44	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	2	5	0	18	30	-1	35	41														X+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCAACATGAGGCAGATTTAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	8	1.0358400662937643E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	4	11	1	3	7	8	18	31	42	38	50														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGATAATCTGTCAGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLDNLSGYTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	3	3	11	1	18	32	48	43	49														CASSLDNLSGYTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCCTTCCGGAGGGGGGTATTTCTACAATGAGCAGTTCTTCGGGCCA	CASNPSGGGYFYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	7	5	1	3	10	6	18	28	44	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPSGGGYFYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAACGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSKTGLAKNIQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	0	10	0	5	0	18	30	-1	35	41						01,02								CASSKTGLAKNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGGGAAAGGAGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPGGKGATNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	0	1	8	18	30	38	31	46														CASSPGGKGATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATGGACAGTGAACACTGAAGCTTTCTTTGGACAA	CASSSWTVNTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	0	3	0	18	31	-1	34	40														CASSSWTVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGACGGAGCGGGGGGCAGCACAGATACGCAGTATTTTGGCCCA	CASSSDGAGGSTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	6	1	0	7	1	18	31	47	38	48														CASSSDGAGGSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGCACAACTAGCCCCGGGGAGCTGTTTTTTGGAGAA	CASSLSTTSPGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	3	7	6	6	1	18	33	45	39	46						01,02								CASSLSTTSPGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCACGGGACAGCGTTGTCCATGGCTACACCTTCGGTTCG	CASSPRDSVVHGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	5	6	4	8	18	30	41	34	49														CASSPRDSVVHGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCTTATGATGGGGGGCCGAGAGACCCAGTACTTCGGGCCA	CASSLMMGGRETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	6	0	4	9	2	18	30	45	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMMGGRETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGTAAGAGGACAGCCTTAGTTAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	1.2948000828672053E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	5	4	6	8	18	30	42	36	50														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCAGGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSSRVSGNTIYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	0	1	1	18	31	37	32	38														CASSSRVSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGCAAACCGCTATGCGAGGCTACACCTTCGGTTCG	CASSLGQTAMRGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	1	9	0	8	0	14	18	-1	37	34	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGQTAMRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGCAAACTCTGGAAACACCATATATTTTGGAGAG	CASSSANSGNTIYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	4	4	6	0	3	2	18	31	36	34	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSANSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACATCCTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLHPSNQPQHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	6	0	0	3	18	-1	35	33	38														CASSLHPSNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCGAAGGAGTAGCGCGGGACAAGAGACCCAGTACTTCGGGCCA	CASSPRRSSAGQETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	7	3	2	15	0	18	30	-1	45	51														CASSPRRSSAGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAAGGACAGGGTTTGACGAGCAGTACGTCGGGCCG	CASSLRTGFDEQYV	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	3	17	1	16	18	33	42	34	58														CASSLRTGFDEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCGGGGGTTCAGGAAACACCATATATTTTGGAGAG	CASSLVGGSGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	8	2	4	1	4	18	34	41	35	45														CASSLVGGSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGTTGTTAGTTACCAACAATGAGCAGTTCTTCGGGCCA	CASSLELLVTNNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	2	5	0	13	18	-1	36	32	49														CASSLELLVTNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTTTAGGGTGGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSFLGWSQETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	5	3	1	3	5	18	32	39	35	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLGWSQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGTCCCCGGGGGCGGGGGCTACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	12	1.5537600994406463E-4		49	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	2	2	9	3	18	29	45	38	48														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAAAGGACAGGGGGGAGATACGCAGTATTTTGGCCCA	CASSKGQGGDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	1	5	3	1	18	30	43	33	44														CASSKGQGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTGGGGGACTAGCGAACCTCCCGAGACCCAGTACTTCGGGCCA	CASSSWGTSEPPETQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	6	5	5	8	18	31	46	36	54						01,02								CASSSWGTSEPPETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTAAGAAATGGGCCCAAGTAGGTGGGGAGACCCAGTACTTCGGGCCA	CASSKKWAQVGGETQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	5	8	13	18	29	41	37	54														CASSKKWAQVGGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGGGGACAGGGCTTCACCTCCTTCACAGATACGCAGTATTTTGGCCCA	CASGGQGFTSFTDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	0	3	2	2	12	18	27	38	29	50														CASGGQGFTSFTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGACCCCTCCGTTCTTAATTCACCCCTCCACTTTGGGAAC	CASSDPSVLNSPLHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	5	2	7	6	0	11	18	-1	33	30	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPSVLNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTGGCTAGCGGGGGGCAAGGAGACCCAGTACTTCGGGCCA	CASSWLAGGKETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	1	5	2	4	18	31	44	33	48														CASSWLAGGKETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAAGCAGGGGCCTATGGCTACACCTTCGGTTCG	CASSLEAGAYGYTF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	4	2	1	18	35	43	37	44														CASSLEAGAYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGGGGACAGAAAGGAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGTERSTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	5	4	3	7	18	30	40	33	47														CASSQGTERSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGTCTACCCGTAAGACAGGGCGTTGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	16	2.0716801325875285E-4		50	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	6	11	5	18	29	47	40	52														X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAACCGGTTGGCAGAAGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	2.4601201574476903E-4		41	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-02	01	7	5	3	6	13	0	18	28	-1	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATACTCCAGGGAAGAGACCCAGTACTTCGGGCCA	CASSLYSREETQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	3	3	5	0	18	33	-1	38	43														CASSLYSREETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGGACAGGGGGGATCACCCCTCCACTTTGGGAAC	CASSLQGQGGSPLHF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	0	1	10	2	2	18	33	46	35	48														CASSLQGQGGSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATGGGGGGTACAATCAGCCCCAGCATTTTGGTGAT	CASSLDGGYNQPQHF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	0	9	1	3	1	2	18	35	42	36	44														CASSLDGGYNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTACAGGCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLQATNEKLFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	4	2	2	2	18	30	37	32	39														CASSLQATNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCTAGGGGGGGGCGGTAATTCACCCCTCCACTTTGGGAAC	CASSSLGGGGNSPLHF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	4	9	0	6	5	4	18	31	43	36	47														CASSSLGGGGNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGACAGGGGGAAATCAGCCCCAGCATTTTGGTGAT	CASSLQTGGNQPQHF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	1	4	2	1	18	33	44	35	45														CASSLQTGGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGACCGGGGGTACAGATACGCAGTATTTTGGCCCA	CASSLTGGTDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	2	3	3	1	18	32	41	35	42														CASSLTGGTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAACTAGCGGGGGGGCGAGATACGCAGTATTTTGGCCCA	CASSLELAGGRDTQYF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	3	0	5	3	2	18	32	48	35	50														CASSLELAGGRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCGGGACAGGGCGCAGATACGCAGTATTTTGGCCCA	CASSPGQGADTQYF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	4	2	2	18	30	41	32	43														CASSPGQGADTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGTTACTAGCGGCGGAGATACGCAGTATTTTGGCCCA	CASSVTSGGDTQYF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	3	5	5	3	3	18	30	41	33	44						01,02								CASSVTSGGDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCACAGGGGGCTGACACCTACGAGCAGTACGTCGGGCCG	CASSAQGADTYEQYV	In	VDJ	3	58	7.509840480629791E-4	8.937514446413437E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	0	17	2	20	18	30	41	32	61														CASSAQGADTYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCAATACAGGGGCATTGGGCTATGGCTACACCTTCGGTTCG	CASSNTGALGYGYTF	In	VDJ	4	77	9.969960638077481E-4	0.0011865320902997149	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	4	3	7	18	30	40	33	47														CASSNTGALGYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCAACAGATTAGTCTCAAATTCACCCCTCCACTTTGGGAAC	CASSLANRLVSNSPLHF	In	VDJ	4	80	0.0010358400662937642	0.0012327606132984052	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	5	7	5	10	18	32	41	37	51														CASSLANRLVSNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTCCAGCGGGGGGTCTTATCGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	5	89	0.0011523720737518126		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	6	1	7	4	8	18	34	47	38	55														X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCTTGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSLSWENTEAFF	In	VDJ	5	97	0.0012559560803811892	0.0014947222436243162	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	2	0	8	1	4	0	18	33	-1	37	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSWENTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTAGCGGGGGCGAAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	99	0.0012818520820385333		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	2	5	0	5	18	-1	41	31	46														X+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTTGGGGATTTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLGLGISSTDTQYF	In	VDJ	6	119	0.0015408120986119744	0.0018337314122813776	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	1	0	8	0	5	5	18	34	43	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLGISSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGACAGGACAGCAGCAGCAGCCCCAGCATTTTGGTGAT	CASSRTGQQQQPQHF	In	VDJ	8	159	0.0020587321317588566	0.00245011171893058	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	1	4	7	1	10	18	30	38	31	48														CASSRTGQQQQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAAGCGGGGGTGTCAGAGACCCAGTACTTCGGGCCA	CASSLEAGVSETQYF	In	VDJ	13	244	0.003159312202195981	0.0037599198705601357	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	6	2	4	3	4	18	32	43	35	47														CASSLEAGVSETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGAACAGGGTGTGGAAGAGACCCAGTACTTCGGGCCA	CASSSEQGVEETQYF	In	VDJ	18	354	0.004583592293349907	0.005454965713845443	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	3	3	4	5	18	31	41	35	46														CASSSEQGVEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTAGGTATTTTGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLGILDTGELFF	In	VDJ	19	361	0.004674228299150611	0.005562832267509053	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	4	8	3	0	9	18	-1	37	33	46						01,02								CASSLLGILDTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGGCATGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGTGMSNTGELFF	In	VDJ	24	477	0.006176196395276569	0.0073503351567917406	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	0	2	5	18	31	41	33	46														CASSSGTGMSNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGACAGGGGGCTTAATTGTCGAAAAACTGTTTTTTGGCAGT	CASSFWTGGLIVEKLFF	In	VDJ	64	1257	0.01627563704164077	0.01936975113645119	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	1	0	8	2	9	18	32	45	34	54														CASSFWTGGLIVEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCTGATGGGGTCAAGACTCCTACGAGCAGTACGTCGGGCCG	CASSLP*WGQDSYEQYV	Stop	VDJ	130	2534	0.03281023409985498		51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	6	2	17	7	23	18	33	44	40	67				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLP*WGQDSYEQYV+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACGTTCACGGGGAATGGTGAGCAGTTCTTCGGGCCA	CASTFTGNGEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	8	3	9	11	5	26	31	47	42	52														CASTFTGNGEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCACGACAGGGCGCCTAGAGACCCAGTACTTCGGGCCA	CASGTTGRLETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	3	4	3	5	26	37	47	40	52														CASGTTGRLETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGCCCTTTCCGGCACTGAAGCTTTCTTTGGACAA	CASALSGTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	8	5	4	7	0	26	36	-1	43	46						01,02								CASALSGTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCTAGTTTCCCGACAGGGAGGGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	14	1.8127201160140875E-4		49	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-03	01	6	2	3	6	12	4	26	37	56	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAACCAGGACAGGGGCAATGGCTACACCTTCGGTTCG	CASNQDRGNGYTF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	1	2	6	9	2	26	31	49	40	51														CASNQDRGNGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCGCTACAGGGCGAGGGAGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	16	2.0716801325875285E-4		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	3	3	17	3	25	26	31	40	34	65														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTGAAGACCCGAGGGTCGGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	17	2.201160140874249E-4		47	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	11	0	7	8	4	26	38	51	46	55														X+TCRBV12-05+TCRBJ01-06	TCRBV12-05*01	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGACCGGGACAGGGAGGAACCGGGGAGCTGTTTTTTGGAGAA	CASGPGQGGTGELFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	5	3	4	26	37	49	40	53														CASGPGQGGTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTACACAGGGATTTGAACACTGAAGCTTTCTTTGGACAA	CASGLHRDLNTEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	3	0	2	3	26	40	48	42	51														CASGLHRDLNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACGGGACAGCGCTATGGCTACACCTTCGGTTCG	CASTGQRYGYTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	36	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	0	5	4	6	2	26	31	44	37	46														CASTGQRYGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCGTCGTCGAGGCTCCGGCCCCCTCATTTGGACAA	CASVVEAPAPSF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	12	6	6	17	1	23	26	31	36	32	59						01,02								CASVVEAPAPSF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCCGGACAGCAACACTGAAGCTTTCTTTGGACAA	CASGPDSNTEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	2	3	1	26	37	46	40	47														CASGPDSNTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAAGCCAGGTTAGCACAGATACGCAGTATTTTGGCCCA	CASGLSQVSTDTQYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	4	0	4	2	26	40	48	44	50														CASGLSQVSTDTQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTCCTCAAATCTTTTGGGGGTAGAGACCCAGTACTTCGGGCCA	CASGSSNLLGVETQYF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	48	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-05	01	4	6	1	4	13	1	26	39	57	52	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGSSNLLGVETQYF+TCRBV12-05+TCRBJ02-05	TCRBV12-05*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGCAGGATACACTGAAGCTTTCTTTGGACAA	CASGLAGYTEAFF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	4	3	0	2	26	-1	46	42	48														CASGLAGYTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGAAGGGCGGCAGCCCCAGCATTTTGGTGAT	CASGPEGRQPQHF	In	VDJ	3	51	6.603480422622747E-4	7.858848909777333E-4	39	TCRBV12	TCRBV12-05	01				TCRBJ01	TCRBJ01-05	01	5	5	3	7	5	3	26	38	47	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPEGRQPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGAGGCTGGGGCAGCGCAGTATTTTGGCCCA	CASGLEAGAAQYF	In	VDJ	3	64	8.286720530350114E-4	9.86208490638724E-4	39	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	10	5	2	26	42	52	47	54														CASGLEAGAAQYF+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGCCTAGGTTTGCCCCAGCATTTTGGTGAT	CASGLGLPQHF	In	VDJ	9	180	0.0023306401491609697	0.0027737113799214115	33	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	4	8	9	1	4	26	37	42	38	46						01,02								CASGLGLPQHF+TCRBV12-05+TCRBJ01-05	TCRBV12-05*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTATGGACCCGGTTCCTCCGGGGAGCTGTTTTTTGGAGAA	CASSQDYGPGSSGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-02	01	2	1	7	6	6	9	20	35	45	41	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDYGPGSSGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTGAAGCCATTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASS*SHYSNQPQHF	Stop	VDJ	1	7	9.063600580070438E-5		45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	6	7	0	4	5	20	31	38	35	43						01,02								CASS*SHYSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTAAGGACAGGCGCCAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLRTGASSGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	4	0	5	6	20	31	43	36	49														CASSLRTGASSGNTIYF+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCGCGCCTCCGCGAATTCACCCCTCCACTTTGGGAAC	CASSQDRASANSPLHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	7	6	7	4	8	20	35	42	39	50						01,02								CASSQDRASANSPLHF+TCRBV23-01+TCRBJ01-06	TCRBV23-01*01	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATAATTGGAGACAGTCTGGTGAAAAACTGTTTTTTGGCAGT	CASSQDNWRQSGEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	5	7	10	5	20	35	50	45	55														CASSQDNWRQSGEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATTGGTGGGACAGGGTGACCAAAAACATTCAGTACTTCGGCGCC	CASSQDWWDRVTKNIQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	3	2	7	3	20	35	51	42	54														CASSQDWWDRVTKNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAAAAGAAATCCGTAGACAGATTGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	11	1.4242800911539258E-4		53	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	5	17	14	15	20	37	56	51	71														X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAAATGGACAGGGTGCGACACTGAAGCTTTCTTTGGACAA	CASKWTGCDTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	1	3	3	3	4	20	30	41	33	45														CASKWTGCDTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTACGGACAGGGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	1.5537600994406463E-4		43	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	3	4	1	20	31	45	35	46														X+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCGGGACTAGCGGGACTAAAATGGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	15	1.942200124300808E-4		58	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	0	3	1	2	8	20	35	50	37	58														X+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGGGACAGGGGGAAGAGGGAACATTCAGTACTTCGGCGCC	CASSQGTGGRGNIQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	1	7	0	7	20	-1	46	35	53														CASSQGTGGRGNIQYF+TCRBV23-01+TCRBJ02-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGACGGGACAGCCGACCGCGAACACCGGAGAGCTGTTTTTTGGAGAA		Out	VDJ	1	19	2.4601201574476903E-4		55	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	11	7	18	20	31	45	38	63														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAGGGCAGGTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	27	3.4959602237414543E-4		49	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-03	01	0	4	4	0	4	2	20	37	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-03	TCRBV23-01*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGGCCAACGCGCAAAAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	29	3.7549202403148953E-4		43	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	9	7	6	2	6	6	20	28	37	34	43						01,02								X+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATCGGGGTCAGCCCCAGCATTTTGGTGAT	CASSQDRGQPQHF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	6	3	0	20	35	-1	38	43														CASSQDRGQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD02-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTAAGATTGTCGGGGAGACCCAGTACTTCGGGCCA	CASSKIVGETQYF	In	VDJ	4	82	0.0010617360679511083	0.0012635796286308652	39	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	4	5	8	0	20	32	-1	40	44						01,02								CASSKIVGETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAGTCAGACAGGTATCGCACTGAAGCTTTCTTTGGACAA	CASSQSDRYRTEAFF	In	VDJ	19	371	0.004803708307437332	0.005716927344171354	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	4	7	5	20	31	44	38	49														CASSQSDRYRTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTGAGACTAGCGGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	6	7.768800497203231E-5		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	2	2	0	5	1	23	34	51	39	52														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTACGAGAACACCGGGGAGCTGTTTTTGGAGAA		Out	VDJ	1	6	7.768800497203231E-5		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	3	18	14	5	23	35	54	49	59						01,02								X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCCGATTGGGCTTGGGAATACGCAGTATTTTGGCCCA	CASSSPIGLGNTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	4	0	8	7	14	0	23	36	-1	50	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPIGLGNTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGGGACAGGGGCCAAGAAAAACTGTTTTTTGGCAGT	CASSSRDRGQEKLFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	2	8	3	4	23	36	49	39	53														CASSSRDRGQEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACGACAGGAATGGAAGTGAGGGTCGGGGTGAACAATGAGCAGTTCTTCGGGCCA	CASRTTGMEVRVGVNNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	60	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	4	5	3	23	21	32	41	35	64														CASRTTGMEVRVGVNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCATGACAATATACAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSHDNIQGNTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	1	12	0	23	34	-1	46	52														CASSHDNIQGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGACCAGCTTCCGGGAGACCCAGTACTTCGGGCCA	CASSRTSFRETQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	6	1	7	5	2	10	23	34	40	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRTSFRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGAATCGCCGGGGAGCTGTTTTTTGGAGAA	CASRRIAGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	11	2	6	0	5	23	-1	37	34	42														CASRRIAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACTAGCGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSGLAGATDTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	2	2	0	1	23	-1	48	35	49														CASSGLAGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCATCGGGACGGAGGAAAGGTCGGGGAGCTGTTTTTTGGAGAA	CASSYHRDGGKVGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	2	0	7	7	4	11	23	38	47	42	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYHRDGGKVGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATTAGCGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSYSISGVAKNIQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	5	3	0	3	1	23	40	51	43	52														CASSYSISGVAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGCACTATCCCAATTCTATGGCTACACCTTCGGTTCG	CASSSALSQFYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	9	4	4	8	23	36	44	40	52						01,02								CASSSALSQFYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGACGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSWGRASNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	4	0	7	1	1	5	23	36	42	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWGRASNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGGACTAGCGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CAIRTSAGANVLTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	6	2	6	4	0	2	23	-1	42	34	44						01,02								CAIRTSAGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYAGGNTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	7	4	1	0	3	23	-1	43	38	46						01,02								CASSYAGGNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGCAGGGGAGAGGACGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	17	4	17	23	38	48	42	65														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATAAGGGTCGTAATTCACCCCTCCACTTTGGGAAC	CASSYKGRNSPLHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	3	5	3	6	2	3	23	37	43	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYKGRNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGACAGGGGACAGCCCCAGCATTTTGGTGAT	CASSSDRGQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	1	2	7	1	1	23	36	46	37	47														CASSSDRGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCACTATGGGACACCAGAACACTGAAGCTTTCTTTGGACAA	CAITMGHQNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	0	6	1	7	3	23	30	43	37	46														CAITMGHQNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGGACGCAGGGGGGGCCCCACAGATACGCAGTATTTTGGCCCA	CAISGRRGGPTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	5	4	1	2	5	5	23	35	47	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISGRRGGPTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCACCGCGAGAGGGGTCGAGCGGGGACTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	6	3	17	15	18	23	33	55	48	73														X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACGCCCTCAGGGGGGGCCGCCCATGAGCAGTTCTTCGGGCCA	CASTPSGGAAHEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	4	1	8	6	8	23	33	46	39	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTPSGGAAHEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTCTAGGGGCAGGGGACACAGATACGCAGTATTTTGGCCCA	CASSPLGAGDTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	2	11	1	23	34	51	45	52														CASSPLGAGDTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTTTTTTCGACAGGGGGCTATGGCTACACCTTCGGTTCG	CASSLFSTGGYGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	4	9	0	23	34	-1	43	52														CASSLFSTGGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCGGGTCAAGCTTACAATGAGCAGTTCTTCGGGCCA	CASRSGQAYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	8	4	4	2	7	23	34	40	36	47						01,02								CASRSGQAYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTCAGTACACTGAAGCTTTCTTTGGACAA	CASSPQYTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	5	3	3	1	23	35	41	38	42														CASSPQYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGACAGGGGACCGCAGCCCCAGCATTTTGGTGAT	CASSRDRGPQPQHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	0	2	7	1	4	23	35	46	36	50														CASSRDRGPQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAGATGACAGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSEMTGGQETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	1	5	0	23	35	-1	40	49														CASSEMTGGQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGTTCTAAGCGTGAAAAACTGTTTTTTGGCAGT	CASSGSKREKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	6	6	7	7	0	23	35	-1	42	46						01,02								CASSGSKREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGGACGGACTAATCAATCAGCCCCAGCATTTTGGTGAT	CASRDGLINQPQHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	8	1	9	3	6	2	23	32	44	38	46						01,02								CASRDGLINQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTTCTTCAAGGGGGTACTATGGCTACACCTTCGGTTCG	CASSRGYYGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	5	1	3	7	1	23	28	41	35	42														CASSRGYYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAACTAAGGGGGGCTAACACTGAAGCTTTCTTTGGACAA	CASKLRGANTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	7	5	1	2	5	3	23	33	44	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKLRGANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGACAGGCGAAACAGATACGCAGTATTTTGGCCCA	CASKTGETDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	2	4	3	1	4	23	33	40	34	44														CASKTGETDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACAGGGACTCTGGCACAGATACGCAGTATTTTGGCCCA	CASRNRDSGTDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	3	3	1	2	6	23	34	42	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNRDSGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGGGGTCCAACGAGCAGTACGTCGGGCCG	CASSYGQGSNEQYV	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	17	0	16	23	-1	47	38	63														CASSYGQGSNEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGAGGGGGGCCCAACGCCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASS*RGAQRPNTGELFF	Stop	VDJ	1	10	1.2948000828672053E-4		54	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-02	01	3	5	1	0	1	10	23	37	44	38	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*RGAQRPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGGACAGGGAATGGCTACACCTTCGGTTCG		Out	VDJ	1	10	1.2948000828672053E-4		38	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	6	0	1	23	-1	46	37	47														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATATCCTATCGGACTACATCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	10	1.2948000828672053E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	1	9	17	9	17	23	30	45	39	62						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTCTGAACCGCCCGACAGAGAATTCACCCCTCCACTTTGGGAAC	CATLNRPTENSPLHF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	10	2	5	7	13	2	23	30	48	43	50														CATLNRPTENSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCACCTGGGCCTCAACTATGGCTACACCTTCGGTTCG	CASTHLGLNYGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	8	0	2	7	3	23	33	44	40	47														CASTHLGLNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGGCGACTGGACACCACCTAACCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	11	1.4242800911539258E-4		58	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	6	0	9	11	23	34	48	43	59														X+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTCGGGACTAGCGGGGGGGAAGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	11	1.4242800911539258E-4		52	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	0	0	5	0	4	23	-1	56	40	60														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTTGACAGACCGAACACTGAAGCTTTCTTTGGACAA	CASRLDRPNTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	5	1	4	3	23	34	43	38	46														CASRLDRPNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATAGCGGGGGGGGGCGAGACCCAGTACTTCGGGCCA	CASSIAGGGETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	0	5	2	3	23	34	47	36	50														CASSIAGGGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGGGGATGGGCTATGGCTACACCTTCGGTTCG	CASSPGMGYGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	4	2	5	23	34	41	36	46														CASSPGMGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCAGGGGTTAATTCACCCCTCCACTTTGGGAAC	CASSAGVNSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	4	2	6	1	1	23	35	42	36	43														CASSAGVNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGGACAGGGAAAAGCAATGAGCAGTTCTTCGGGCCA	CASRTGKSNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	3	6	1	5	23	32	41	33	46														CASRTGKSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAACGTGTCACTGGGGGCTGCGTACAATGAAGCTTTCTTTGGACAA	CANVSLGAAYNEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	6	0	7	10	9	23	30	46	40	55														CANVSLGAAYNEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCACCGGGACAGGGGGCGGTTTGTCGCCCCAGCATTTTGGTGAT	CASSTGTGGGLSPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	0	9	4	8	23	34	50	38	58														CASSTGTGGGLSPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCTCCGAACCGCCTTACTAGCCCCACCGGAGAGCTGTTTTTTGGAGAA	CASRSPNRLTSPTGELFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	3	7	11	16	9	23	34	56	50	65						01,02								CASRSPNRLTSPTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAAACAATACGAGCAGTTCTTCGGGCCA	CASSYDKQYEQFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	2	6	10	0	8	23	-1	42	38	50														CASSYDKQYEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGAACAGGACCCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	1.683240107727367E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	4	0	2	4	23	36	43	38	47														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATCCACGGACTAGCGGGGGTACTAGGTCACCAAGAGACCCAGTACTTCGGGCCA	CASIHGLAGVLGHQETQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	1	2	0	5	9	23	33	51	38	60														CASIHGLAGVLGHQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCGTCAGGCCGGCCCTGTGACTAGCGGGGCCACGTTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	1.683240107727367E-4		55	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	2	3	9	18	6	23	30	59	48	65														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAAGGCGGGCACAGATACGCAGTATTTTGGCCCA	CASTKAGTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	7	5	1	5	0	23	33	-1	38	42						01,02								CASTKAGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCGGACGGCAATAATTCACCCCTCCACTTTGGGAAC	CASRPDGNNSPLHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	1	7	5	3	4	23	34	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPDGNNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGCGGATACAGGGGTGAATCACCCCTCCACTTTGGGAAC	CASSRGYRGESPLHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	2	10	7	4	23	35	49	42	53														CASSRGYRGESPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATAGGACAGCTAGCACAGATACGCAGTATTTTGGCCCA	CASSDRTASTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	1	5	0	4	2	23	35	45	39	47														CASSDRTASTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGGGGAGGGTGGCACTGAAGCTTTCTTTGGACAA	CASSYGGEGGTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	9	0	4	0	7	23	-1	45	38	52						01,02								CASSYGGEGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTGGCAGGGGATCAGCCCCAGCATTTTGGTGAT	CASSYSLAGDQPQHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	2	5	5	0	23	40	-1	45	51														CASSYSLAGDQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAACTTACAGGGGTTAGGAGGGCAGCCCCAGCATTTTGGTGAT	CASNLQGLGGQPQHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	3	2	7	4	9	23	33	44	37	53														CASNLQGLGGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCCAACCAGGGGGAGACCAGCATTTTGGTGAT	CASTQPGGDQHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	4	1	12	6	3	23	33	46	39	49														CASTQPGGDQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAAAGCGGGGGAAGGCTCAACGAGCAGTTCTTCGGGCCA	CASRQSGGRLNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	10	4	10	23	34	46	38	56														CASRQSGGRLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCGACAGAACACCGAGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	15	1.942200124300808E-4		40	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	5	10	3	8	23	34	42	37	50														X+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTTACAGGGGGCTCTAAGTGAGACCCAGTACTTCGGGCCA	CASRLQGALSETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	0	5	3	7	23	34	46	37	53														CASRLQGALSETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAATCAGTGACTCGGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.942200124300808E-4		38	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	2	10	8	6	2	23	37	47	43	49						01,02								X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGGTGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGVSSYNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	6	2	0	0	4	23	-1	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGVSSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGTGAGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.942200124300808E-4		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	11	1	0	2	0	23	38	-1	40	44														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACCGGGACAGGGGGGTCAATGAGCAGTTCTTCGGGCCA	CASRDRDRGVNEQFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	1	6	5	2	23	34	50	39	52														CASRDRDRGVNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGGGACTGGAACACTGAAGCTTTCTTTGGACAA	CASSRDWNTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	10	1	1	1	23	35	42	36	43						01,02								CASSRDWNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGGAGGAGGGTCGATCACCCCTCCACTTTGGGAAC	CASSREEGRSPLHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	8	1	10	0	8	23	-1	42	35	50														CASSREEGRSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCATCGACGGGGGGGCCCGGTACGCAGTATTTTGGCCCA	CASSPSTGGPGTQYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	8	0	8	8	5	23	34	50	42	55														CASSPSTGGPGTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGTCCCACTGACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASRSH*QGDTEAFF	Stop	VDJ	1	17	2.201160140874249E-4		45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	3	8	2	23	34	49	42	51														CASRSH*QGDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACACTAGCGGGGGGGCCGATGAGCAGTTCTTCGGGCCA	CASSDTSGGADEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	0	8	3	3	23	35	51	38	54														CASSDTSGGADEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGACAGGGGGGCATGAACACTGAAGCTTTCTTTGGACAA	CASSSRQGGMNTEAFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	1	0	3	3	23	36	48	39	51														CASSSRQGGMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCCCCCCAGTACACTGAAGCTTTCTTTGGACAA	CASSPQYTEAFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	4	5	3	6	1	23	32	41	38	42														CASSPQYTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTGGACTAGCCTTGCAGATACGCAGTATTTTGGCCCA	CASSWTSLADTQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	1	7	4	2	4	23	34	44	36	48						01,02								CASSWTSLADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGCGTTACGAGCAGTACGTCGGGCCG	CASSPGTGRYEQYV	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	17	3	16	23	35	47	38	63														CASSPGTGRYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTTAGCGGGGGCGGACGTACGCAGTATTTTGGCCCA	CASSDLSGGGRTQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	8	5	6	23	35	49	40	55														CASSDLSGGGRTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGGGGCTCTGGGGGAGACCCAGTACTTCGGGCCA	CASSYPGALGETQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	2	5	1	8	23	38	45	39	53														CASSYPGALGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGACAGGGAGGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSYRQGGVNTEAFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	2	2	3	0	1	5	23	38	46	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRQGGVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAGGACGGAACTATGGCTACACCTTCGGTTCG	CASSYLGRNYGYTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	2	1	7	2	3	2	23	38	45	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLGRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATGGCCCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	18	2.3306401491609695E-4		46	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	9	0	0	3	1	23	40	46	43	47														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGGCCACCTCCGTTCCAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.3306401491609695E-4		50	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	8	0	2	0	12	23	-1	43	39	55														X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCCCCCAGGAGGTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	18	2.3306401491609695E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	3	10	1	1	7	0	23	37	-1	44	49														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTTGGCGGGGGGGTCCGGGATACGCAGTATTTTGGCCCA	CASSYFGGGVRDTQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	6	3	5	23	39	51	42	56														CASSYFGGGVRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCTGGAGACACCTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	2.5896001657344105E-4		46	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	2	6	0	8	2	23	35	47	43	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGGGACTCGTTTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPGLVYTGELFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	0	10	3	2	5	23	35	43	37	48						01,02								CASSPGLVYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGTAGCGGGAAACGGCTACACCTTCGGTTCG	CASSVAGNGYTF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	5	3	8	1	3	23	35	44	36	47														CASSVAGNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGCGCAGGCTGGAACACTGAAGCTTTCTTTGGACAA	CASSYRAGWNTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	5	3	23	37	46	42	49														CASSYRAGWNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGGGGTCGCACTGAAGCTTTCTTTGGACAA	CASSYGGRTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	6	1	4	1	3	23	37	43	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYGGRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCTAGTGGGACAGGGCGTGCAAAACTGTTTTTTGGCAGT	CASSPSGTGRAKLFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	3	10	7	5	23	34	50	41	55														CASSPSGTGRAKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGGGGGCACACTGAAGCTTTCTTTGGACAA	CASSYRGHTEAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	0	3	0	0	23	-1	-1	38	45														CASSYRGHTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCYGGGACAGGGAGGTACGAGCAGTACGTCGGGCCG	CASSPGTGRYEQYV	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	17	3	16	23	35	47	38	63														CASSPGTGRYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAGTTTACAGCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSSLQLAKNIQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	5	0	5	2	23	35	44	40	46														CASSSLQLAKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGGACAGATGTTAACACTGAAGCTTTCTTTGGACAA	CASSYGTDVNTEAFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	2	0	5	23	-1	45	38	50														CASSYGTDVNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTAGGGACTGGATGGCGGGGAGTTGTTTTTTGGAGAA	CASS*GLDGGELFF	Stop	VDJ	1	24	3.1075201988812925E-4		42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	0	10	15	0	14	23	-1	43	37	57						01,02								CASS*GLDGGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGCTAGGACTTGCGACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	24	3.1075201988812925E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	5	1	10	2	4	4	23	35	44	39	48						01,02								X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCGGGAAGTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASTGKFSGANVLTF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	7	8	3	0	1	4	23	33	39	34	43														CASTGKFSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAATGGCAGGGCAGAACAAACCGGGGAGCTGTTTTTTGGAGAA	CASSNGRAEQTGELFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	5	5	8	23	35	45	40	53														CASSNGRAEQTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACTTTCAGCGGGGCGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	25	3.2370002071680133E-4		44	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	6	3	4	3	2	23	39	49	42	51														X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCTTCGGGGGCAGAGACCCAGTACTTCGGGCCA	CASSSSGAETQYF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	6	0	4	4	0	23	36	-1	40	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSSGAETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAGGGTCCTCCAGGTCTGGAAACACCATATATTTTGGAGAG	CASSRGSSRSGNTIYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	11	0	1	1	9	23	35	41	36	50														CASSRGSSRSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTCACTAGCGGGGCGAATACGCAGTATTTTGGCCCA	CASSYFTSGANTQYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	3	3	7	2	3	23	39	51	41	54														CASSYFTSGANTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGCGTTTCCGGGGGTGGCTACACCTTCGGTTCG	CASRVSGGGYTF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	8	8	2	7	8	0	23	32	-1	40	46														CASRVSGGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCCTTGAGTAATGAGCAGTTCTTCGGGCCA	CASSYSLSNEQFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	11	2	7	6	1	23	37	46	43	47														CASSYSLSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGATCCGGGACAGAAAGCTTTCTTTGGACAA	CASRDPGQKAFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	9	6	1	23	34	47	40	48														CASRDPGQKAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGAAATACGAGCAGTACGTCGGGCCG	CASSPGTGKYEQYV	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	17	3	16	23	35	47	38	63														CASSPGTGKYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGATACAGTCGTCCGGGCGTCAGCCCCAGCATTTTGGTGAT	CASRIQSSGRQPQHF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	3	5	6	3	11	23	34	41	37	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRIQSSGRQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCGGAAGGACGGCCTCTGGAAACACCATATATTTTGGAGAG	CAGRTASGNTIYF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	11	1	7	0	4	3	23	29	37	33	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAGRTASGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACAGTGAACCCGACTAGCGGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	30	3.884400248601616E-4		58	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	2	3	0	11	3	23	34	56	45	59														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGATTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRGFSYNEQFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	6	0	8	0	0	2	23	-1	38	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGFSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACAACAGGGTCTTTGAACACTGAAGCTTTCTTTGGACAA	CASSTTGSLNTEAFF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	0	3	4	23	35	44	38	48														CASSTTGSLNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGTCCGGTGTACCAAGAGACCCAGTACTTCGGGCCA	CASGPVYQETQYF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	8	5	0	4	3	23	32	39	36	42						01,02								CASGPVYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGTAGCGGGGACCCAAGAGACCCAGTACTTCGGGCCA	CASSYSVAGTQETQYF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	3	1	2	2	23	40	50	42	52														CASSYSVAGTQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGTACAGGAAACTCACCCCTCCACTTTGGGAAC	CASSSGTGNSPLHF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	3	4	10	5	4	23	36	46	41	50														CASSSGTGNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTACTTGGGGGAGATCTGGAGAAAAACTGTTTTTTGGCAGT	CASTWGRSGEKLFF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	9	6	1	8	5	9	23	31	41	36	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTWGRSGEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTCACTCGGCTGGGACGGATCCTACGAGCAGTACGTCGGGCCG	CATSLGWDGSYEQYV	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	0	7	17	12	19	23	30	47	42	66				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLGWDGSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCGCCGGGACAGGGATATGGCTACACCTTCGGTTCG	CASSPPGQGYGYTF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	3	5	6	1	23	34	49	40	50														CASSPPGQGYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCACAGGGAAACCGGGGAGCTGTTTTTTGGAGAA	CASSHRETGELFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	3	5	1	2	23	35	42	36	44														CASSHRETGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGCGCCGGACAGCGAACTGGCTACACCTTCGGTTCG	CASGAGQRTGYTF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	1	5	7	6	5	23	32	44	38	49														CASGAGQRTGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATGGACAGGGCAACGGCTACACCTTCGGTTCG	CASSYGQGNGYTF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	8	1	4	23	37	46	38	50														CASSYGQGNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACACAGGGTAGCTCCTACGAGCAGTACGTCGGGCCG	CATQGSSYEQYV	In	VDJ	2	41	5.308680339755541E-4	6.317898143154326E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	3	3	17	1	20	23	30	37	31	57														CATQGSSYEQYV+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACTAGACAGGATCAAGAGACCCAGTACTTCGGGCCA	CASSTRQDQETQYF	In	VDJ	2	41	5.308680339755541E-4	6.317898143154326E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	4	2	4	2	23	35	45	39	47														CASSTRQDQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCTACAGAAACACTGAAGCTTTCTTTGGACAA	CASSTYRNTEAFF	In	VDJ	2	43	5.567640356328983E-4	6.626088296478928E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	2	4	1	23	35	43	39	44														CASSTYRNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAAGTATGGGGCGGCCGGCTACACCTTCGGTTCG	CASSKYGAAGYTF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	7	0	8	7	4	23	34	46	41	50														CASSKYGAAGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACCTACAGGGGGAGGGAGCTTTCTTTGGACAA	CASSDLQGEGAFF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	1	10	5	4	23	35	48	40	52														CASSDLQGEGAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCCGAAATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRNSGANVLTF	In	VDJ	2	46	5.956080381189145E-4	7.08837352646583E-4	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-06	01	8	2	8	1	1	3	23	32	35	33	38				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRNSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAAACAGGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASTNRGSTDTQYF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	3	2	0	3	1	23	33	43	36	44														CASTNRGSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAGGACAGGGAACACTGAAGCTTTCTTTGGACAA	CASSRTGNTEAFF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	4	1	2	0	23	34	-1	36	43														CASSRTGNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCTCCTGGGGAGGCAGGTGCCTTTAATTTTTTTGGCTACACCTTCGGTTCG		Out	VDJ	3	51	6.603480422622747E-4		56	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	1	7	6	19	23	35	47	41	66														X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCTATCCCGGGACAGGGGGCCCTAGGGAAAAACTGTTTTTTGGCAGT	CASSPYPGTGGPREKLFF	In	VDJ	3	53	6.862440439196188E-4	8.167039063101933E-4	54	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	0	8	10	6	23	34	56	44	62														CASSPYPGTGGPREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTCGGGGGAGGTAATGAGCAGTTCTTCGGGCCA	CASSFGGGNEQFF	In	VDJ	3	55	7.121400455769629E-4	8.475229216426535E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	2	7	1	4	23	36	43	37	47						01,02								CASSFGGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGGGGCGGGACTCTAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	57	7.38036047234307E-4		53	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	10	0	7	2	23	40	53	47	55						01,02								X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACTCGACGATCGGGACAGCAAGAGACCCAGTACTTCGGGCCA	CATRRSGQQETQYF	In	VDJ	3	58	7.509840480629791E-4	8.937514446413437E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	0	5	2	10	0	23	30	-1	40	47														CATRRSGQQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATACGACAGGAGCTATGGCTACACCTTCGGTTCG	CASRYDRSYGYTF	In	VDJ	3	65	8.416200538636834E-4	0.0010016179983049541	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	4	4	0	2	23	-1	44	38	46														CASRYDRSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAGCGCTTAATTCACCCCTCCACTTTGGGAAC	CASTALNSPLHF	In	VDJ	3	66	8.545680546923555E-4	0.0010170275059711842	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	6	6	6	1	2	23	33	38	34	40						01,02								CASTALNSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAGAGGTTTAACAGCAATGAGCAGTTCTTCGGGCCA	CASSYQRFNSNEQFF	In	VDJ	3	66	8.545680546923555E-4	0.0010170275059711842	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	2	3	5	6	10	0	23	38	-1	48	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYQRFNSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGGGACAGGAACTATGGCTACACCTTCGGTTCG	CASRRDRNYGYTF	In	VDJ	3	67	8.675160555210276E-4	0.0010324370136374143	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	4	2	2	0	23	34	-1	36	44														CASRRDRNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACAGAGCGGGGGGGATACGAGGCACAGATACGCAGTATTTTGGCCCA	CASSYRAGGIRGTDTQYF	In	VDJ	4	78	0.0010099440646364202	0.001201941597965945	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	0	1	2	7	23	38	50	40	57														CASSYRAGGIRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGAACAAGGACAGGTCCTCAATCAGCCCCAGCATTTTGGTGAT	CATEQGQVLNQPQHF	In	VDJ	4	83	0.0010746840687797805	0.0012789891362970953	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	10	1	4	3	8	4	23	30	45	38	49														CATEQGQVLNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACTCCGGGACACTCCTAAGGGATACGCAGTATTTTGGCCCA	CASRDSGTLLRDTQYF	In	VDJ	5	91	0.001178268075409157	0.0014022651976269358	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	6	6	7	9	23	34	47	41	56														CASRDSGTLLRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACCAACAGGGTGTGGGAGCTTTCTTTGGACAA	CASSNQQGVGAFF	In	VDJ	5	96	0.001243008079552517	0.0014793127359580861	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	10	5	6	23	35	46	40	52														CASSNQQGVGAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCCGGACTAGCGGGGACCATGTACCAAGAGACCCAGTACTTCGGGCCA	CASSAGLAGTMYQETQYF	In	VDJ	6	116	0.0015019680961259581	0.0017875028892826875	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	1	3	0	3	7	23	35	50	38	57														CASSAGLAGTMYQETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCTTCGGGACGGGAGACGACTTATAACACTGAAGCTTTCTTTGGACAA	CASSYASGRETTYNTEAFF	In	VDJ	6	125	0.0016185001035840065	0.001926188458278758	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	8	2	2	9	9	23	38	53	47	62														CASSYASGRETTYNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTGAGCACAACAAGTCATCAGCCCCAGCATTTTGGTGAT	CASSYLSTTSHQPQHF	In	VDJ	6	125	0.0016185001035840065	0.001926188458278758	48	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	1	3	6	5	5	7	23	39	47	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYLSTTSHQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAACAACTCGAGATACGCAGTATTTTGGCCCA	CASKTTRDTQYF	In	VDJ	7	142	0.0018386161176714316	0.002188150088604669	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	7	3	6	5	2	5	23	33	38	35	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASKTTRDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCCGGGGGGAAACTGAAGCTTTCTTTGGACAA	CAISVRGETEAFF	In	VDJ	8	157	0.002032836130101512	0.00241929270359812	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	5	3	2	23	35	45	38	47														CAISVRGETEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCTCTCACCCTTTAGGGACAGGGGCCGGGCAGCCCCAGCATTTTGGTGAT	CASSHPLGTGAGQPQHF	In	VDJ	8	158	0.0020457841309301844	0.00243470221126435	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	2	7	12	5	23	32	54	44	59														CASSHPLGTGAGQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGACTAGCGGCCACACAGATACGCAGTATTTTGGCCCA	CASSYSTSGHTDTQYF	In	VDJ	8	159	0.0020587321317588566	0.00245011171893058	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	5	2	0	3	23	-1	49	40	52						01,02								CASSYSTSGHTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCTACTACAGGGTGGCGCAGATACGCAGTATTTTGGCCCA	CASSLLQGGADTQYF	In	VDJ	9	168	0.002175264139216905	0.0025887972879266507	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	4	6	5	23	34	46	40	51														CASSLLQGGADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGATGGAGGGTCGGGCAAAAACATTCAGTACTTCGGCGCC	CASSDGGSGKNIQYF	In	VDJ	9	173	0.0022400041433602654	0.002665844826257801	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	0	3	3	5	23	35	44	38	49														CASSDGGSGKNIQYF+TCRBV06-08+TCRBJ02-04	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGATCCCGAGAAGGTTCACCCCTCCACTTTGGGAAC	CASRSREGSPLHF	In	VDJ	9	182	0.002356536150818314	0.0028045303952538717	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-06	01	6	5	4	9	9	0	23	34	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSREGSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAAACGGACAGGAGCAGTTCTTCGGGCCA	CASSYLNGQEQFF	In	VDJ	12	229	0.0029650921897659	0.0035287772555666844	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	5	10	6	0	23	38	-1	44	50														CASSYLNGQEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAACCGGGACAGGGGCACAGATACGCAGTATTTTGGCCCA	CASRNRDRGTDTQYF	In	VDJ	12	236	0.0030557281955666043	0.003636643809230295	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	3	1	5	0	23	34	-1	39	48														CASRNRDRGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGGACAGGGCTTACCCTACAATGAGCAGTTCTTCGGGCCA	CASSYGQGLPYNEQFF	In	VDJ	18	342	0.004428216283405842	0.005270051621850682	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	1	3	2	0	5	23	-1	46	38	51														CASSYGQGLPYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTTGGGGTGAGATGAGCAGTTCTTCGGGCCA	CASTLG*DEQFF	Stop	VDJ	19	364	0.004713072301636628		36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	7	6	2	8	4	4	23	33	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLG*DEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGAAGGGGGCAAGGAGACCCAGTACTTCGGGCCA	CASSPEGGKETQYF	In	VDJ	21	400	0.005179200331468821	0.006163803066492025	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	5	0	5	5	3	23	35	47	40	50														CASSPEGGKETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCTACGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPYENTGELFF	In	VDJ	57	1107	0.014333436917339962	0.01705832498651668	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	4	9	1	2	3	23	35	40	37	43						01,02								CASSPYENTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCCGGAGGGGGGGGAACCAATGAGCAGTTCTTCGGGCCA	CASSPSGGGGTNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	6	6	4	24	39	52	45	56													Vb 18	CASSPSGGGGTNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGCTACGGGGAAGGGATATGGCTACACCTTCGGTTCG	CASSPATGKGYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	3	5	5	6	24	38	48	43	54													Vb 18	CASSPATGKGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGACAGTCTATGGCTACACCTTCGGTTCG	CASSPTTVYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	2	1	24	39	46	41	47													Vb 18	CASSPTTVYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACTAGCGGGGGGATAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPTSGGIAKNIQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	3	1	0	0	2	24	-1	51	39	53													Vb 18	CASSPTSGGIAKNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCAGGCACAGGGGACGCTAATTCACCCCTCCACTTTGGGAAC	CASSSGTGDANSPLHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	2	6	6	4	24	36	49	42	53													Vb 18	CASSSGTGDANSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAAGTTCAAGTGCTCCAGGGAGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSSSSAPGRSNQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	9	1	1	15	0	24	36	-1	51	57													Vb 18	CASSSSSAPGRSNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGACTTCAGCACAGATACGCAGTATTTTGGCCCA	CASSPGDFSTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	10	0	1	2	24	39	46	40	48						01,02							Vb 18	CASSPGDFSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGGGGCCGGTCAAGATACGCAGTATTTTGGCCCA	CASSPGGAGQDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	5	0	7	24	-1	46	39	53													Vb 18	CASSPGGAGQDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSPGYQETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	2	0	9	0	0	1	24	-1	42	39	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGYQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGGACAGGGAATCACCGGGGAGCTGTTTTTTGGAGAA	CASSPGQGITGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	3	4	0	3	24	-1	47	38	50													Vb 18	CASSPGQGITGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAATATGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQYATNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	5	9	0	2	2	24	37	41	39	43						01,02							Vb 18	CASSQYATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACGACTGATAATTCACCCCTCCACTTTGGGAAC	CASSPTTDNSPLHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	2	10	5	2	1	24	39	45	41	46						01,02							Vb 18	CASSPTTDNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACTAGGACAGGGGGCGGTTGGAGAGACCCAGTACTTCGGGCCA	CASSPLGQGAVGETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	0	4	2	6	24	40	53	42	59													Vb 18	CASSPLGQGAVGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTATGGTTCTGGCTACACCTTCGGTTCG	CASSPYGSGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	0	10	7	4	3	24	38	44	42	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPYGSGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTACTAACGCTTAACAATGAGCAGTTCTTCGGGCCA	CASSLLTLNNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	3	9	5	1	7	24	37	42	38	49						01,02							Vb 18	CASSLLTLNNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGAGCAGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSEQATNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	4	0	3	0	24	36	-1	39	43													Vb 18	CASSEQATNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGATAGTTCTAACTATGGCTACACCTTCGGTTCG	CASSPDSSNYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	1	8	0	0	5	24	-1	41	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDSSNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGACTAGCGGGGGCTTATACGCAGTATTTTGGCCCA	CASSRLAGAYTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	2	2	7	2	3	24	35	49	37	52													Vb 18	CASSRLAGAYTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTTCGGAGGCACAGATACGCAGTATTTTGGCCCA	CASSFGGTDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	10	2	1	4	0	24	35	-1	39	43													Vb 18	CASSFGGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGACAGGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSQDRGTSTDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	1	0	1	3	24	37	48	38	51													Vb 18	CASSQDRGTSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGGGCCCCCCCCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	1.5537600994406463E-4		40	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	7	0	7	24	-1	42	37	49													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGTTTGAGACTAAACTCTGGAAACACCATATATTTTGGAGAG	CASSPPSLRLNSGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	0	2	9	0	8	2	24	41	54	49	56						01,02							Vb 18	CASSPPSLRLNSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGGCATCTCTGGAAACACCATATATTTTGGAGAG	CASSPGGISGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	6	0	0	0	2	24	-1	45	39	47													Vb 18	CASSPGGISGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTACGACTGGGACTCCGGTGGGTACAGATACGCAGTATTTTGGCCCA	CASSPTTGTPVGTDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	54	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	0	10	3	7	9	24	38	51	45	60						01,02							Vb 18	CASSPTTGTPVGTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACACGGGATCTTGAACGAAAAACTGTTTTTTGGCAGT	CASSHGILNEKLFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	8	3	8	1	8	24	37	43	38	51													Vb 18	CASSHGILNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCGGGGACGGTCGCCTATGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	1.683240107727367E-4		46	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	0	7	7	2	9	24	41	48	43	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGTCAGCGCGAACACTGAAGCTTTCTTTGGACAA	CASSPVSANTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	6	6	1	4	1	24	38	46	42	47						01,02							Vb 18	CASSPVSANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTAGGACAGCGCGAACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	15	1.942200124300808E-4		52	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	5	0	3	6	24	39	48	42	54													Vb 18	X+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGAACAGGGGAGTAGGTTATGGCTACACCTTCGGTTCG	CASSRNRGVGYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	2	5	3	7	24	37	47	40	54													Vb 18	CASSRNRGVGYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTTAAAACAGGGGAGCGGGGAGCTGTTTTTTGGAGAA	CASSLKQGSGELFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	2	7	6	2	24	35	48	41	50													Vb 18	CASSLKQGSGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCCGTTGGACAGAGCACAGATACGCAGTATTTTGGCCCA	CASSPPVGQSTDTQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	5	0	4	0	24	41	-1	45	51													Vb 18	CASSPPVGQSTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGGGGACAGGGGACGGCTACACCTTCGGTTCG	CASSPEGTGDGYTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	8	3	2	24	39	52	42	54													Vb 18	CASSPEGTGDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGAGGGTACTAGGTCACCCCTCCACTTTGGGAAC	CASSPEGTRSPLHF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	2	3	8	10	6	1	24	39	50	45	51						01,02							Vb 18	CASSPEGTRSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAAGCGGCGATAACAGGGGCCCGCTACGAGCAGTACGTCGGGCCG	CASSPEAAITGARYEQYV	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	54	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	17	13	18	24	38	58	51	76													Vb 18	CASSPEAAITGARYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSPQGNYGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	2	2	0	0	24	-1	-1	40	45													Vb 18	CASSPQGNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGACAGGTCATTCTTTACCGGGGAGCTGTTTTTTGGAGAA	CASSDRSFFTGELFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	4	5	0	9	24	-1	42	36	51													Vb 18	CASSDRSFFTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGATGGACAGCTATAATTCACCCCTCCACTTTGGGAAC	CASSQMDSYNSPLHF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	5	3	4	0	24	37	-1	41	47													Vb 18	CASSQMDSYNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAGGGAATACTGAAGCTTTCTTTGGACAA	CASSPPGNTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	5	1	2	24	41	46	42	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGACCTTCCCCTCTGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGPSPLGNTEAFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	1	7	1	0	13	24	-1	43	39	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPGPSPLGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGTAGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSPQVGAYNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	2	4	0	24	40	-1	44	49													Vb 18	CASSPQVGAYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGAGTTTGAATGAGCAGTTCTTCGGGCCA	CASSPGSLNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	9	2	7	0	4	24	-1	44	39	48													Vb 18	CASSPGSLNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAACTATCAGGGGGGCTGAAAAACTGTTTTTTGGCAGT	CASSTIRGAEKLFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	1	7	5	2	24	36	48	41	50													Vb 18	CASSTIRGAEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATCGTCAATGAACACTGAAGCTTTCTTTGGACAA	CASSPSSMNTEAFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	2	4	6	0	4	1	24	39	45	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPSSMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTTCCTCCGGGGACGGGCGGACCTCCGGGACCCAGTACTTCGGGCCA	CSSGDGRTSGTQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	14	0	7	7	7	14	24	27	39	34	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CSSGDGRTSGTQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGACAGGGGGAAATTCACCCCTCCACTTTGGGAAC	CASSRGTGGNSPLHF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	1	7	2	1	24	37	50	39	51													Vb 18	CASSRGTGGNSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGGGGGATTACTATGAACACTGAAGCTTTCTTTGGACAA	CASSRGITMNTEAFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	6	1	0	0	7	24	-1	42	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSRGITMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCGCCAGGGATCAGGCTGGAAACACCATATATTTTGGAGAG	CASSARDQAGNTIYF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	4	3	2	3	6	24	35	43	38	49													Vb 18	CASSARDQAGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTTGTCCCGACTCTGGAAACACCATATATTTTGGAGAG	CASCPDSGNTIYF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-03	01	9	2	8	0	7	0	24	32	-1	39	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASCPDSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCTGGACAGAAGAGACCCAGTACTTCGGGCCA	CASSWTEETQYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	5	3	2	0	24	35	-1	37	43													Vb 18	CASSWTEETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGAGCGGGGGGCCCGCAGATACGCAGTATTTTGGCCCA	CASSPPSGGPADTQYF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	1	4	1	4	24	41	51	42	55													Vb 18	CASSPPSGGPADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGACAGACTAGAAGCTTTCTTTGGACAA	CASSPGDRLEAFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	5	8	1	4	24	39	47	40	51													Vb 18	CASSPGDRLEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAGACAGCTAATCAGCCCCAGCATTTTGGTGAT	CASSPETANQPQHF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	2	5	4	3	2	24	38	46	41	48													Vb 18	CASSPETANQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGATCGGCGGCGGAACACTGAAGCTTTCTTTGGACAA	CASSPDRRRNTEAFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	7	5	1	6	2	24	38	48	44	50						01,02							Vb 18	CASSPDRRRNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCTCGGACTAGCGGGGTCACATACGAGCAGTACGTCGGGCCG	CASSARTSGVTYEQYV	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	1	3	17	4	18	24	36	52	40	70													Vb 18	CASSARTSGVTYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGACCTTGATTCACCCCTCCACTTTGGGAAC	CASSPDLDSPLHF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-06	01	6	1	7	8	3	4	24	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPDLDSPLHF+TCRBV18-01+TCRBJ01-06	TCRBV18-01*01		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGTTTCTAGCGGTTCAAAAGATACGCAGTATTTTGGCCCA	CASSPVSSGSKDTQYF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	5	5	4	6	24	39	50	43	56						01,02							Vb 18	CASSPVSSGSKDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCTGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPVNTGELFF	In	VJ	2	32	4.143360265175057E-4	4.93104245319362E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-02	01	0	0	0	1	0	3	24	-1	41	-1	44													Vb 18	CASSPPVNTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGCCTACGACTGCGGACAGGGGGCTTGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	32	4.143360265175057E-4		62	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	0	5	15	4	13	30	56	45	60													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGACAGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQTGGNQPQHF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	2	1	2	24	37	44	38	46													Vb 18	CASSQTGGNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCACCGTTCTAGCTTGCCAGCCACTGAAGCTTTCTTTGGACAA	CASSPHRSSLPATEAFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	4	7	4	8	8	24	38	51	46	59						01,02							Vb 18	CASSPHRSSLPATEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTAACAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLTTNEKLFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	4	9	0	1	1	24	35	39	36	40						01,02							Vb 18	CASSLTTNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGACAGTTGTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	34	4.402320281748498E-4		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	3	1	4	24	38	46	39	50													Vb 18	X+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCGGACGGCAGCCGTGGCTACACCTTCGGTTCG	CASSADGSRGYTF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	5	1	7	7	2	8	24	36	42	38	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSADGSRGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTCGTACAGGGAACCCTTGGGGTAGATACGCAGTATTTTGGCCCA	CASSLVQGTLGVDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	5	6	12	24	35	47	41	59													Vb 18	CASSLVQGTLGVDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTTAGAGCAGGAGATTATTGAGACCCAGTACTTCGGGCCA	CASSPPLEQEIIETQYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	0	4	4	5	7	8	24	41	52	48	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPLEQEIIETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGGGCAGCAAGCTCCTACGAGCAGTACGTCGGGCCG	CASSPGAASSYEQYV	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	7	0	17	0	23	24	-1	44	39	67													Vb 18	CASSPGAASSYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTGTCAAAACAGGGAGAAACTGAAGCTTTCTTTGGACAA	CASSLSKQGETEAFF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	5	7	4	24	37	50	44	54													Vb 18	CASSLSKQGETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCAATTTAGGCGGACTATCGAACCCTGAAGCTTTCTTTGGACAA	CASSNLGGLSNPEAFF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	1	9	6	10	7	24	35	51	45	58						01,02							Vb 18	CASSNLGGLSNPEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTCAACGGACAGGGGGAGACTGAAGCTTTCTTTGGACAA	CASSLNGQGETEAFF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	5	7	2	24	35	52	42	54													Vb 18	CASSLNGQGETEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGAGGAGGGTAGGCGGGGAGCTGTTTTTTGGAGAA	CASSPRRVGGELFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	10	0	7	2	4	24	38	46	40	50													Vb 18	CASSPRRVGGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAGGGGACAGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGTGDTGELFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	2	3	4	0	24	35	-1	39	49													Vb 18	CASSQGTGDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGTTCTCAAGGACAGGGAAGCACTGAAGCTTTCTTTGGACAA	CASSQGQGSTEAFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	9	1	3	4	7	3	24	32	47	39	50													Vb 18	CASSQGQGSTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTTCCCAAGGGGAGCCCCAGCATTTTGGTGAT	CASSPSQGEPQHF	In	VDJ	2	41	5.308680339755541E-4	6.317898143154326E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	5	2	8	6	0	24	38	-1	44	49													Vb 18	CASSPSQGEPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGCACGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPHGDTGELFF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	0	8	3	3	3	0	24	41	-1	44	49													Vb 18	CASSPPHGDTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAACAGAAAACACTGAAGCTTTCTTTGGACAA	CASSPTENTEAFF	In	VDJ	2	47	6.085560389475865E-4	7.24246860312813E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	2	0	2	24	-1	43	39	45													Vb 18	CASSPTENTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGACTCCGTCTATGGCTACACCTTCGGTTCG	CASSPDSVYGYTF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	2	10	4	0	4	24	-1	43	39	47						01,02							Vb 18	CASSPDSVYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGCGCGGGGGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSPARGGQETQYF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	0	1	2	0	24	39	-1	41	50													Vb 18	CASSPARGGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATACCTTGGACACYCGAACACTGAAGCTTTCTTTGGACAA	CASSYLGHXNTEAFF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	6	1	6	3	24	36	47	42	50													Vb 18	CASSYLGHXNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCACGACAGGGGCCCACTGAAGCTTTCTTTGGACAA	CASSPPRQGPTEAFF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	2	2	4	2	2	24	41	51	43	53													Vb 18	CASSPPRQGPTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTTGAACGCACAGATACGCAGTATTTTGGCCCA	CASSPFERTDTQYF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	2	2	8	1	3	2	24	39	44	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPFERTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAAGACAGGGAGTCTACGAGCAGTACGTCGGGCCG	CASSPRQGVYEQYV	In	VDJ	3	51	6.603480422622747E-4	7.858848909777333E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	3	17	1	17	24	39	47	40	64													Vb 18	CASSPRQGVYEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTCTGACTCGATGAACACTGAAGCTTTCTTTGGACAA	CASSPSDSMNTEAFF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	2	10	0	4	3	24	38	46	42	49						01,02							Vb 18	CASSPSDSMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGGGTTAAGACAGGGCGCGTTTACGCAGTATTTTGGCCCA	CASSPPGLRQGAFTQYF	In	VDJ	3	55	7.121400455769629E-4	8.475229216426535E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	2	3	8	8	6	24	41	56	49	62													Vb 18	CASSPPGLRQGAFTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAAGGGAATCCCTACAATGAGCAGTTCTTCGGGCCA	CASSPEGNPYNEQFF	In	VDJ	3	57	7.38036047234307E-4	8.783419369751136E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	3	0	8	2	4	3	24	38	46	42	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPEGNPYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGCTAGCGGGGGTGCTGAGCAGTTCTTCGGGCCA	CASSPPASGGAEQFF	In	VDJ	3	65	8.416200538636834E-4	0.0010016179983049541	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	9	2	3	24	41	53	43	56													Vb 18	CASSPPASGGAEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTTGGGACACTTATTAACACTGAAGCTTTCTTTGGACAA	CASSLGTLINTEAFF	In	VDJ	4	86	0.0011135280712657966	0.0013252176592957856	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	6	2	2	6	24	37	45	39	51													Vb 18	CASSLGTLINTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTCTCTCCGGACCACGAGCAGTACGTCGGGCCG	CASSLSPDHEQYV	In	VDJ	6	110	0.0014242800911539258	0.001695045843285307	39	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	4	1	7	17	7	13	24	37	48	44	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLSPDHEQYV+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCCCACCGGACAAGAGACCCAGTACTTCGGGCCA	CASSPPTGQETQYF	In	VDJ	6	117	0.0015149160969546301	0.0018029123969489176	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-05	01	3	1	8	2	7	0	24	38	-1	45	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPTGQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCGGGACAGACCCCCGAATTGACGGGCCA	CASSSGTDPRID	In	VDJ	8	154	0.0019939921276154963	0.0023730641805994298	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02			5	0	5	21	3	13	24	36	46	39	59								TCRBJ02-01,TCRBJ02-05					Vb 18	CASSSGTDPRID+TCRBV18-01+TCRBJ02-X	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCAACAGGACAGGGAGCAAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	25	479	0.006202092396933913		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	3	7	6	6	24	35	49	41	55													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAATGAGGAGGGCTGGGCAATAGAAGCTTTCTTTGGACAA	CASNEEGWAIEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	12	10	0	8	9	10	26	31	46	40	56	TCRBV09,TCRBV12													CASNEEGWAIEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCCTGACAGATACGCAGTATTTTGGCCCA	CASSRLTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	10	0	3	2	3	26	37	41	39	44		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRLTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTATAATCGGGGAGCTGTTTTTTGGAGAA	CASSLIIGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	4	10	7	1	6	26	37	40	38	46		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLIIGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCGTTTCAACCTTGGCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVSTLAGANVLTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	6	9	0	4	12	1	26	37	52	49	53	TCRBV12,TCRBV21													CASSVSTLAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTCCTCGGCGGGGGGGCCATACAATGAGCAGTTCTTCGGGCCA	CASSSSAGGPYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	7	0	4	7	3	26	37	53	44	56	TCRBV09,TCRBV12													CASSSSAGGPYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTATTTCATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLFHSNQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	6	0	3	0	26	41	-1	44	46		TCRBV12-03,TCRBV12-04												CASSLFHSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTTTTCCAGGGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFPGVGANVLTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	4	2	3	2	1	26	40	48	42	49	TCRBV09,TCRBV12													CASSFPGVGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCGGGGGCTTTAAGGTTGAAGCTTTCTTTGGACAA	CASGGFKVEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	12	6	2	7	1	9	26	31	40	32	49	TCRBV12,TCRBV21													CASGGFKVEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGAARCYYRRGGAYTCAGCWGTGTATTTTTGTGCTAGTGCTGGGGAAGCCAATGAGCAGTTCTTCGGGCCA	CASAGEANEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	unresolved						TCRBJ02	TCRBJ02-01	01	7	0	8	6	3	3	26	36	43	39	46	TCRBV12,TCRBV16			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAGEANEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ACGTTTGGTGCATCCTGAAGACAGCAGCTTTACATCTGCAGTGCTAGGGGCAGGGGTATAGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	6	7.768800497203231E-5		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	21	4	2	2	20	5	37	30	56	50	61		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCGGACAGGGGCCGGAGAAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	6	7.768800497203231E-5		50				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	2	1	1	7	24	35	45	36	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGACAGGGGGCGGGATACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	6	7.768800497203231E-5		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	0	5	0	5	26	-1	55	43	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTGCAGGGGACGGATGGCTACACCTTCGGTTCG	CASSQLQGTDGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	2	6	3	4	26	41	50	44	54		TCRBV03-01,TCRBV03-02												CASSQLQGTDGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGCGGACGGATTAGAGTATGGCTACACCTTCGGTTCG	CASSADGLEYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	5	1	7	5	2	9	26	38	44	40	53	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSADGLEYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGCGGGGAGACAGGGAATAATTCACCCCTCCACTTTGGGAAC	CASSGETGNNSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	5	5	1	26	38	50	43	51	TCRBV03,TCRBV09													CASSGETGNNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGYYWGGWGACWCWGCWSKGTATTTCTGTGCCAGCAGCGTAGTCAGGGCCGGTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	6	7.768800497203231E-5		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	3	1	5	4	26	38	48	43	52	TCRBV03,TCRBV21													X+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTCCCGAACTGGACAGTCGGAGGGGCTACACCTTCGGTTCG	CASSPELDSRRGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	8	9	7	26	37	52	46	59		TCRBV03-01,TCRBV03-02												CASSPELDSRRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGTTACAGAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	6	7.768800497203231E-5		34	TCRBV03						TCRBJ01	TCRBJ01-01	01	8	3	5	5	3	3	26	35	42	38	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCAAAGGGGGGGCGATAACACAGATACGCAGTATTTTGGCCCA	CSAQRGGDNTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	9	0	2	5	6	26	34	46	39	52		TCRBV20-01,TCRBV20-or09_02												CSAQRGGDNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCCCGGACAGGAGGCAATCAGCCCCAGCATTTTGGTGAT	CSASRTGGNQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	1	4	2	5	2	26	34	46	39	48		TCRBV20-01,TCRBV20-or09_02												CSASRTGGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACGTATCGGGGCTACTAGCACAGATACGCAGTATTTTGGCCCA	CSATRIGATSTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	7	0	0	8	4	26	36	49	44	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATRIGATSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTCGGGGGACTAACACAGATACGCAGTATTTTGGCCCA	CSARGRGTNTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	0	9	2	5	1	26	39	51	44	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGRGTNTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCCCTTTCGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	6	7.768800497203231E-5		37	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	3	8	5	7	8	0	26	37	-1	45	48		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCGGACCACTGAAGCTTTCTTTGGACAA	CSARRTTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	1	7	4	2	0	26	37	-1	39	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRTTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCAGCAGGGGCGGGTCAGCCCCAGCATTTTGGTGAT	CSAPAGAGQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	2	6	4	4	26	35	45	39	49		TCRBV20-01,TCRBV20-or09_02												CSAPAGAGQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGACAGGGGCCAAGAGACCCAGTACTTCGGGCCA	CSAEDRGQETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	1	2	0	26	35	-1	37	46		TCRBV20-01,TCRBV20-or09_02												CSAEDRGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTCGCGACAGGACTCAATCAGCCCCAGCATTTTGGTGAT	CSVATGLNQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	2	4	3	4	3	26	33	43	37	46		TCRBV20-01,TCRBV20-or09_02												CSVATGLNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CYMCCWSYCARACWKCTKTKTACTTCTGTGCCAGCAGGTTCGACGGGATTCGCTATGGCTACACCTTCGGTTCG	CASRFDGIRYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	13	8	3	4	14	4	25	28	47	42	51	TCRBV06,TCRBV22													CASRFDGIRYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAACAGCCAAGGAAATAGACGGACCGGGGAGCTGTTTTTTGGAGAA	CANSQGNRRTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved						TCRBJ02	TCRBJ02-02	01	1	2	7	5	6	2	23	39	48	45	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANSQGNRRTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCTAGACGGACGCCGGGACTCGGAAGCTTTCTTTGGACAA	CASSLDGRRDSEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	0	10	8	14	2	22	33	53	47	55		TCRBV12-03,TCRBV12-04				01,02								CASSLDGRRDSEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGCGCGGGGGGGCGACACACCGGGGAGCTGTTTTTTGGAGAA	CASSAGGRHTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	0	3	1	4	22	33	43	34	47	TCRBV11,TCRBV12													CASSAGGRHTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGTAGTCGGGGCCCCTAGTGAGACCCAGTACTTCGGGCCA	CASSVVGAPSETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved						TCRBJ02	TCRBJ02-05	01	6	7	0	5	7	7	22	33	45	40	52	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVGAPSETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGGGGACAGGGTTCCTACGAGCAGTACGTCGGGCCG	CASRGQGSYEQYV	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	3	17	0	17	22	-1	42	33	59	TCRBV02,TCRBV12													CASRGQGSYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCARSSASWCAGCTSTKTACTTCTGTGCCAGCAGTCTACAGGATTACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQDYTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	3	4	3	2	3	22	34	41	36	44	TCRBV12,TCRBV24													CASSLQDYTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTCAGTATTGGGATACAAGAGACCCAGTACTTCGGGCCA	CASSFSIGIQETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	TCRBV12						TCRBJ02	TCRBJ02-05	01	3	0	8	2	7	2	22	36	47	43	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSIGIQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCGCTAGACAGGGGATGAACACTGAAGCTTTCTTTGGACAA	CAARQGMNTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	2	0	4	1	22	28	40	32	41	TCRBV09,TCRBV12													CAARQGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACACCGGGACAGTGAGTGGATGGCTACACCTTCGGTTCG	CATSDTPGQ*VDGYTF	Stop	VDJ	1	6	7.768800497203231E-5		48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	6	5	7	24	39	51	44	58		TCRBV24-01,TCRBV24-or09_02												CATSDTPGQ*VDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCACCAAAAAGGGTAAAGGTTTTGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	6	7.768800497203231E-5		50	unresolved						TCRBJ01	TCRBJ01-05	01	11	5	3	2	9	10	24	31	44	40	54	TCRBV06,TCRBV10,TCRBV24			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSSSASWCAKCYSTGTACTTSTGTGCCAGCACTCCCCAGGGTAATTCACCCCTCCACTTTGGGAAC	CASTPQGNSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	4	3	6	5	0	23	33	-1	38	43	TCRBV06,TCRBV13													CASTPQGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGACAAACAGGGGGTTTCACCGGGGAGCTGTTTTTTGGAGAA	CASRQTGGFTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	1	4	4	3	23	34	46	38	49	TCRBV06,TCRBV10													CASRQTGGFTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTSSSASWCAKCYSTGTACTTSTGTGCCAGCAGTGCGGTCGGTAAAAACATTCAGTACTTCGGCGCC	CASSAVGKNIQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	7	5	4	0	5	23	-1	39	35	44	TCRBV06,TCRBV13					01,02								CASSAVGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCCCGAGCGGGGGGGGAAGTTATACGAGCAGTACGTCGGGCCG		Out	VDJ	1	6	7.768800497203231E-5		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	8	6	0	17	3	20	23	32	45	35	65	TCRBV06,TCRBV10													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ACGACTCGGCYSTGTATCTCTGTGCCAGCAGCTTAGTGGGACAGGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLVGQENTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	4	1	1	1	19	35	44	36	45	TCRBV05,TCRBV07													CASSLVGQENTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTTGAGCAGGGTTTCACTGAAGCTTTCTTTGGACAA	CASSFEQGFTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	3	4	4	3	19	33	42	37	45	TCRBV07,TCRBV11													CASSFEQGFTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCATGGCGAGGGGCCTCAATTCACCCCTCCACTTTGGGAAC	CASMARGLNSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved						TCRBJ01	TCRBJ01-06	01	7	5	2	7	5	4	26	36	46	41	50	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMARGLNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGAATGACTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASRMTSSYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	8	0	3	0	26	37	-1	40	46	TCRBV06,TCRBV10					01,02								CASRMTSSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCSCTCYCAGACWTCTGTKTAYTTCTGYGCCAGCAGTTCTTCGACAGATAGGAGCACTGAAGCTTTCTTTGGACAA	CASSSSTDRSTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	5	4	4	7	26	39	48	43	55	TCRBV06,TCRBV10													CASSSSTDRSTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCKCTGTGCCAGCAGCTTAGGYGCCGGACAGAATCAGCCCCAGCATTTTGGTGAT	CASSLGAGQNQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	1	5	4	5	0	18	34	-1	39	45	TCRBV05,TCRBV07,TCRBV11													CASSLGAGQNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTCGTCCGGACAGGGGAATATGGCTACACCTTCGGTTCG	CASSFVRTGEYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	2	5	5	2	18	32	46	37	48	TCRBV07,TCRBV11													CASSFVRTGEYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGTCCTCGGACGGGAATGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	6	7.768800497203231E-5		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	8	3	1	8	3	18	29	42	37	45	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCAACGGCTCAGGGGGGATGTCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	0	8	5	18	30	45	38	50	TCRBV07,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCGTAGGGGGCCTCACGGACACTGAAACTTTCTTTGGACAA	CASSVGGLTDTETFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	1	6	12	10	6	18	34	49	44	55	TCRBV07,TCRBV11													CASSVGGLTDTETFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCGTCGGACAGGAGTGGGAGACCCAGTACTTCGGGCCA	CASSVGQEWETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	4	5	3	5	18	30	40	33	45	TCRBV07,TCRBV11													CASSVGQEWETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGCGGCCGGCAGCACAATTAGAGAACTATGGCTACACCTTCGGTTCG	CASSLRPAAQLENYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	7	5	2	0	18	18	-1	36	32	54	TCRBV07,TCRBV11					01,02								CASSLRPAAQLENYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCGAATTTACTAGACAGGGGAGATCAGCCCCAGCATTTTGGTGAT	CASSPNLLDRGDQPQHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	2	2	5	12	2	18	30	50	42	52	TCRBV07,TCRBV11													CASSPNLLDRGDQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGATCGAGGGGTGGGCGATGGCTACACCTTCGGTTCG	CASSLDRGVGDGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved						TCRBJ01	TCRBJ01-02	01	0	5	2	6	3	6	18	35	43	38	49	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRGVGDGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGACTCCTAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGLLNTGELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	2	10	2	0	4	18	-1	38	34	42	TCRBV07,TCRBV11					01,02								CASSLGLLNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTGCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLVRGSTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	2	0	1	0	18	34	-1	35	42	TCRBV07,TCRBV11													CASSLVRGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTATTTTTGGTTCAGGACACTGAAGCTTTCTTTGGACAA	CASSLFLVQDTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	3	9	0	18	33	-1	42	46	TCRBV05,TCRBV11													CASSLFLVQDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGCGGCGCCGGGACAGGGTCTTAGAGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	8	8	7	18	32	49	40	56	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTGGAGGGAAGGGGGGCTATGGCTACACCTTCGGTTCG	CASSFGGKGGYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved						TCRBJ01	TCRBJ01-02	01	3	5	1	4	8	1	18	32	46	40	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGGKGGYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCACCCTGGTGGGTTCTAACTATGGCTACACCTTCGGTTCG	CASTLVGSNYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved						TCRBJ01	TCRBJ01-02	01	7	0	9	0	7	2	20	30	40	37	42	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLVGSNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAAGACAGCTCGAACACTGAAGCTTTCTTTGGACAA	XASSQDSSNTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	2	2	5	1	0	3	20	-1	40	35	43	TCRBV04,TCRBV23			TCRBD01,TCRBD02										XASSQDSSNTEAFF+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGRGACWCRGCMSTGTATCTCTRCGCCAGCAGCCAATCAGGAATCTATGGCTACACCTTCGGTTCG	XASSQSGIYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	2	4	4	4	1	3	22	37	42	38	45	TCRBV04,TCRBV23			TCRBD01,TCRBD02										XASSQSGIYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GARGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTAGACAGGGGGTCTCGGGAGCTGTTTTTTGGAGAA	CASSLDRGSRELFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	3	1	9	0	4	19	-1	43	35	47	TCRBV04,TCRBV07													CASSLDRGSRELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCKCTGTGCCAGAAGCTTGGAGGCGGACAGGGGGTTGCTGGAGCAGTTCTTCGGGCCA	CARSLEADRGLLEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	1	10	4	6	19	35	49	39	55	TCRBV05,TCRBV07													CARSLEADRGLLEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTAGAGACGTGGGGGGCCTACAATGAACAGTTCTTCGGGCCA	CASSLETWGAYNEQFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved						TCRBJ02	TCRBJ02-01	01	1	6	0	13	7	10	19	35	48	42	58	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLETWGAYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTATTTCCGGGACTAGCAGCAGATACGCAGTATTTTGGCCCA	CASSLFPGLAADTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	0	7	4	5	2	19	34	48	39	50	TCRBV07,TCRBV11					01,02								CASSLFPGLAADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAAGAAGGACAGCGTCAATTCACCCCTCCACTTTGGGAAC	CASKKDSVNSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	5	7	4	4	19	29	39	33	43	TCRBV05,TCRBV07													CASKKDSVNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMCTGTATCTCTGYGCCAGCAGCCAAGAACTGTGGGAGGATACAAACCTAGCTAACTATGGCTACACCTTCGGTTCG	CASSQELWEDTNLANYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	1	0	5	12	19	36	47	41	59	TCRBV04,TCRBV23													CASSQELWEDTNLANYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCAAGGAACTAGCGGGGGGCAGGAGACCCAGTACTTCGGGCCA	CASSQGTSGGQETQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	3	1	5	2	3	19	35	49	37	52	TCRBV04,TCRBV05													CASSQGTSGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTACAGGGAATGAGCAGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		40	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	8	0	8	19	-1	39	33	47	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTAGCGGGTGGGACTAGCGGGCCAGAAAATACGCAGTATTTTGGCCCA	CASSLAGGTSGPENTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	54	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	0	4	7	4	7	19	36	52	40	59	TCRBV05,TCRBV11					01,02								CASSLAGGTSGPENTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCTTAGTAGGAGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSLVGGGTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	1	1	2	2	22	38	45	40	47	TCRBV07,TCRBV12													CASSLVGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGTGCATCCTGAAGACAGCAGCTTCACATCTGCAGTGCTAGAGATCTTGCGCTCACCCAGAACAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	6	7.768800497203231E-5		50	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	20	4	8	5	12	23	31	25	41	37	64		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCTATAGTCGAGGAGTCGAGGCCCTTCTGACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		53	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	10	10	2	3	11	14	24	31	46	42	60	TCRBV09,TCRBV21													X+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCCCTGACAGCTCCTATGGCTACACCTTCGGTTCG	CASSPDSSYGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	5	4	4	3	23	34	43	38	46	TCRBV02,TCRBV21													CASSPDSSYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGAACGGAGCGGGAGGCTTTAGCACAGATACGCAGTATTTTGGCCCA	CASRNGAGGFSTDTQYF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	1	0	6	4	23	34	49	40	53	TCRBV02,TCRBV21													CASRNGAGGFSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCACCGGACAGGATACCTCACCCCTCCACTTTGGGAAC	CATGQDTSPLHF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	9	1	4	10	2	5	23	30	39	32	44	TCRBV02,TCRBV09													CATGQDTSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCCCTTCCGAGGACGGGGCGGATGTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	6	7.768800497203231E-5		52	unresolved						TCRBJ01	TCRBJ01-02	01	3	7	0	5	13	6	23	36	54	49	60	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCTTACAGGGGGGGATCGCCGATGGCTACACCTTCGGTTCG	CASSLQGGIADGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	1	6	2	9	23	35	45	37	54	TCRBV02,TCRBV09,TCRBV13													CASSLQGGIADGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCAGTTTCGCTACCGGGTGGGGCTACACCTTCGGTTCG	CASSFATGWGYTF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	4	8	9	3	23	34	47	43	50	TCRBV03,TCRBV09					01,02								CASSFATGWGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCWMYCAGACAKCTSTKTACTTCTGTGCCATCAGTGAGTCTGAGGGTACTGAAGCTTTCTTTGGACAA	CAISESEGTEAFF	In	VDJ	1	6	7.768800497203231E-5	9.245704599738038E-5	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	11	0	5	4	1	28	42	51	46	52	TCRBV06,TCRBV24													CAISESEGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGTCGACAGGGGCCTCTGGAAACACCATATATTTTGGAGAG	CASRSTGASGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	2	2	0	3	1	26	37	48	40	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRSTGASGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGGGACTAGCGGAACAGATACGCAGTATTTTGGCCCA	CASSPGTSGTDTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	5	3	3	1	26	38	52	41	53		TCRBV12-03,TCRBV12-04				01,02								CASSPGTSGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCCCGGACAGGGGGCTAGATACGCAGTATTTTGGCCCA	CASSFPDRGLDTQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	0	5	3	1	26	40	54	43	55		TCRBV12-03,TCRBV12-04												CASSFPDRGLDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCTTTCAATATTTTGCGAGCAGTACGTCGGGCCG		Out	VDJ	1	7	9.063600580070438E-5		41	TCRBV12						TCRBJ02	TCRBJ02-07	01	3	4	5	17	18	4	26	40	61	58	65		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGACTATCGCCCCGGGGAGCTGTTTTTTGGAGAA	CASSLDYRPGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	1	9	6	0	5	26	-1	46	40	51		TCRBV12-03,TCRBV12-04				01,02								CASSLDYRPGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGCATAGCGGGGGGGGTAAACAATAAGCAGTTCTTCGGGCCA	CASSIAGGVNNKQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	5	0	11	2	10	24	35	48	37	58	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSIAGGVNNKQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCATGCCAACGGTGAATTCACCCCTCCACTTTGGGAAC	CASMPTVNSPLHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39				TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	8	5	7	6	2	24	34	43	40	45	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASMPTVNSPLHF+X+TCRBJ01-06		TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTCCTTGGACAGGGGGCGACTCACCCCTCCACTTTGGGAAC	CASSQAPWTGGDSPLHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	1	0	10	6	3	26	42	59	48	62		TCRBV03-01,TCRBV03-02												CASSQAPWTGGDSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACTCGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQGLGTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	2	10	4	0	3	26	-1	46	42	49		TCRBV03-01,TCRBV03-02				01,02								CASSQGLGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTTCCGAGGGGGCTGGCTACACCTTCGGTTCG	CASSQGSEGAGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	0	7	6	0	26	42	-1	48	55		TCRBV03-01,TCRBV03-02												CASSQGSEGAGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTTTCAACCAAGGCGACGGAGGCGGCTACACCTTCGGTTCG	CASSFNQGDGGGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	10	1	8	16	1	26	37	58	53	59		TCRBV03-01,TCRBV03-02												CASSFNQGDGGGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAGGGGGCAGGGGTGGATCAGCCCCAGCATTTTGGTGAT	CSAKGAGVDQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	5	0	5	2	8	26	34	43	36	51		TCRBV20-01,TCRBV20-or09_02												CSAKGAGVDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGTGCCTATTTCCGGGACAGGGGACTGGGCAAATGAGCAGTTCTTCGGGCCA	CSAVPISGTGDWANEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	7	13	8	26	34	57	47	65		TCRBV20-01,TCRBV20-or09_02												CSAVPISGTGDWANEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGCCGGGACTAAGGTGGGAGACCCAGTACTTCGGGCCA	CSARRPGLRWETQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	9	5	5	6	26	38	50	43	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRPGLRWETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCAGGGGCAAGCAATCAGCCCCAGCATTTTGGTGAT	CSARAGASNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	1	0	2	26	-1	45	39	47		TCRBV20-01,TCRBV20-or09_02												CSARAGASNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGAACAGGACCACAATGAGCAGTTCTTCGGGCCA	CSARGEQDHNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	3	4	5	4	3	26	39	48	43	51		TCRBV20-01,TCRBV20-or09_02												CSARGEQDHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTAGCGGTTTCCCCTACAATGAGCAGTTCTTCGGGCCA	CSARSSGFPYNEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	5	2	2	5	26	37	46	39	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSSGFPYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCATTTCCTGGGCGGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSAAFPGRGDTGELFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	7	1	3	11	0	26	35	-1	46	54		TCRBV20-01,TCRBV20-or09_02												CSAAFPGRGDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGGCTGGGAGGGGCCGCCGGGGACCGCCTTCGGTTCG	CASSGWEGPPGTAF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	15	5	14	22	33	45	38	59		TCRBV12-03,TCRBV12-04												CASSGWEGPPGTAF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGAAGGCTAAGCGGCGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	7	9.063600580070438E-5		41	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	6	5	6	8	2	22	33	46	41	48		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGACGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASRTYSNQPQHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	39	TCRBV12						TCRBJ01	TCRBJ01-05	01	6	2	7	0	0	3	22	-1	36	33	39		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRTYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGTCGACAGGGCAAGAGACCCAGTACTTCGGGCCA	CATSESTGQETQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	3	2	3	0	24	38	-1	41	48		TCRBV24-01,TCRBV24-or09_02												CATSESTGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCTTAACTGGAAACTATGGCTACACCTTCGGTTCG	CATSDSLTGNYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV24						TCRBJ01	TCRBJ01-02	01	2	1	8	2	8	0	24	40	-1	48	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDSLTGNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGGACAGGGGAACCAAAAACATTCAGTACTTCGGCGCC	CATSDWDRGTKNIQYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	2	0	2	2	0	2	24	-1	50	40	52		TCRBV24-01,TCRBV24-or09_02												CATSDWDRGTKNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGGGGGACAGGGGTTCTACTATGGCTACACTTTCGGTTCG	CASSFGGQGFYYGYTF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	17	5	18	24	36	51	41	69		TCRBV24-01,TCRBV24-or09_02												CASSFGGQGFYYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGGGATCCTAATTCACCCCTCCACTTTGGGAAC	CASSFGDPNSPLHF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	0	8	6	4	3	24	36	44	40	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGDPNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATGGGGACTAGCGGGGGTACCAGCCCCCCTTGAGCAGTTCTTCGGGCCA	CASSLWGLAGVPAPLEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	57	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	9	2	13	24	39	55	41	68		TCRBV12-03,TCRBV12-04												CASSLWGLAGVPAPLEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTTCGGGGTCCCCATGAGCAGTTCTTCGGGCCA	CASSEFRGPHEQFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	42	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	3	8	3	5	23	38	46	41	51		TCRBV06-01,TCRBV06-08												CASSEFRGPHEQFF+TCRBV06-X+TCRBJ02-01	TCRBV06	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGGCTTCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSLAASTNEKLFF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	9	0	2	0	4	18	-1	38	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAASTNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTCTCAGAAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSLSEVSGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	5	0	4	4	19	31	38	35	42		TCRBV05-06,TCRBV05-07												CASSLSEVSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGGAGGGGCGCGTGGAAACACCATATATTTTGGAGAG	CASSLGGARGNTIYF	In	VDJ	1	7	9.063600580070438E-5	1.0786655366361044E-4	45	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	10	0	3	1	5	19	33	40	34	45		TCRBV05-06,TCRBV05-07												CASSLGGARGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCYRTGTATYKYTGTGCCAGCAGCTTAGGGGGGGTCGGCCGCACAGATACGCAGTATTTTGGCCCA	CASSLGGVGRTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	1	1	0	6	26	-1	48	42	54	TCRBV07,TCRBV12													CASSLGGVGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACCCGTTTCGGCTTCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLPVSASTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV12						TCRBJ02	TCRBJ02-02	01	2	9	0	4	8	3	26	41	52	49	55		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPVSASTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGACGGATATGGCTACACCTTCGGTTCG	CASSFDGYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	TCRBV12						TCRBJ01	TCRBJ01-02	01	3	1	8	5	4	0	26	40	-1	44	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFDGYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGTGGGACTAGCGGGTCCGTCACAGATACGCAGTATTTTGGCCCA	CASGTSGSVTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	2	4	2	0	5	26	-1	47	37	52	TCRBV09,TCRBV12					01,02								CASGTSGSVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAACGGGGCAGGGGGCGCGACACTGAAGCTTTCTTTGGACAA	XASSQRGRGRDTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	0	3	5	3	23	38	51	43	54	TCRBV01,TCRBV04													XASSQRGRGRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CASCWMCCAGACATCTRTGTACYTCTGTGCCAGCAGGGACAGGGAGCGTATTGACTGGCTACACCTTCGGTTCG		Out	VDJ	1	8	1.0358400662937643E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	7	0	11	24	-1	43	35	54	TCRBV06,TCRBV10,TCRBV28													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTACCAGCAGCCCCAGTAACTATGGCTACACCTTCGGTTCG	CTSSPSNYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	4	4	5	1	1	0	26	39	-1	40	43	TCRBV03,TCRBV12			TCRBD01,TCRBD02										CTSSPSNYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCGGGGGATCGGGACAGGGACCAATGAGCAGTTCTTCGGGCCA	CASTRGIGTGTNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	3	6	11	2	26	36	56	47	58		TCRBV03-01,TCRBV03-02												CASTRGIGTGTNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGGTTAGGTCTAACGGGGGGGCGGAGACCCAGTACTTCGGGCCA	CASSQGVRSNGGAETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	5	13	2	26	42	63	55	65		TCRBV03-01,TCRBV03-02												CASSQGVRSNGGAETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGGATCCTGGAGGGAAAAACTGTTTTTTGGCAGT	CASSPGSWREKLFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	4	10	1	8	9	0	26	39	-1	48	53		TCRBV03-01,TCRBV03-02												CASSPGSWREKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCCCACTCGGTTATGGCTACACCTTCGGTTCG	CASSPPLGYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	3	10	5	4	4	26	39	46	43	50		TCRBV03-01,TCRBV03-02				01,02								CASSPPLGYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
RGGGGACTCAGCYSTGTATCTCTGTGCCAGCAGCGAACAGGGATTGAAAGCAGATACGCAGTATTTTGGCCCA	CASSEQGLKADTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	3	4	4	8	22	32	42	36	50	TCRBV05,TCRBV07													CASSEQGLKADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASGTGGTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	0	2	1	0	0	22	-1	-1	31	41	TCRBV05,TCRBV07													CASGTGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAAGCCGGGGCCGGCACAGATACGCAGTATTTTGGCCCA	CSAQAGAGTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	6	7	0	1	7	2	26	34	46	41	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQAGAGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGGACAGGGGTAAAGAGACCCAGTACTTCGGGCCA	CSAADRGKETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	2	3	3	2	26	34	46	37	48		TCRBV20-01,TCRBV20-or09_02												CSAADRGKETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAAGGTGGGTAGCGGGGGGCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		52	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	1	17	9	17	26	40	59	49	76		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGTCTAGGCGGGGGTGGCACAGATACGCAGTATTTTGGCCCA	CSARDRLGGGGTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	2	1	8	2	26	40	55	48	57		TCRBV20-01,TCRBV20-or09_02												CSARDRLGGGGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCTGGGGAGCTCGGGACAGTGTAGCGGGTGAGCAGTTCTTCGGGCCA	CSARGWGARDSVAGEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	0	5	9	12	9	26	39	58	51	67		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGWGARDSVAGEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCCCACTAGCACAGATACGCAGTATTTTGGCCCA	CSARVPTSTDTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	10	0	5	0	26	39	-1	44	47		TCRBV20-01,TCRBV20-or09_02				01,02								CSARVPTSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGGGGACAGGGGGCCTCCTATGGCTACACCTTCGGTTCG	CSGGQGASYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	0	0	4	1	3	26	33	46	34	49		TCRBV20-01,TCRBV20-or09_02												CSGGQGASYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCAGTCCCCTCGCGGGGGCTTTGGCGGCTTTCTTTGGACAA	CASSPLAGALAAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	7	2	11	6	8	25	37	50	43	58	TCRBV24,TCRBV28													CASSPLAGALAAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGGGCTAGAGAGGTTACAGGAGAACACTGAAGCTTTCTTTGGACAA	CTSSQGLERLQENTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	4	1	13	1	23	39	57	52	58	TCRBV01,TCRBV04													CTSSQGLERLQENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGTGGAGGGAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	8	1.0358400662937643E-4		46	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	10	0	0	1	2	23	39	46	40	48	TCRBV01,TCRBV04													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCGGTGGACCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	8	1.0358400662937643E-4		40	unresolved						TCRBJ01	TCRBJ01-02	01	4	1	7	4	5	2	23	36	45	41	47	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGCGTCCAGGGGGAGCAGTTCTTCGGGCCA	CASSRVQGEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	2	10	5	0	23	36	-1	41	47	TCRBV01,TCRBV04													CASSRVQGEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCTACACAGGGGGAAATGGCTACACCTTCGGTTCG	CASSYTGGNGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	1	6	3	2	23	35	46	38	48	TCRBV01,TCRBV04													CASSYTGGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAAAAGTTATGAGAATCAGCCCCAGCATTTTGGTGAT	CASKSYENQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	11	2	4	8	0	22	32	-1	40	43	TCRBV09,TCRBV12													CASKSYENQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCTTAGCAGGGGGCCTCTCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLAGGLSGANVLTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	0	5	0	4	0	6	22	-1	46	39	52		TCRBV12-03,TCRBV12-04												CASSLAGGLSGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGCCGGGACAGCAGAGGAAAACTGTTTTTTGGCAGT		Out	VDJ	1	8	1.0358400662937643E-4		40	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	10	3	6	22	33	43	36	49		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCTAGCAGTCAGTGGACAGGGAGAAACTATGGCTACACTTTCGGTTCG	CASSQWTGRNYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	3	17	4	18	22	34	46	38	64	TCRBV09,TCRBV12													CASSQWTGRNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTGACTAGCGGGGGAACCGGGGAGCTGTTTTTTGGAGAA	CATSLTSGGTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	2	2	5	3	1	24	35	50	38	51		TCRBV24-01,TCRBV24-or09_02												CATSLTSGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MSCWMCCAGACAKCTSTKTACTTCTGTGCCAGCAGTCCAGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSPGQGNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	1	3	0	24	36	-1	39	47	TCRBV06,TCRBV10,TCRBV24													CASSPGQGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCAAGGGGGACTGAAGCTTTCTTTGGACAA	CASSLSRGTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	1	5	6	0	24	36	-1	42	48	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSRGTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGACAGATCGAGCAGTACGTCGGGCCG		Out	VDJ	1	8	1.0358400662937643E-4		35	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	5	17	3	13	24	36	44	39	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCCGATTGACAGGGACTCTGCGGACTGAAGCTTTCTTTGGACAA	CASRLTGTLRTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	2	3	5	7	9	24	31	45	38	54		TCRBV24-01,TCRBV24-or09_02												CASRLTGTLRTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCCTTCGGACGGATTCACCCCTCCACTTTGGGAAC	CASSLRTDSPLHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved						TCRBJ01	TCRBJ01-06	01	6	1	7	8	5	2	23	34	43	39	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRTDSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCCTAGGGGGGGCGAAAACTATGGCTACACCTTCGGTTCG	CASSPRGGENYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	5	9	0	2	4	4	23	35	46	39	50	TCRBV06,TCRBV10													CASSPRGGENYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGATACCCTGGGGAGCGGCTACACCTTCGGTTCG	CASSDTLGSGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	9	2	8	9	1	23	35	49	44	50	TCRBV06,TCRBV10													CASSDTLGSGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCGCCCCGACAGGGGAACGGCGAGAGGGCTACACCTTCGGTTCG	CAIAPTGERREGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	2	2	8	7	11	23	30	45	37	56	TCRBV06,TCRBV10													CAIAPTGERREGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCAGCAGAGGGGGCGCTTGGAAAGAGACCCAGTACTTCGGGCCA	CASRGGAWKETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	0	3	0	7	26	-1	44	37	51	TCRBV06,TCRBV24													CASRGGAWKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCAGCAGTCGGGACAAGGTGGCCTTGAACACTGAAGCTTTCTTTGGACAA	CASSRDKVALNTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	6	0	1	9	26	38	45	39	54	TCRBV06,TCRBV24													CASSRDKVALNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAAGACTCGGCCSTGTATSTCTGTGCCAGCAGCGCTCAACGCACTAGCGGGGGGGGAACAGAGTTCTTCGGGCCA	CASSAQRTSGGGTEFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	0	14	9	6	21	33	55	42	61	TCRBV04,TCRBV11													CASSAQRTSGGGTEFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCRGCYRTGTATYKYTGTGCCAGCAGCGTAGGACCGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSVGPGQETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-05	01	1	8	4	1	3	0	18	34	-1	37	41	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASSVGPGQETQYF+X+TCRBJ02-05	unresolved	unresolved	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAATGGTTTTATTCTATGGCTACACCTTCGGTTCG	CASSLMVLFYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	2	0	10	4	2	7	18	33	37	35	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMVLFYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAAACCCGATTAGGGGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	8	1.0358400662937643E-4		46				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	5	2	7	10	0	18	34	-1	44	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02												X+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTGTATSTCTGTGCCAGAAGCTTCTGTAGTCTTATCAACGGACAGGGGTCCCGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	8	1.0358400662937643E-4		62	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	1	16	4	18	32	57	48	61	TCRBV05,TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACCCCCCAGGGGGGGGATACAATGAGCAGTTCTTCGGGCCA	CASNPPGGGYNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	7	4	1	4	6	4	18	28	41	34	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPPGGGYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGAAGACTCRGCCSTGTATSTCTGYGCCAGCAGCCACTCCGGGACTAGCTCTAGTGAGCAGTTCTTCGGGCCA	CASSHSGTSSSEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	9	6	5	18	30	45	36	50	TCRBV04,TCRBV11					01,02								CASSHSGTSSSEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGAGACAGGGGGCGCTCACTGAAGCTTTCTTTGGACAA	CASSSRQGALTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	0	4	3	3	18	31	44	34	47	TCRBV07,TCRBV11													CASSSRQGALTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGGGCCAGGGCCTCCAGCCCCAGCATTTTGGTGAT	CASSLEGQGLQPQHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	3	7	4	4	18	35	44	39	48	TCRBV07,TCRBV11													CASSLEGQGLQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAGCTAGCGGGGGGGCCAAAAGAGAGACCCAGTACTTCGGGCCA	CASSLASGGAKRETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	0	4	0	7	18	-1	46	35	53	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASGGAKRETQYF+X+TCRBJ02-05		TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGGGTGGGGGATAACTATGGCTACACCTTCGGTTCG	CASSLGVGDNYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	1	6	1	1	4	1	18	34	43	38	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGVGDNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTATTAGGGGCAGGGCTCTACGAGCAGTACGTCGGGCCG	CASSLLGAGLYEQYV	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	17	7	16	18	33	45	40	61	TCRBV07,TCRBV11													CASSLLGAGLYEQYV+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGACAGGCCGGGGGGACTGAAGCTTTCTTTGGACAA	CASSLGQAGGTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	4	5	0	8	18	-1	40	32	48	TCRBV07,TCRBV11													CASSLGQAGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTCGACTAGCGGGGGGAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSFRLAGGGTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	2	1	4	2	3	18	32	47	34	50	TCRBV07,TCRBV11													CASSFRLAGGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGATCTGGGACAGCGAACTATGGCTACACCTTCGGTTCG	CASRSGTANYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	2	4	2	20	31	42	35	44	TCRBV11,TCRBV23													CASRSGTANYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCCTACAGGGGGCTGCTGAAAAACTGTTTTTTGGCAGT	CASSLQGAAEKLFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	0	7	3	3	20	31	43	34	46	TCRBV11,TCRBV23													CASSLQGAAEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGCTTGGAACTGGACACCGCCGGGCACAATGAGCAGTTCTTCGGGCCA	CASSLELDTAGHNEQFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	1	6	5	9	9	20	31	45	40	54	TCRBV11,TCRBV23													CASSLELDTAGHNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCACGGGACTAATTCACCCCTCCACTTTGGGAAC	XASSHGTNSPLHF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved						TCRBJ01	TCRBJ01-06	01	3	0	7	6	1	0	22	36	-1	37	42	TCRBV04,TCRBV07,TCRBV17			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									XASSHGTNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGCTTAGAGGGGTCAGGTTATGGCTACACCTTCGGTTCG	CASSLEGSGYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	5	2	5	0	6	19	-1	40	35	46	TCRBV07,TCRBV11													CASSLEGSGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCGGCCMTGTATCTCTGTGCCAGCAGCCCTACGGGACAGGACTATGGCTACACCTTCGGTTCG	CASSPTGQDYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	4	3	5	0	19	31	-1	36	44	TCRBV05,TCRBV11													CASSPTGQDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCAAGCCCCRGGCGGACGGAACTATGGCTACACCTTCGGTTCG	CASSQAPGGRNYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved						TCRBJ01	TCRBJ01-02	01	4	1	7	2	12	2	19	31	47	43	49	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAPGGRNYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGATTGGACAGGGGGAAAAGGCTACACCTTCGGTTCG	CASSLDWTGGKGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	1	8	5	4	19	33	48	38	52		TCRBV05-06,TCRBV05-07												CASSLDWTGGKGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTGCAGGTGCGGAAAGAGACCCAGTACTTCGGGCCA	CASSLQVRKETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	1	4	4	3	0	6	19	-1	38	34	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQVRKETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCAAGAGGGCACCACAGGTTACTATGGCTACACCTTCGGTTCG	CASSQEGTTGYYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	48	unresolved			unresolved			TCRBJ01	TCRBJ01-02	01	0	3	4	3	7	2	19	36	48	43	50	TCRBV04,TCRBV11			TCRBD01,TCRBD02										CASSQEGTTGYYGYTF+X+TCRBJ01-02	unresolved	unresolved	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMCTGTATCTCTGYGCCAGCAGCCAAGCCCGAAGGGGGGCTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQARRGASGANVLTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	54	unresolved						TCRBJ02	TCRBJ02-06	01	1	5	1	1	5	3	19	35	46	40	49	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQARRGASGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCTGGGACAGCTCCACGGACGGCTACACCTTCGGTTCG	CASSWDSSTDGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	5	8	0	10	19	-1	39	32	49	TCRBV05,TCRBV07													CASSWDSSTDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMCTKTATCTYTGCGCCAGCAGCTTGGCCGGAGCAAACACTGAAGCTTTCTTTGGACAA	CASSLAGANTEAFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	2	2	2	2	19	35	41	37	43	TCRBV05,TCRBV23													CASSLAGANTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CRGRRGACTCAGCYSTGTATCTCTGYGCCAGCAGCCAAGTCGGGGAGAGCCTCTATGGCTACACCTTCGGTTCG	CASSQVGESLYGYTF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	3	4	5	7	22	34	44	39	51	TCRBV04,TCRBV07					01,02								CASSQVGESLYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGGAGACWCRGCMSKGTATKTCTGTGCCAGCAGATGTGGTACGGGACTGGGGGACACCGGGGAGCTGTTTTTTGGAGAA	CASRCGTGLGDTGELFF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	0	10	3	9	5	24	35	50	44	55	TCRBV11,TCRBV21					01,02								CASRCGTGLGDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCCCWMCCARACAKCTSTKTACTTCTGTGCCAGCAGTCCGGGACTAGCGGGGGAGACCCAGTACTTCGGGCCA	CASSPGLAGETQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	0	3	5	2	0	25	37	-1	39	52	TCRBV06,TCRBV24													CASSPGLAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTKGGKGACTCWGCTKTGTATTTCTGTGCCAGCACCTCGTGGGGGGCCGATACGCAGTATTTTGGCCCA	CASTSWGADTQYF	In	VDJ	1	8	1.0358400662937643E-4	1.232760613298405E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	6	6	0	6	7	1	23	33	46	40	47	TCRBV03,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTSWGADTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAACCGAACGCCAATTCACCCCTCCACTTTGGGAAC	CASSEPNANSPLHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV12						TCRBJ01	TCRBJ01-06	01	5	2	8	7	0	10	26	-1	40	38	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEPNANSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGTGGGCAAAACATTCAGTACTTCGGCGCC	CASSLGGQNIQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	8	0	5	2	0	26	42	-1	44	48		TCRBV12-03,TCRBV12-04												CASSLGGQNIQYF+TCRBV12-X+TCRBJ02-04	TCRBV12	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGTTGGGGCCCCAAGCTTTCTTTGGACAA	CASSQGLGPQAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	9	4	3	26	42	51	46	54		TCRBV03-01,TCRBV03-02												CASSQGLGPQAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTTGCATTTGGGGAAAAACTGTTTTTTGGCAGT	CASSFAFGEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV03						TCRBJ01	TCRBJ01-04	01	5	0	9	8	9	0	26	38	-1	47	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFAFGEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACGACTAGCGGGGGGCGCACAGATACGCAGTATTTTGGCCCA	CSARTTSGGRTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	2	1	1	2	1	26	38	53	40	54		TCRBV20-01,TCRBV20-or09_02												CSARTTSGGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACAGGTCACAGATACGCAGTATTTTGGCCCA	CSARQVTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	4	2	0	1	26	-1	42	38	43		TCRBV20-01,TCRBV20-or09_02												CSARQVTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTTTGTTGGGGGAGGGCACTACACCTTCGGTTCG	CSAREFVGGGHYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	9	0	10	9	2	26	40	56	49	58		TCRBV20-01,TCRBV20-or09_02												CSAREFVGGGHYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGACAGGGGGAGTGGCTACACCTTCGGTTCG	CSARDDRGSGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	1	7	1	2	26	40	50	41	52		TCRBV20-01,TCRBV20-or09_02												CSARDDRGSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCGCCCGGGGTAGAGGAAAAACTGTTTTTTGGCAGT	CSARAPGVEEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	1	8	3	8	4	5	26	39	48	43	53		TCRBV20-01,TCRBV20-or09_02												CSARAPGVEEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VJ	1	9	1.1653200745804848E-4		34	TCRBV20						TCRBJ01	TCRBJ01-04	01	1	0	0	3	0	1	26	-1	39	-1	40		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTAAACGGACCGGGGCCGGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	9	1.1653200745804848E-4		46	TCRBV20						TCRBJ01	TCRBJ01-04	01	3	7	0	8	12	3	26	37	54	49	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGCTCCGAGCACAGATACGCAGTATTTTGGCCCA	CSASAPSTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	10	0	0	1	4	26	37	40	38	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASAPSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCTCGGCAGAATAATCAGCCCCAGCATTTTGGTGAT	CSASSRQNNQPQHF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	4	5	4	7	3	26	37	47	44	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSRQNNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCGGGAACACCGGGGAACTGTTTTTTGGAGAA	CSAGGNTGELFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	7	3	14	1	11	26	35	42	36	53		TCRBV20-01,TCRBV20-or09_02												CSAGGNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACTCTGGAAACACCATATATTTTGGAGAG	CSAYSGNTIYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	9	0	0	0	26	-1	-1	35	37		TCRBV20-01,TCRBV20-or09_02				01,02								CSAYSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATGGCAAGGAGGGCACAGATACGCAGTATTTTGGCCCA	CSAYGKEGTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	10	1	1	8	0	26	35	-1	43	48		TCRBV20-01,TCRBV20-or09_02												CSAYGKEGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCCGAACAGGGAATTTAGGAAACACCATATATTTTGGAGAG	CASTRTGNLGNTIYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	3	4	5	6	22	32	43	37	49		TCRBV12-03,TCRBV12-04												CASTRTGNLGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCACCCTCGGGACGGGGAACACTGAAGCTTTCTTTGGACAA	CASTLGTGNTEAFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	7	0	7	1	5	3	22	32	42	37	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTLGTGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGGGACTAGCGGGGACGAGCAGTTCTTCGGGCCA	CASSGTSGDEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	10	1	2	22	33	47	34	49		TCRBV12-03,TCRBV12-04												CASSGTSGDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGGGACAGGAAACACCATATATTTTGGAGAG	CASSLGTGNTIYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	1	6	4	0	0	22	-1	-1	38	43		TCRBV12-03,TCRBV12-04												CASSLGTGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAACGCAACGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CANATGATNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	8	2	0	6	0	24	31	-1	37	43		TCRBV24-01,TCRBV24-or09_02												CANATGATNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGGACAGGTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDPDRSYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	4	1	3	0	24	38	-1	41	48		TCRBV24-01,TCRBV24-or09_02												CATSDPDRSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGCCCACAGGGGAGCACAGATACGCAATATTTTGGCCCA	CATSGPQGSTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	15	4	15	24	37	48	41	63		TCRBV24-01,TCRBV24-or09_02												CATSGPQGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTTAGACAGCCAAGAGACCCAGTACTTCGGGCCA	CATSLDSQETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	5	1	3	0	24	36	-1	39	44		TCRBV24-01,TCRBV24-or09_02												CATSLDSQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCTCGGACAGGGGGCATTATTAACTATGGCTACACCTTCGGTTCG	CASSPRTGGIINYGYTF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	0	1	4	5	24	36	51	40	56		TCRBV24-01,TCRBV24-or09_02												CASSPRTGGIINYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACTCGGATGGGGGTAATGAAAAACTGTTTTTTGGCAGT	CASSQDSDGGNEKLFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	48							TCRBJ01	TCRBJ01-04	01	0	6	1	4	7	0	18	35	-1	42	47	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSDGGNEKLFF+X+TCRBJ01-04			TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGAGGGCAGCCAAGAGACCCAGTACTTCGGGCCA	CASSLAEGSQETQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	10	0	1	0	3	18	-1	41	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAEGSQETQYF+X+TCRBJ02-05		TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCCCCCGGTGGCATCCGGGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPPGGIRGPSYNEQFF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	57	TCRBV05						TCRBJ02	TCRBJ02-01	01	4	6	0	0	16	1	19	31	53	47	54		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGGIRGPSYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTACAGGCGATGGTGATACGCAGTATTTTGGCCCA	CASSFTGDGDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	3	4	6	1	7	19	33	39	34	46		TCRBV05-06,TCRBV05-07												CASSFTGDGDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGCTGTGTATTTTTGTGCCAGCAGCCGCCGCGATTACCGGGACTACCCTCAGAGCACAGATACGCAGTATTTTGGCCCA	CASSRRDYRDYPQSTDTQYF	In	VDJ	1	9	1.1653200745804848E-4	1.3868556899607057E-4	60				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	9	0	13	7	15	27	47	40	54	TCRBV07,TCRBV09,TCRBV12,TCRBV16	TCRBV07-04,TCRBV09-01,TCRBV12-03,TCRBV12-04,TCRBV12-05,TCRBV16-01				01,02								CASSRRDYRDYPQSTDTQYF+X+TCRBJ02-03		TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCCTCGACACAGCTACGTATGGCTACACCTTCGGTTCG	CASSLDTATYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	6	5	4	8	26	37	45	41	53	TCRBV07,TCRBV12													CASSLDTATYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTGGGACACTCAACCAACACTGAAGCTTTCTTTGGACAA	CASSLGHSTNTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	6	2	3	7	26	37	46	40	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLGHSTNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTGACATTTCTGAAGCTTTCTTTGGACAA	CASSLDISEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	6	6	4	3	26	37	45	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLDISEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGGCACAGATACGCAGTATTTTGGCCCA	CASRGTDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	TCRBV12						TCRBJ02	TCRBJ02-03	01	6	0	10	1	0	0	26	-1	-1	37	39		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACGGCAGGGGACACTGAAGCTTTCTTTGGACAA	CASSTAGDTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	3	4	0	26	38	-1	42	48		TCRBV12-03,TCRBV12-04												CASSTAGDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCGCGGGGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSAGAGANVLTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	4	7	2	2	2	0	26	39	-1	41	48		TCRBV12-03,TCRBV12-04												CASSSAGAGANVLTF+TCRBV12-X+TCRBJ02-06	TCRBV12	TCRBD02-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGAGTCGGCAGGTTCACCCCTCCACTTTGGGAAC	CASSFESAGSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	4	9	8	0	26	40	-1	48	52		TCRBV12-03,TCRBV12-04												CASSFESAGSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ACGACTCGGCCSTGTATSTCTGTGCCAGCAGCAATCCTAACAGGCGAGAGACCCAGTACTTCGGGCCA	CASSNPNRRETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	4	4	7	2	20	32	44	39	46	TCRBV05,TCRBV11													CASSNPNRRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCTAGCGGAACCAAAAACATTCAGTACTTCGGCGCC	CASSPSGTKNIQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	5	4	5	2	1	2	24	36	44	37	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03				01,02								CASSPSGTKNIQYF+X+TCRBJ02-04		TCRBD02-01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGAGGACAGGGGAAGCTTTCTTTGGACAA	CASSQRTGEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	3	8	2	0	26	40	-1	42	50		TCRBV03-01,TCRBV03-02												CASSQRTGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTAACAGGGATGGCTACACCTTCGGTTCG	CASSNRDGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	3	6	2	0	26	37	-1	39	45	TCRBV03,TCRBV12													CASSNRDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGATACTAATAATGAGCAGTTCTTCGGGCCA	CASSDTNNEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	3	9	7	4	2	26	37	45	41	47		TCRBV03-01,TCRBV03-02				01,02								CASSDTNNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTTAATAACTAGCCCAGAGACCCAGTACTTCGGGCCA	CASSLITSPETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	3	7	4	7	2	26	37	50	44	52	TCRBV03,TCRBV12					01,02								CASSLITSPETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTTAGGCAGGGGCCGGATCGAAGAGCAGTTCTTCGGGCCA	CASSLGRGRIEEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	10	3	10	22	36	45	39	55	TCRBV05,TCRBV11													CASSLGRGRIEEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGTTTGGGAGTGGCTACACCTTCGGTTCG	CSATFGSGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	9	2	7	5	0	26	36	-1	41	46		TCRBV20-01,TCRBV20-or09_02												CSATFGSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGACAATGGCTACACCTTCGGTTCG	CSARRDNGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	6	1	0	26	38	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARRDNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGACAGGGAATGGCTACACCTTCGGTTCG	CSARDRTGNGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	6	2	1	26	40	50	42	51		TCRBV20-01,TCRBV20-or09_02												CSARDRTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCGCCAACCAAGAGACCCAGTACTTCGGGCCA	CSARDLANQETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	4	6	0	6	0	26	40	-1	46	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLANQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGACAGGGCCCCATAACTATGGCTACACCTTCGGTTCG	CSARGTGPHNYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	1	0	5	26	-1	47	39	52		TCRBV20-01,TCRBV20-or09_02												CSARGTGPHNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCCGTCTCAGGACTAGCGACAGATACGCAGTATTTTGGCCCA	CSASPVSGLATDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	1	6	3	10	0	26	37	-1	47	56		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPVSGLATDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGTGAGTCTCGTCGGCCCCTATAATTCACCCCTCCACTTTGGGAAC	CSAGVSLVGPYNSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	51	TCRBV20						TCRBJ01	TCRBJ01-06	01	5	6	2	2	0	15	26	-1	39	35	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGVSLVGPYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCACCAGCAGCCAAGGTCACGCGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	10	1.2948000828672053E-4		43	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	6	2	5	1	23	39	47	44	48	TCRBV01,TCRBV04					01,02								X+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCGGACAGGGGCACTGAAGCTTTCTTTGGACAA	CASSQDPDRGTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	4	3	0	23	40	-1	43	52	TCRBV01,TCRBV04													CASSQDPDRGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCACAACCGAGGGGGGAAGAACTGAAGCTTTCTTTGGACAA	CASTTEGGRTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	7	5	1	5	6	5	22	32	44	38	49	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTTEGGRTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SRGGGACTYRGCTGTGTAYYTCTGTGCCAGCAGTGAAATAAGGACCCCTACCTACGAGCAGTACGTCGGGCCG	CASSEIRTPTYEQYV	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	5	1	7	17	7	20	22	34	45	41	65	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEIRTPTYEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCWSSSASWCAKCTGTGTACTTSTGTGCCAGCAGTGAAGCTGATCCGGGCCGCTACACCTTCGGTTCG	CASSEADPGRYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	unresolved						TCRBJ01	TCRBJ01-02	01	5	8	0	9	11	1	22	34	49	45	50	TCRBV06,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEADPGRYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGACCTTATTAACCTCCACAGCGGGGGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	10	1.2948000828672053E-4		56	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	6	2	5	18	2	22	34	60	52	62	TCRBV09,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTGAGTCAGGGATGGAAAATCAGCCCCAGCATTTTGGTGAT	CASSESGMENQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	4	4	6	22	34	43	38	49		TCRBV12-03,TCRBV12-04												CASSESGMENQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGATCAGGGGATAGGTGAAGCTTTCTTTGGACAA	CASSDQGIGEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	7	3	5	22	34	43	37	48		TCRBV12-03,TCRBV12-04												CASSDQGIGEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTATACCGGGACTAGTTCTGAGACCCAGTACTTCGGGCCA	CASSYTGTSSETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	8	5	5	4	22	35	48	40	52		TCRBV12-03,TCRBV12-04				01,02								CASSYTGTSSETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTCTAACAGGGAAGGGGTCTGGAAACACCATATATTTTGGAGAG	CASSFLTGKGSGNTIYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	3	3	1	4	6	22	36	46	40	52		TCRBV12-03,TCRBV12-04												CASSFLTGKGSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCACAACTAACGTACACAATGAGCAGTTCTTCGGGCCA	CASTTNVHNEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	3	9	5	2	6	23	33	39	35	45	TCRBV24,TCRBV27					01,02								CASTTNVHNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGGGACTAGCGGGGGTGGAGACCCAGTACTTCGGGCCA	CATSDPGLAGVETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	5	3	2	24	38	55	41	57		TCRBV24-01,TCRBV24-or09_02												CATSDPGLAGVETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCAGGGGACAGGGGGGACTGAGGGCTACACCTTCGGTTCG	CATSDQGTGGTEGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	1	8	3	7	24	39	53	42	60		TCRBV24-01,TCRBV24-or09_02												CATSDQGTGGTEGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGACGACAGGGGGCGAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	10	1.2948000828672053E-4		44	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	0	5	1	1	24	38	49	39	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAATAGGGGGACAGGAGTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSEIGGQEYSGANVLTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	57	TCRBV25			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	2	0	4	0	5	4	23	38	51	43	55		TCRBV25-01,TCRBV25-or09_02												CASSEIGGQEYSGANVLTF+TCRBV25-X+TCRBJ02-06	TCRBV25	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCKCTGTGCCAGAAGCTTGGGTTCGAGGTATTAGGGTATCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	10	1.2948000828672053E-4		55	unresolved						TCRBJ01	TCRBJ01-02	01	3	5	3	0	14	3	18	32	50	46	53	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTAGCGTCAACAGGGCCCTCACCCCTCCACTTTGGGAAC	CASSLASTGPSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	3	10	4	3	18	35	45	39	48	TCRBV05,TCRBV07													CASSLASTGPSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCKGCYGTGTATYTCTGTGCCAGCAGCTTAAGAGACAGGGGGCGTCAGCCCCAGCATTTTGGTGAT	CASSLRDRGRQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	0	6	3	1	18	33	46	36	47	TCRBV03,TCRBV11													CASSLRDRGRQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCAGACAGGGGGGGATACAGATACGCAGTATTTTGGCCCA	CASSQTGGDTDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	1	3	2	4	18	30	41	32	45	TCRBV07,TCRBV11													CASSQTGGDTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTCGCCGGGAACCAAGAGACCCAGTACTTCGGGCCA	CASSLAGNQETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	8	3	0	5	0	18	30	-1	35	40	TCRBV07,TCRBV11													CASSLAGNQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCGCACCGAACAGGGAGAACTATGGCTACACCTTCGGTTCG	CASSAPNRENYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	2	7	2	18	30	43	37	45	TCRBV07,TCRBV11													CASSAPNRENYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCGGCAGGGTTTCTGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	10	1.2948000828672053E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	4	3	7	4	6	18	31	40	35	46	TCRBV07,TCRBV11													X+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGGGACAGGGGGCAAAGAGACCCAGTACTTCGGGCCA	CASSFGTGGKETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	0	3	1	1	18	32	45	33	46	TCRBV07,TCRBV11													CASSFGTGGKETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTGGTGCCGAGGAGGAATCAGCCCCAGCATTTTGGTGAT	CASSLVPRRNQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	10	1	4	8	0	18	32	-1	40	45	TCRBV05,TCRBV11													CASSLVPRRNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCCCCGGGGGCAGAGGGTGGACCCAGTACTTCGGGCCA	CASSPGGRGWTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	5	6	0	7	3	8	19	31	40	34	48	TCRBV07,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGGRGWTQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCYRTGTATYKYTGTGCCAGCAGCGTAGCGTACAGTAATTCACCCCTCCACTTTGGGAAC	CASSVAYSNSPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	0	3	5	6	2	0	19	36	-1	38	42	TCRBV07,TCRBV12			TCRBD01,TCRBD02										CASSVAYSNSPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASGACTCRGCCMTGTATCKCTGTGCCAGCAGCTTCACAGGGACGAGGAATCAGCCCCAGCATTTTGGTGAT	CASSFTGTRNQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	3	3	4	1	6	19	33	40	34	46	TCRBV05,TCRBV07													CASSFTGTRNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCCAACGACAGGGGTTGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPTTGVDTGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	2	3	5	3	19	31	44	36	47	TCRBV07,TCRBV11													CASSPTTGVDTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGATGGGGGACAGGGGTCGGATACGCAGTATTTTGGCCCA	CASSLDGGQGSDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	2	6	4	3	19	35	49	39	52	TCRBV07,TCRBV11													CASSLDGGQGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCGCCCAGACTAGCGGGGGTATCCAAGAGACCCAGTACTTCGGGCCA	CASAQTSGGIQETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	2	2	1	5	3	19	28	45	33	48	TCRBV07,TCRBV11													CASAQTSGGIQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCGCGGGACCGATTAACTATGGCTACACCTTCGGTTCG	CASSAGPINYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	7	3	1	0	5	19	-1	37	31	42	TCRBV05,TCRBV07													CASSAGPINYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAACAGGGTTAAACACTGAAGCTTTCTTTGGACAA	CASSLTGLNTEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	2	1	3	19	33	40	34	43	TCRBV05,TCRBV07													CASSLTGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGACGCGGCGAGCTATGGCTACACCTTCGGTTCG	CASSLDAASYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	7	5	4	4	4	19	33	41	37	45	TCRBV05,TCRBV11					01,02								CASSLDAASYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGAGGGGGACGGACCACCCCTCCACTTTGGGAAC	CASSLEGDGPPLHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-06	01	0	5	1	11	0	6	19	-1	41	35	47	TCRBV05,TCRBV11			TCRBD01,TCRBD02										CASSLEGDGPPLHF+X+TCRBJ01-06	unresolved	unresolved	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAACAACTGGGGGACATACAATGAGCAGTTCTTCGGGCCA	CASNNWGTYNEQFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	6	4	8	0	19	29	-1	37	43	TCRBV05,TCRBV11													CASNNWGTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCCMTGTACTTCTGTGCCAGCAGCGGACTACAGGGGAACTATGGCTACACCTTCGGTTCG	CASSGLQGNYGYTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	2	2	5	0	20	32	-1	37	44	TCRBV02,TCRBV13													CASSGLQGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCGACTAGGGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSRLGADTGELFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	2	8	3	1	6	22	34	41	35	47	TCRBV07,TCRBV11					01,02								CASSRLGADTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCCCGCTGGGACTAGGATTAAAGACCCAGTACTTCGGGCCA	CASSPLGLGLKTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	0	8	6	5	6	22	34	47	39	53	TCRBV07,TCRBV11					01,02								CASSPLGLGLKTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGGACAGGGGCCGTGGGAGACCCAGTACTTCGGGCCA	CASSLGQGPWETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	2	5	2	6	22	35	46	37	52	TCRBV07,TCRBV11													CASSLGQGPWETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTGAGAACTAGTGGGGTTGAGACCCAGTACTTCGGGCCA	CASSLRTSGVETQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	8	5	5	7	22	35	45	40	52	TCRBV07,TCRBV11					01,02								CASSLRTSGVETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGCTACAGGGAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSYREGNQPQHF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	5	3	3	2	1	3	24	36	43	37	46	TCRBV02,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYREGNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCRGCYKTGTATKTCTGTGCCAGCAGCCTTGGACAGGTTATCTCTGAGGCCAACGTCCTGACTTTCGGGGCC	CASSLGQVISEANVLTF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	4	6	3	10	23	35	45	38	55	TCRBV09,TCRBV11													CASSLGQVISEANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCGGACGGGGGACCTCAGATACGCAGTATTTTGGCCCA	CASSVGRGTSDTQYF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	4	4	4	23	37	47	41	51	TCRBV09,TCRBV21													CASSVGRGTSDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTCRGCYKTGTATKTCTGTGCCAGCAGCTCCCCCCGAAGGGCTTCAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	10	1.2948000828672053E-4		50	unresolved						TCRBJ01	TCRBJ01-05	01	4	5	3	1	9	4	23	35	48	44	52	TCRBV09,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCRGCYYTGTATYTCTGTGCCAGCAGCTTTAGTGGGGCACCTGAAGCTTTCTTTGGACAA	CASSFSGAPEAFF	In	VDJ	1	10	1.2948000828672053E-4	1.5409507666230065E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	7	0	6	6	2	23	35	46	41	48	TCRBV05,TCRBV09													CASSFSGAPEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACTCTCTAGCGGGGTAGATACGCAGTATTTTGGCCCA	CASRLSSGVDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	5	5	1	26	37	51	42	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRLSSGVDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGACCCTGGCAGGGGGGTCCTCTCGGGTGAAAAACTGTTTTTTGGCAGT	CASSDPGRGVLSGEKLFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	54				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	1	7	6	11	24	38	51	44	62	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSDPGRGVLSGEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCGCGGCCGACCCACTGAAGCTTTCTTTGGACAA	CASSSRGRPTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	5	4	4	6	26	38	46	42	52		TCRBV03-01,TCRBV03-02				01,02								CASSSRGRPTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACTCCGGACAGGGGGGCGAGTTATAGCTGAAGCTTTCTTTGGACAA	CSALRTGGRVIAEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	1	6	5	11	26	34	49	39	60		TCRBV20-01,TCRBV20-or09_02												CSALRTGGRVIAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGGACAGGGTTGGAAACACCATATATTTTGGAGAG	CSARDRVGNTIYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	3	2	1	26	34	45	36	46		TCRBV20-01,TCRBV20-or09_02												CSARDRVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGACCGCTGGGGCAGGGAGAGACCCAGTACTTCGGGCCA	CSAGPLGQGETQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	3	4	13	0	26	34	-1	47	52		TCRBV20-01,TCRBV20-or09_02												CSAGPLGQGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGATTCGAACGGGTTTCGGCACTGAAGCTTTCTTTGGACAA	CSAIRTGFGTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	8	4	4	8	6	26	34	46	42	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSAIRTGFGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCGGGTTTAACGGGGGGGTCGTCCAGTGAGCAGTTCTTCGGGCCA	CSAAGLTGGSSSEQFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	0	9	11	8	26	34	53	45	61		TCRBV20-01,TCRBV20-or09_02												CSAAGLTGGSSSEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGTTTGACTGAAGCTTTCTTTGGACAA	CSARDSLTEAFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	5	0	4	26	-1	43	40	47		TCRBV20-01,TCRBV20-or09_02												CSARDSLTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGCGGGCTCTCTGGAAACACCATATATTTTGGAGAG	CSARGGLSGNTIYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	1	7	4	0	0	2	26	-1	44	39	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSARGGLSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGGGGCTGAATACGCAGTATTTTGGCCCA		Out	VDJ	1	11	1.4242800911539258E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	6	0	7	2	3	26	39	47	41	50		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCCTACTAGCGCAAACCCTCACTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	11	1.4242800911539258E-4		49	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	3	6	17	4	24	26	38	49	42	73		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAAGTCGGCTACTTTGGCTACACCTTCGGTTCG	CSAQVGYFGYTF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	36	TCRBV20						TCRBJ01	TCRBJ01-02	01	5	9	0	7	6	5	26	35	44	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQVGYFGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTTCGACTCATCATGTCTGATACGCAGTATTTTGGCCCA	CSALRLIMSDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	10	6	4	10	26	35	43	39	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSALRLIMSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCTGGGACAGCGCTCACCGGGGAGCTGTTTTTTGGAGAA	CATSDSGTALTGELFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	5	4	4	4	24	38	49	42	53		TCRBV24-01,TCRBV24-or09_02												CATSDSGTALTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCCCCCCGCGTTTCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	11	1.4242800911539258E-4		37	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	9	7	6	4	5	4	24	33	41	38	45		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCTCGCTACAGATACGCAGTATTTTGGCCCA	CASSLALATDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42							TCRBJ02	TCRBJ02-03	01	0	10	0	3	0	5	18	-1	37	35	42	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLALATDTQYF+X+TCRBJ02-03			TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCACCGGTAATCGACACACCATATATTTTGGAGAG	CASTGNRHTIYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	36	unresolved						TCRBJ01	TCRBJ01-03	01	7	2	7	8	9	0	23	33	-1	42	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTGNRHTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTCAGGCCCGCAGGGGGTAGGGCAGTACGTCGGGCCG	CASSSGPQGVGQYV	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	1	17	8	12	19	32	47	40	59		TCRBV05-06,TCRBV05-07												CASSSGPQGVGQYV+TCRBV05-X+TCRBJ02-07	TCRBV05	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTGGGCGGGAATACAAGATACGCAGTATTTTGGCCCA	CASSWAGIQDTQYF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	TCRBV05			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	3	5	2	5	19	32	40	34	45		TCRBV05-06,TCRBV05-07												CASSWAGIQDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGCAAGCCACGTTTSRYSMMMSMSASAYCTMTGTACCTCTGTGCCAGCAGTACAGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSTGATNEKLFF	In	VDJ	1	11	1.4242800911539258E-4	1.695045843285307E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	2	0	0	0	39	-1	-1	51	58	TCRBV25,TCRBV27,TCRBV28													CASSTGATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGCCAGGGGCCTGTATAATTCACCCCTCCACTTTGGGAAC	CASSLARGLYNSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	2	4	0	4	26	-1	49	43	53		TCRBV12-03,TCRBV12-04												CASSLARGLYNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGGTCGAGGGCGTGACCCAGTACTTCGGGCCA	CASSLGVEGVTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	11	0	7	5	3	26	42	52	47	55		TCRBV12-03,TCRBV12-04												CASSLGVEGVTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*02	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATGCCGCCTACGATGGAGGGAGCTACACCTTCGGTTCG	CASSQDAAYDGGSYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	10	0	9	13	1	23	40	59	53	60	TCRBV01,TCRBV23													CASSQDAAYDGGSYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAGATGGGGCAGGGATAAACTATGACTACACCTTCGGTTCG	XASSQDGAGINYDYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	10	5	11	23	40	50	45	61	TCRBV01,TCRBV04													XASSQDGAGINYDYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGACGGGGGGACCGGGTCTCGCTACACCTTCGGTTCG	CASSDGGTGSRYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	9	0	10	24	-1	45	38	55	TCRBV06,TCRBV10													CASSDGGTGSRYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCGGGGTACGGGGTTGGGGCACTGAAGCTTTCTTTGGACAA	CASGVRGWGTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	7	3	4	0	13	24	-1	37	31	50	TCRBV06,TCRBV10													CASGVRGWGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACAACCTTTCCATTTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.5537600994406463E-4		50	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	2	7	4	19	0	26	38	-1	57	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACAAGAGGGCGGTATCCTCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	12	1.5537600994406463E-4		49	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	11	0	17	3	24	26	41	49	44	73		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*02	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCAGGACAGGGCATGACCCAGTACTTCGGGCCA	CASSQDSGQGMTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	1	3	7	4	3	26	43	55	47	58		TCRBV03-01,TCRBV03-02												CASSQDSGQGMTQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCGTTTTACAATGAGCAGTTCTTCGGGCCA	CASSSFYNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	8	6	4	1	3	26	38	41	39	44		TCRBV03-01,TCRBV03-02				01,02								CASSSFYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASGACTCSGCCSTGTATCTCTGTGCCAGCAGCCTACAGGGGGCCCCGAATAATAATTCACCCCTCCACTTTGGGAAC	CASSLQGAPNNNSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	0	5	2	8	20	32	43	34	51	TCRBV05,TCRBV07													CASSLQGAPNNNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCSGCCGTGTATSTCTGTGCCAGCAGCTGGGGGACTAGCGGGGGCGGGGAGACCCAGTACTTCGGGCCA	CASSWGTSGGGETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	5	2	4	20	33	49	35	53	TCRBV07,TCRBV11													CASSWGTSGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCCGACTCGATCCCCGTTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	1.5537600994406463E-4		41	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	8	2	10	4	3	12	26	32	39	35	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAACCGGGGGCAGGACACTGAAGCTTTCTTTGGACAA	CSANRGQDTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	6	0	3	5	3	26	34	45	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSANRGQDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCAGGTCGGGTCTGGAAACACCATATATTTTGGAGAG	CSAQVGSGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	4	4	1	1	5	26	34	39	35	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAQVGSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGACAGGCTGAAGCTTTCTTTGGACAA	CSARGQAEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	4	6	0	0	26	-1	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSARGQAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAGGGGCTGGATCAGCCCCAGCATTTTGGTGAT	CSASEGLDQPQHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	TCRBV20						TCRBJ01	TCRBJ01-05	01	3	5	2	5	2	4	26	37	44	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASEGLDQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCACTCGGGGGGGGTACACTGAAGCTTTCTTTGGACAA	CASTRGGYTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	8	0	3	2	2	22	32	42	34	44	TCRBV02,TCRBV12													CASTRGGYTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCRGCYRTGTAYYKCTGTGCCAGCAGTCCCCGTACAGGTATGAACACTGAAGCTTTCTTTGGACAA	CASSPRTGMNTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	0	6	2	22	34	45	40	47	TCRBV07,TCRBV12													CASSPRTGMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTTCGACAGGGATCGGGGAGCTGTTTTTTGGAGAA	CASSSTGIGELFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	3	7	1	2	22	35	43	36	45	TCRBV02,TCRBV12													CASSSTGIGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACTCGGACAGGGGGGAGACCCAGTACTTCGGGCCA	CATSDSDRGETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	1	5	3	0	24	38	-1	41	51		TCRBV24-01,TCRBV24-or09_02												CATSDSDRGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAATTCGTTCCAGGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	1.5537600994406463E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	2	2	9	0	24	41	-1	50	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTCCGGGTACCTCGGATTCACCCCTCCACTTTGGGAAC	CASSPGTSDSPLHF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	6	8	4	8	1	8	24	36	41	37	49	TCRBV24,TCRBV27					01,02								CASSPGTSDSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAACCAGGGGGGGGAGGGAGATACGCAGTATTTTGGCCCA	CANQGGEGDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	39	unresolved						TCRBJ02	TCRBJ02-03	01	10	4	1	5	2	7	23	30	39	32	46	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CANQGGEGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGAGGGGGATTTAACTATGGCTACACCTTCGGTTCG	CASSERGGFNYGYTF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	5	1	1	2	3	23	38	46	40	49		TCRBV06-01,TCRBV06-08												CASSERGGFNYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASGACTCGGCYSTGTATCTCTGTGCCAGCAGCTTAGGGGCCGCTACGGATACGCAGTATTTTGGCCCA	CASSLGAATDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	8	0	6	0	7	19	-1	39	35	46	TCRBV05,TCRBV07													CASSLGAATDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCCATCGACTAGCGGGTTCAACAATGAGCAGTTCTTCGGGCCA	CASSPSTSGFNNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	4	5	5	4	18	30	45	35	49	TCRBV07,TCRBV11					01,02								CASSPSTSGFNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGCCAGCGAATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASESYNEQFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	6	6	1	1	2	18	35	40	36	42	TCRBV07,TCRBV11					01,02								CASSLASESYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTTAATGCTAGCGGGAGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	12	1.5537600994406463E-4		50	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	4	3	1	5	0	18	32	-1	37	46	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTAGAGGCCAGGGGCTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	12	1.5537600994406463E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	17	7	14	18	32	45	39	59	TCRBV05,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGCAGCTTAAGCTGGGACAGGGGGGATGGCACTGAAGCTTTCTTTGGACAA	CASSLSWDRGDGTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	1	4	8	5	20	31	50	39	55	TCRBV05,TCRBV23													CASSLSWDRGDGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGSGACTCRGCYGTGTATCTCTRYGCCAGCAGCCAAGAATCGAACACCTTCTCTGGAAACACCATATATTTTGGAGAG	XASSQESNTFSGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	3	6	0	5	4	22	39	47	44	51	TCRBV03,TCRBV04,TCRBV07													XASSQESNTFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCGAGACAGGGGGCTAACTGAAGCTTTCTTTGGACAA	CASSRDRGLTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	0	5	3	2	19	31	44	34	46	TCRBV07,TCRBV11													CASSRDRGLTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCRTGTATCTCTGTGCCAGCAGCTTTCTCTCCGGATATTCCGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSFLSGYSGTNEKLFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	54	unresolved						TCRBJ01	TCRBJ01-04	01	3	1	8	1	7	8	19	33	43	40	51	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFLSGYSGTNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAACGCCGGGACAGGAGAGGAAAAACTGTTTTTTGGCAGT	CASNAGTGEEKLFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	4	8	5	4	19	29	42	34	46	TCRBV05,TCRBV23													CASNAGTGEEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTATCGATTCGACAGTCAGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSLSIRQSGLNTEAFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	0	8	7	19	33	46	41	53	TCRBV05,TCRBV11													CASSLSIRQSGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGTGGTCGGCAGGGAATTTGGCTGGAAACACCATATATTTTGGAGAG	CASSLWSAGNLAGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	3	2	7	7	19	34	46	41	53		TCRBV05-06,TCRBV05-07												CASSLWSAGNLAGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTKTATSTYTGYGCCAGCAGCTTAGCGACAGGGGAAGAGACCCAGTACTTCGGGCCA	CASSLATGEETQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	2	3	3	0	19	33	-1	36	44	TCRBV05,TCRBV07,TCRBV11													CASSLATGEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCTCCAGACAGGGGAGAGGGTACACAGATACGCAGTATTTTGGCCCA	CASSSRQGRGYTDTQYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	2	3	8	22	35	46	38	54	TCRBV07,TCRBV11													CASSSRQGRGYTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAATGCAGGGAGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLMQGDTGELFF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	4	4	3	3	5	2	22	35	45	40	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMQGDTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTTGAACCCGGGGGGGGGCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	12	1.5537600994406463E-4		47	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	5	8	4	24	36	52	44	56	TCRBV09,TCRBV21													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTACAAGGTCGGCTCGGAAACACCATATATTTTGGAGAG	CASSVQGRLGNTIYF	In	VDJ	1	12	1.5537600994406463E-4	1.8491409199476077E-4	45	unresolved						TCRBJ01	TCRBJ01-03	01	1	5	4	4	2	7	23	38	43	40	50	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVQGRLGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCGAGGAGTAGGGGACAGATACGCAGTATTTTGGCCCA	CASEE*GTDTQYF	Stop	VDJ	1	12	1.5537600994406463E-4		39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	5	2	3	7	0	23	32	-1	39	44	TCRBV09,TCRBV12													CASEE*GTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCAGCCGGGGGCTGGTCCACCGGGGAGCTGTTTTTTGGAGAA	CASRPAGGWSTGELFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	6	0	4	7	5	26	37	50	44	55		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPAGGWSTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGGACAGATCATGAACACTGAAGCTTTCTTTGGACAA	CASSGQIMNTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	0	0	4	26	-1	44	38	48		TCRBV12-03,TCRBV12-04												CASSGQIMNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAAGGGGACAGCCCCCAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	13	1.683240107727367E-4		40				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	0	5	4	2	5	24	34	43	36	48	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCCGGGACAGGGGAACATTGAAGCTTTCTTTGGACAA	CASSPGQGNIEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	2	7	2	5	24	36	48	38	53	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSPGQGNIEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGTTCCAGGGGGCTGGCAGCCCCAGCATTTTGGTGAT	CASSVPGGWQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	0	7	3	3	24	37	48	40	51	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSVPGGWQPQHF+X+TCRBJ01-05		TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTGTAGCAAACGTCGGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	1.683240107727367E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	5	7	1	2	9	26	42	48	44	57		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCAAGGCTGAAGCTTTCTTTGGACAA	CASSLKAEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	33	TCRBV03						TCRBJ01	TCRBJ01-01	01	4	5	4	6	3	0	26	39	-1	42	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKAEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGATTAGGACAGGGGGAAAACGAGCAGTACGTCGGGCCG		Out	VDJ	1	13	1.683240107727367E-4		38	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	1	17	4	15	26	33	47	37	62		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGCGGGGGGGCCCTCACGCAGTATTTTGGCCCA	CSARGGALTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	36	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	9	1	5	26	35	45	36	50		TCRBV20-01,TCRBV20-or09_02												CSARGGALTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACGACGAGTGGGGCACTGAAGCTTTCTTTGGACAA	CSADDEWGTEAFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	6	2	4	10	0	26	35	-1	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSADDEWGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGCGGCAGGGGCGCAACGGAATGAGCAGTTCTTCGGGCCA	CASSQAAGAQRNEQFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	4	2	7	3	8	23	39	48	42	56	TCRBV04,TCRBV23													CASSQAAGAQRNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCTCCGGCCAGGGGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	1.683240107727367E-4		43	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	2	5	8	1	22	33	47	41	48		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAGACAGGGGAGGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLDRGGTNEKLFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	3	2	1	0	3	22	-1	45	38	48		TCRBV12-03,TCRBV12-04												CASSLDRGGTNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCTAGCAGTGAGGGCACCATTTCGGCGCAGTATTTTGGCCCA	CASSEGTISAQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	39	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	11	0	10	0	11	22	-1	39	34	50		TCRBV12-03,TCRBV12-04												CASSEGTISAQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCAGGGAAAACCGGGGAGCTGTTTTTTGGAGAA	CATSDAGKTGELFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	5	2	3	24	38	45	40	48		TCRBV24-01,TCRBV24-or09_02												CATSDAGKTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCCCGACAGGGGGAGGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	13	1.683240107727367E-4		50	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	1	4	4	5	24	40	53	44	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCCGGGGGGTTAACAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	13	1.683240107727367E-4		37	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	8	1	5	0	6	23	-1	36	29	42	TCRBV06,TCRBV10													X+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGASGACTCRGCYRTGTAYYTCTGTGCCAGCAGTGACGGTCAGGGTTTCTCTGGAAACACCATATATTTTGGAGAG	CASSDGQGFSGNTIYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	8	4	3	0	10	3	19	27	42	37	45	TCRBV02,TCRBV07													CASSDGQGFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGCGGTGACAGGGTGGGATGGCTACACCTTCGGTTCG	CASSLAVTGWDGYTF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	6	3	4	18	35	45	38	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAVTGWDGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATAGTAGTGGTACCGCTAATGAGCAGTTCTTCGGGCCA	CASSQDSSGTANEQFF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	5	8	7	2	13	20	35	40	37	53	TCRBV01,TCRBV23					01,02								CASSQDSSGTANEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCACACAGGGGCTAATCAGCCCCAGCATTTTGGTGAT	CASSHTGANQPQHF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	4	3	2	19	31	41	34	43		TCRBV05-06,TCRBV05-07												CASSHTGANQPQHF+TCRBV05-X+TCRBJ01-05	TCRBV05	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTAGGGTTCTTAAGCACAGATACGCAGTATTTTGGCCCA	CASSLGFLSTDTQYF	In	VDJ	1	13	1.683240107727367E-4	2.0032359966099084E-4	45	TCRBV05						TCRBJ02	TCRBJ02-03	01	4	5	3	0	2	6	19	31	37	33	43		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGFLSTDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGGACAGGGATGGGAATGGGGTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	13	1.683240107727367E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	2	3	2	0	13	23	-1	43	36	56	TCRBV09,TCRBV12													X+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCACCCATAGCACAGATACGCAGTATTTTGGCCCA	CASSFTHSTDTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV12						TCRBJ02	TCRBJ02-03	01	3	3	7	0	1	4	26	40	43	41	47		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFTHSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAAGGGGTAGGGGACACTGAAGCTTTCTTTGGACAA	CASSKGVGDTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	3	4	0	26	42	-1	46	51		TCRBV03-01,TCRBV03-02												CASSKGVGDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCAGGGGTCGACCGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	14	1.8127201160140875E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	2	4	0	8	26	-1	48	42	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAACCTAGCGGGGGGCCGAGAGACCCAGTACTTCGGGCCA	CASSQGNLAGGRETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	4	5	3	26	42	58	47	61		TCRBV03-01,TCRBV03-02												CASSQGNLAGGRETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCGATACTAGCGGGGGAGACAATGAGCAGTTCTTCGGGCCA	CASSDTSGGDNEQFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	3	2	5	3	2	26	38	52	41	54	TCRBV03,TCRBV12													CASSDTSGGDNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAAACAGGGATCCTACGGAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	14	1.8127201160140875E-4		50	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	2	4	10	26	38	48	42	58	TCRBV03,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGKGACTCKGCYSTGTATYTCTGTGCCAGCAGCTTAGGCCACGGGGGGTGGCGAGAGACCCAGTACTTCGGGCCA	CASSLGHGGWRETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	1	4	8	5	26	38	53	46	58	TCRBV03,TCRBV05,TCRBV11													CASSLGHGGWRETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAGTCTGGGGGTACTCTGGACAGGGCGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	14	1.8127201160140875E-4		58	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	1	3	4	16	4	20	34	58	50	62	TCRBV05,TCRBV11													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGGGACTCRGCCSTGTATCTCTGTGCCAGCAGCTCCCAGTCCCGGGGGGACTATGGCTACACCTTCGGTTCG	CASSSQSRGDYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	1	3	11	0	22	32	-1	43	50	TCRBV05,TCRBV11													CASSSQSRGDYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCACGGGACAGGGGGTAATACTAACTATGGCTACACCTTCGGTTCG	CSAHGTGGNTNYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	0	4	5	26	34	49	38	54		TCRBV20-01,TCRBV20-or09_02												CSAHGTGGNTNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCAGTAGGAGCCAGGAACTATGGCTACACCTTCGGTTCG	CSAPVGARNYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV20						TCRBJ01	TCRBJ01-02	01	6	4	4	2	12	0	26	34	-1	46	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPVGARNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACACCCCCGTCCGACAGGGTTATAGCTTTCTTTGGACAA	CSATPPSDRVIAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	10	11	4	26	36	54	47	58		TCRBV20-01,TCRBV20-or09_02												CSATPPSDRVIAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAACAGGGGTAGACTATGGCTACACCTTCGGTTCG	CSARTGVDYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	3	0	3	26	-1	45	38	48		TCRBV20-01,TCRBV20-or09_02												CSARTGVDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGAGGTATACACTGAAGCTTTCTTTGGACAA	CSARDQEVYTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	11	1	3	4	3	26	40	48	44	51		TCRBV20-01,TCRBV20-or09_02												CSARDQEVYTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCCGACAGTTTATGAACACTGAAGCTTTCTTTGGACAA	CSARARQFMNTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	0	3	4	26	39	47	42	51		TCRBV20-01,TCRBV20-or09_02												CSARARQFMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTCTAGCGGGGAGGCAAGAGACCCAGTACTTCGGGCCA	CSARVLAGRQETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	2	2	3	26	39	50	41	53		TCRBV20-01,TCRBV20-or09_02												CSARVLAGRQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCGGGACCGAACAATGAGCAGTTCTTCGGGCCA	CSASPGPNNEQFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	7	5	3	3	26	37	45	40	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASPGPNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTAGGACAGGCAGAGTTTCTACTGGCTACACCTTCGGTTCG	CSAIRTGRVSTGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	4	7	3	12	26	36	46	39	58		TCRBV20-01,TCRBV20-or09_02												CSAIRTGRVSTGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTATCCCTCGGGGGGAGGAGACACTGAAGCTTTCTTTGGACAA	CSAYPSGGGDTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	8	1	3	7	5	26	35	49	42	54		TCRBV20-01,TCRBV20-or09_02												CSAYPSGGGDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCAAGCGGGAGGGACCACTGAAGCTTTCTTTGGACAA	CASSQAGGTTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	6	0	4	3	2	22	33	46	36	48	TCRBV09,TCRBV12													CASSQAGGTTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCGCGCCATGAACACTGAAGCTTTCTTTGGACAA	CASSRAMNTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	0	1	3	22	34	38	35	41	TCRBV02,TCRBV12					01,02								CASSRAMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTTTACTAGGGAGGACTGGCTACACCTTCGGTTCG	CASSLLGRTGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	9	1	7	3	2	22	37	46	40	48	TCRBV09,TCRBV12													CASSLLGRTGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTGGGGGCCCCGTCTGAAGCTTTCTTTGGACAA	CASSLGAPSEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	6	0	6	0	5	23	-1	43	37	48	TCRBV24,TCRBV27													CASSLGAPSEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCCGCGGGGGCGGGAGACCCAGTACTTCGGGCCA	CATSPRGRETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	7	2	5	3	3	24	35	45	38	48		TCRBV24-01,TCRBV24-or09_02												CATSPRGRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCAGGGGCTATGGCTACACCTTCGGTTCG	CATSDPRGYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	4	2	0	24	39	-1	41	47		TCRBV24-01,TCRBV24-or09_02												CATSDPRGYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGGGACAGGGGGTGAGACCCAGTACTTCGGGCCA	CATSDAGTGGETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	1	5	3	1	24	39	53	42	54		TCRBV24-01,TCRBV24-or09_02												CATSDAGTGGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCAAGGGCCCGGGGAGCTGTTTTTTGGAGAA	CATSDLQGPGELFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	0	5	3	6	2	1	24	42	48	44	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLQGPGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CTCCCWMYCAGACWKCTSTTTACTTCTGTGCCATCAGTTCCGGGACTCTCAATGAGCAGTTCTTCGGGCCA	CAISSGTLNEQFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	10	6	3	2	24	36	45	39	47	TCRBV06,TCRBV24					01,02								CAISSGTLNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTGCGGGGACTTCCCATAATTCACCCCTCCACTTTGGGAAC	CASSAGTSHNSPLHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	5	0	10	5	3	4	23	35	44	38	48	TCRBV06,TCRBV10					01,02								CASSAGTSHNSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTACGCTCTCCTGTACGAGATTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSLRSPVRDSGANVLTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	57	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	2	11	2	1	13	2	18	33	49	46	51	TCRBV05,TCRBV07													CASSLRSPVRDSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD02-01*02	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTAATAGCGGGGGGTCAAGAGACCCAGTACTTCGGGCCA	CASSLIAGGQETQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	2	1	1	18	33	44	34	45	TCRBV07,TCRBV11													CASSLIAGGQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTACGATAGTTCTCGCGCGGCAGGGGTCGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSLR*FSRGRGRTNEKLFF	Stop	VDJ	1	14	1.8127201160140875E-4		63				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	4	2	1	17	3	18	33	56	50	59	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												CASSLR*FSRGRGRTNEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCGGGACAGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	14	1.8127201160140875E-4		44	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	5	0	1	0	18	31	-1	32	39	TCRBV07,TCRBV11													X+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTTTTCTCAGGGTTTTGACTATGGCTACACCTTCGGTTCG	CASSFSQGFDYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	3	7	5	18	29	41	36	46	TCRBV07,TCRBV11													CASSFSQGFDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTCCGGGACAGGGTTCTCCGCAGATACGCAGTATTTTGGCCCA	CASSSGTGFSADTQYF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	0	3	4	2	7	19	32	43	34	50	TCRBV07,TCRBV11													CASSSGTGFSADTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTTCTAGCGGGGGACGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSFLAGDVTGELFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	4	2	4	1	4	19	33	44	34	48	TCRBV05,TCRBV07													CASSFLAGDVTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCCTCCGACAGGGTCCGACTACTGAAGCTTTCTTTGGACAA	CASSLRQGPTTEAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	3	5	4	7	22	34	45	38	52	TCRBV07,TCRBV11													CASSLRQGPTTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTCRGCYGTGTATCTCTGTGCCAGCAGCTCCAGGGGGACAGTTAACTATGGCTACACCTTCGGTTCG	CASSSRGTVNYGYTF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	5	1	5	1	22	35	47	40	48	TCRBV07,TCRBV11													CASSSRGTVNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
YCMRRMSASACAGCWCKKTAYTTCTGTGCCAGCAGCGACTTTGACCTGTCAGGGGCTTTCTTTGGACAA	CASSDFDLSGAFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	11	13	0	24	36	-1	49	54	TCRBV21,TCRBV24													CASSDFDLSGAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCCGGTTTGGGATTAATGAAAAACTGTTTTTTGGCAGT	CASRFGINEKLFF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	39	unresolved						TCRBJ01	TCRBJ01-04	01	7	0	8	4	6	1	23	32	42	38	43	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRFGINEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCWSKSASWCAKCTGTGTACTTCTGTGCCAGCAGTTACTCGCAGCAGGTGGATTCACCCCTCCACTTTGGGAAC	CASSYSQQVDSPLHF	In	VDJ	1	14	1.8127201160140875E-4	2.1573310732722088E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	4	4	8	4	3	28	45	53	49	56	TCRBV06,TCRBV12													CASSYSQQVDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTGAGGAGGGTGTCGACGCGAATTCACCCCTCCACTTTGGGAAC	CASSEEGVDANSPLHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	48	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	5	10	0	7	2	10	26	38	46	40	56		TCRBV12-03,TCRBV12-04												CASSEEGVDANSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGGGACATACACAACACTGAAGCTTTCTTTGGACAA	CASSLRDIHNTEAFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	6	2	1	5	26	41	48	42	53		TCRBV12-03,TCRBV12-04												CASSLRDIHNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTCGGGGGGGCCGGGAATGAGCAGTTCTTCGGGCCA	CASSLFGGAGNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	0	7	3	5	26	40	51	43	56		TCRBV12-03,TCRBV12-04												CASSLFGGAGNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGAGGGGTGGATAATTCACCCCTCCACTTTGGGAAC	CASRGVDNSPLHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	2	5	0	3	26	-1	42	37	45		TCRBV03-01,TCRBV03-02												CASRGVDNSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAAGAGGGGTAATCCAAGAGACCCAGTACTTCGGGCCA	CASSLRGVIQETQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	5	2	1	4	4	26	39	48	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGVIQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGGACAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSLDRGTGELFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	2	4	1	0	26	39	-1	40	49		TCRBV03-01,TCRBV03-02												CASSLDRGTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGGGGGGACAGGGACGAAAAACTGTTTTTTGGCAGT	CASSWGDRDEKLFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	0	3	8	4	2	26	38	51	42	53		TCRBV03-01,TCRBV03-02												CASSWGDRDEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGGCGGGGGGGCGATAGATACGCAGTATTTTGGCCCA	CSARVGGGAIDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	5	3	4	26	39	51	42	55		TCRBV20-01,TCRBV20-or09_02												CSARVGGGAIDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGGTACCGAGCGGGGGGTAGACACAGATACGCAGTATTTTGGCCCA	CSGTERGVDTDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	6	1	2	6	4	26	33	48	39	52		TCRBV20-01,TCRBV20-or09_02												CSGTERGVDTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAACCGACGGGCCACAGATACGCAGTATTTTGGCCCA	CATSDNRRATDTQYF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV24						TCRBJ02	TCRBJ02-03	01	3	8	0	2	7	0	24	39	-1	46	50		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDNRRATDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCTCAGACACAACTGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDTTANTGELFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	2	6	0	3	6	24	33	40	36	46		TCRBV24-01,TCRBV24-or09_02												CATSDTTANTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCACCTCGGACTTGGCAGGGGTCCACAATGAGCAGTTCTTCGGGCCA	CATSDLAGVHNEQFF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	9	4	2	5	10	3	24	33	49	43	52	TCRBV06,TCRBV24													CATSDLAGVHNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCATCAGTGATTTGTTGTGGACCCAGTACTTCGGGCCA	CAISDLLWTQYF	In	VJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	36	TCRBV24						TCRBJ02	TCRBJ02-05	01	0	0	0	7	0	5	24	-1	42	-1	47		TCRBV24-01,TCRBV24-or09_02												CAISDLLWTQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGACGAGGGGGTCCCTAATCAGCCCCAGCATTTTGGTGAT	CASSDEGVPNQPQHF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	1	4	5	5	23	34	45	39	50	TCRBV02,TCRBV09													CASSDEGVPNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCATCAGTGAAAAGGTCCCGACCACCTATGGCTACACCTTCGGTTCG	CAISEKVPTTYGYTF	In	VDJ	1	15	1.942200124300808E-4	2.3114261499345096E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	3	2	7	4	9	3	28	42	54	51	57	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAISEKVPTTYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTTTAAACGATCAGCCCCAGCATTTTGGTGAT	CASSLNDQPQHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	36	unresolved						TCRBJ01	TCRBJ01-05	01	2	3	7	5	1	1	26	41	44	42	45	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLNDQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGTACGGCGGGGAGCTGTTTTTTGGAGAA	CASSQEYGGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	5	7	3	0	26	43	-1	46	49		TCRBV03-01,TCRBV03-02				01,02								CASSQEYGGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATCCAAGCAGTACGTCGGGCCG		Out	VDJ	1	16	2.0716801325875285E-4		35	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	4	5	17	9	4	26	43	55	52	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTAACGGGGGGGCCGGAGAGACCCAGTACTTCGGGCCA	CASSQGNGGAGETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	8	0	4	4	4	26	42	54	46	58		TCRBV03-01,TCRBV03-02												CASSQGNGGAGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGACAACAACCGGACAGCTTACTAACTATGGCTACACCTTCGGTTCG	CASSQTTTGQLTNYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	0	10	4	26	40	56	50	60		TCRBV03-01,TCRBV03-02												CASSQTTTGQLTNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAAGATTAGCGGGGGGGTCTACGCAGTATTTTGGCCCA	CASSPRLAGGSTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	8	6	2	26	39	56	45	58		TCRBV03-01,TCRBV03-02												CASSPRLAGGSTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGGGACTCRGCCSTGTATSTCTGTGCCAGCAGCTCGCGGGGGACTAGCGGGGATACGCAGTATTTTGGCCCA	CASSSRGTSGDTQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	4	6	8	0	22	32	-1	40	52	TCRBV05,TCRBV11					01,02								CASSSRGTSGDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCAGCATCCCTCGGGGGGACAGGGTATGAACACTGAAGCTTTCTTTGGACAA	CSAQHPSGGQGMNTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	0	14	2	26	35	58	49	60		TCRBV20-01,TCRBV20-or09_02												CSAQHPSGGQGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGGGAGGCGCAGGGGGCAGGGGAGACCCAGTACTTCGGGCCA	CSAGEAQGAGETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	0	5	9	4	26	35	52	44	56		TCRBV20-01,TCRBV20-or09_02												CSAGEAQGAGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTMMCCWSYCARACAKCTKTGTACTTCTGTGCCAGCAGTTACGGTATGGGCAACTATGGCTACACCTTCGGTTCG	CASSYGMGNYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	13	8	0	2	17	0	25	28	-1	45	49	TCRBV06,TCRBV22													CASSYGMGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAGGGCCGGGACAGCGGCGTTCAGCAGTACGTCGGGCCG	CATSEGRDSGVQQYV	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	5	17	5	17	24	38	50	43	67		TCRBV24-01,TCRBV24-or09_02												CATSEGRDSGVQQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCAGGGGCGGACACCGGGGAGCTGTTTTTTGGAGAA	CATSAGADTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	2	3	0	3	24	-1	43	37	46		TCRBV24-01,TCRBV24-or09_02												CATSAGADTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGATTCAGGGGCGATGGGAAAAACTGTTTTTTGGCAGT	CASSLSIQGRWEKLFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	2	8	9	6	24	36	51	45	57	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01												CASSLSIQGRWEKLFF+X+TCRBJ01-04		TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGGCCCTCAATGACAGGGGGGAACTATGGCTACACCTTCGGTTCG	CASRPSMTGGNYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	1	2	9	1	23	34	52	43	53	TCRBV06,TCRBV10													CASRPSMTGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACGTTGGCAAAGCTACGAGCAGTACGTCGGGCCG	CASSERWQSYEQYV	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV06						TCRBJ02	TCRBJ02-07	01	2	4	5	17	18	4	23	38	59	56	63		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERWQSYEQYV+TCRBV06-X+TCRBJ02-07	TCRBV06		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCGGGGTGGTTGGCAGTATGAAAACACCATATATTTTGGAGAG		Out	VDJ	1	16	2.0716801325875285E-4		44	unresolved			unresolved			TCRBJ01	TCRBJ01-03	01	10	8	3	6	1	15	23	30	36	31	51	TCRBV06,TCRBV10			TCRBD01,TCRBD02										X+X+TCRBJ01-03	unresolved	unresolved	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GARGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTTTTATATGAGGGACAGGATTCGGAGACCCAGTACTTCGGGCCA	CASSFLYEGQDSETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	4	5	11	5	21	33	52	44	57	TCRBV04,TCRBV05													CASSFLYEGQDSETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCACACCGTATACACCATCCCCTGACAGGGCTACTGAAGCTTTCTTTGGACAA	CASTPYTPSPDRATEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	5	20	2	18	28	55	48	57	TCRBV07,TCRBV11													CASTPYTPSPDRATEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAGTTCCGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLSSVNTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	unresolved						TCRBJ02	TCRBJ02-02	01	2	5	5	1	0	6	18	-1	35	33	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSVNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCACCCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLAPNTGELFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42							TCRBJ02	TCRBJ02-02	01	0	3	7	2	0	2	18	-1	37	35	39	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLAPNTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGGCCTTACTTCCCAAGAGACCCAGTACTTCGGGCCA	CASSLGLTSQETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	8	0	1	0	8	18	-1	36	32	44	TCRBV07,TCRBV11													CASSLGLTSQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGTATCAGGTGGGAACACTGAAGCTTTCTTTGGACAA	CASSVSGGNTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	1	4	3	19	31	39	35	42	TCRBV05,TCRBV11													CASSVSGGNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTCGGGTGTCCCGGGACAGCCAGACCAAGAGACCCAGTACTTCGGGCCA	CASSSGVPGQPDQETQYF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	0	5	0	10	4	19	32	49	42	53	TCRBV05,TCRBV11													CASSSGVPGQPDQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCCTCAAAGGCGGGACTTACAATGAGCAGTTCTTCGGGCCA	CASLKGGTYNEQFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	42	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	0	10	4	9	0	19	28	-1	37	43		TCRBV05-06,TCRBV05-07				01,02								CASLKGGTYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTCRGCYGTGTATSTCTGTGCCAGCAGCGCCTGGACAGGCCAAAATTCACCCCTCCACTTTGGGAAC	CASSAWTGQNSPLHF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	4	7	4	4	22	34	45	38	49	TCRBV07,TCRBV11													CASSAWTGQNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCTTAGTCGGGACAGGGGGCCGGAGGACTGAAGCTTTCTTTGGACAA	CASSLVGTGGRRTEAFF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	0	5	2	6	22	38	52	40	58	TCRBV07,TCRBV12													CASSLVGTGGRRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGTCAGTGGACAGGGAGAAACTATGGCTACACCTTCGGTTCG	CASSQWTGRNYGYTF	In	VDJ	1	16	2.0716801325875285E-4	2.46552122659681E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	2	5	3	22	33	46	38	49	TCRBV07,TCRBV12													CASSQWTGRNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACAGGTCCGAACCCTGAAGCTTTCTTTGGACAA	CASSTGPNPEAFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	6	0	8	26	-1	43	38	51		TCRBV12-03,TCRBV12-04												CASSTGPNPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTCTCGGACTCTATGAGCAGTTCTTCGGGCCA	CASSLGLYEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	1	10	8	3	2	26	38	46	41	48	TCRBV09,TCRBV12					01,02								CASSLGLYEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACGGTCTCTGGAAACACCATATATTTTGGAGAG	CASSLTVSGNTIYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	2	8	5	0	1	1	26	41	45	42	46		TCRBV12-03,TCRBV12-04				01,02								CASSLTVSGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATTTGGGGCTCAAGGCACTGAAGCTTTCTTTGGACAA	CASSQFGAQGTEAFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	7	0	4	3	6	26	41	49	44	55		TCRBV03-01,TCRBV03-02												CASSQFGAQGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGACTCGTGTTTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.201160140874249E-4		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	2	10	5	0	16	26	-1	42	38	58		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGAGTCGACAGAAACAATGAGCAGTTCTTCGGGCCA	CSARVDRNNEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	5	5	7	2	26	34	46	41	48		TCRBV20-01,TCRBV20-or09_02												CSARVDRNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCCGGACCGGGGCCGGGATGAAAAACTGTTTTTTGGCAGT	CSAPDRGRDEKLFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	6	7	0	6	8	4	26	34	47	42	51		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDRGRDEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCCAGGGGGAGGGAAAAACTGTTTTTTGGCAGT	CSARARGREKLFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	1	8	3	3	26	37	47	40	50		TCRBV20-01,TCRBV20-or09_02												CSARARGREKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCACCCCGGGGGAGGCCGGGGAGCTGTTTTTTGGAGAA	CSAPTPGEAGELFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	2	6	7	3	26	35	48	42	51		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPTPGEAGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCGGGACAGGGGAGCTCCTATAATTCACCCCTCCACTTTGGGAAC	CSSGQGSSYNSPLHF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	8	0	2	0	2	2	26	32	44	34	46		TCRBV20-01,TCRBV20-or09_02												CSSGQGSSYNSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTACAGGGGTCGGGGCAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	17	2.201160140874249E-4		44	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	3	2	7	0	7	22	-1	41	34	48		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCGGGGTTCGACAAAAACAATGAGCAGTTCTTCGGGCCA	CATSPGFDKNNEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	3	5	1	10	24	36	42	37	52		TCRBV24-01,TCRBV24-or09_02												CATSPGFDKNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CMCCARCCARACAGCTYTKTACTTCTGTGCCACCAGTGATGCAGGGGACAATCAGCCCCAGCATTTTGGTGAT	CATSDAGDNQPQHF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	3	1	1	24	39	46	40	47	TCRBV22,TCRBV24													CATSDAGDNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGACAATTAGCGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASRQLAGVTDTQYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	5	2	2	5	1	18	29	43	34	44	TCRBV07,TCRBV11													CASRQLAGVTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCCAAAACTAGCGGGGGGAGCCCTTACAATGAGCAGTTCTTCGGGCCA	CASSLAKTSGGSPYNEQFF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	57				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	1	4	4	6	18	35	51	39	57	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLAKTSGGSPYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTACAGGGGGCGGTGGAGACCCAGTACTTCGGGCCA	CASSLQGAVETQYF	In	VDJ	1	17	2.201160140874249E-4	2.619616303259111E-4	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	3	0	5	0	4	19	-1	42	33	46		TCRBV05-06,TCRBV05-07												CASSLQGAVETQYF+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTTAGCGGCCAGGCATTAAGCTGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	2.201160140874249E-4		50	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	5	5	6	0	15	19	-1	39	33	54		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGARGACTCRGCYSYGTATCTCTGYGCCAGCAGCCAAGATTTCGGCCAAGTGACAGGAAACAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	2.201160140874249E-4		58	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	4	2	12	5	19	36	54	48	59	TCRBV01,TCRBV04													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCCGACTAGCGGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSPRLAGGYNEQFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	2	0	4	4	0	26	38	-1	42	56		TCRBV12-03,TCRBV12-04												CASSPRLAGGYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAGATGGAGGGATCCTGCGGTGGCCCCAGCATTTTGGTGAT		Out	VDJ	1	18	2.3306401491609695E-4		53	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	0	10	0	9	6	11	26	43	55	49	66		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAATACAAGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	18	2.3306401491609695E-4		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	6	3	4	2	26	43	50	47	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAACGAGCAGTACGTCGGGCCG	CASSQGNEQYV	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	1	1	8	17	0	12	26	-1	45	42	57		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGNEQYV+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACGCCGACAGGACAAGAGGCCAACGTCCTGACTTTCGGGGCC	CSATPTGQEANVLTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	2	4	6	4	6	26	36	46	40	52		TCRBV20-01,TCRBV20-or09_02												CSATPTGQEANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGGAGGGGGCCCAGAGACCCAGTACTTTGGGCCA	CSARRGGGPETQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	TCRBV20						TCRBJ02			2	5	0	22	5	18	26	38	50	43	68		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CSARRGGGPETQYF+TCRBV20-X+TCRBJ02-X	TCRBV20		TCRBJ02	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGGAAGACGCTAACTATGGCTACACCTTCGGTTCG	CSARDREDANYGYTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	8	3	0	1	5	26	40	46	41	51		TCRBV20-01,TCRBV20-or09_02												CSARDREDANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCACCCCCTAGCGGGGGCTGATTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	2.3306401491609695E-4		44	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	4	2	4	4	5	22	29	43	33	48		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGACAGGGGCAGGGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.3306401491609695E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	3	2	6	24	38	50	40	56		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCGGGACAGGGGATCTCCTACGAGCAGTACGTCGGGCCG	CASSPGQGISYEQYV	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	2	17	2	19	24	36	48	38	67		TCRBV24-01,TCRBV24-or09_02												CASSPGQGISYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CYSRRSSASWCAGCTYTKTAYTTCTGTGCCAGCAGTGAAACAGGGGTGGGGGAGACCCAGTACTTCGGGCCA	CASSETGVGETQYF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	3	2	5	1	5	24	38	46	39	51	TCRBV09,TCRBV24													CASSETGVGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGGGGGCAGAGCAATGAACACTGAAGCTTTCTTTGGACAA	CASSLGGRAMNTEAFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	0	0	7	19	-1	40	35	47	TCRBV07,TCRBV11													CASSLGGRAMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAGACWCGGCMMTGTATCKCTGYGCCAGCAGCTTAGTGGGGCGCCTCGCAGGGGAGCTGTTTTTTGGAGAA	CASSLVGRLAGELFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	7	0	8	1	8	18	34	40	35	48	TCRBV07,TCRBV23													CASSLVGRLAGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTCAGACGGGACAGGGCCGAATGAGCAGTTCTTCGGGCCA	CASSSDGTGPNEQFF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	7	1	3	18	35	45	36	48	TCRBV03,TCRBV11													CASSSDGTGPNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTTTTCCTCAGGGTTTTGACTATGGCTACACCTTCGGTTCG	CASSFPQGFDYGYTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	3	7	5	18	29	41	36	46	TCRBV07,TCRBV11													CASSFPQGFDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCGGGTAACTTATGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSG*LMTE*KTYGYTF	Stop	VDJ	1	18	2.3306401491609695E-4		54	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	2	10	4	11	11	19	31	46	42	57	TCRBV05,TCRBV07					01,02								CASSG*LMTE*KTYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTTAGAGTTACAGGAAGACTATGGCTACACCTTCGGTTCG	CASSLELQEDYGYTF	In	VDJ	1	18	2.3306401491609695E-4	2.7737113799214115E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	3	4	3	7	3	22	35	47	42	50	TCRBV07,TCRBV11													CASSLELQEDYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCAGRAGACWCRGCMCKGTATYTCTGTGCCAGCAGCCGAGGGGGGAGCTCCGAGCTTTCTTTGGACAA		Out	VDJ	1	18	2.3306401491609695E-4		38	unresolved						TCRBJ01	TCRBJ01-01	01	5	5	1	10	2	8	24	36	44	38	52	TCRBV04,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGCGGGAGGGGTGCCGATTCACCCCTCCACTTTGGGAAC	CASSGRGADSPLHF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	8	0	8	0	6	26	-1	45	37	51	TCRBV02,TCRBV12													CASSGRGADSPLHF+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCCTCCACCATCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDPPPSGANVLTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	51	unresolved						TCRBJ02	TCRBJ02-06	01	0	3	7	1	6	2	23	40	48	46	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDPPPSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGATAGGACAGGGAACTATGGCTACACCTTCGGTTCG	CSADRTGNYGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	2	5	0	26	34	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSADRTGNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAAATATTTTCTTACGATGAACACTGAAGCTTTCTTTGGACAA	CSARKYFLTMNTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	2	8	0	14	0	26	38	-1	52	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARKYFLTMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACAGGGTGTCCACCGGGGAGCTGTTTTTTGGAGAA	CSARDRVSTGELFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	4	0	4	26	-1	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARDRVSTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGGTGGGCAGGTTCGATGAACACTGAAGCTTTCTTTGGACAA	CSARDRWAGSMNTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	4	0	8	5	26	40	52	48	57		TCRBV20-01,TCRBV20-or09_02												CSARDRWAGSMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCCTCCTTCCAGACAGGGACTGGTATGGCTACACCTTCGGTTCG	CSARVLLPDRDWYGYTF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	2	3	5	11	5	26	39	57	50	62		TCRBV20-01,TCRBV20-or09_02												CSARVLLPDRDWYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCGGAGGGACACTGAAGCTTTCTTTGGACAA	CSASRRDTEAFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	3	2	0	26	37	-1	39	45		TCRBV20-01,TCRBV20-or09_02												CSASRRDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCGGACAGGGGGAGACCCAGTACTTCGGGCCA	CSASGQGETQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	2	5	1	0	26	37	-1	38	47		TCRBV20-01,TCRBV20-or09_02												CSASGQGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGTCTGTGAGAGGGCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARSVRGPNTGELFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	3	11	0	0	8	1	26	37	50	45	51		TCRBV20-01,TCRBV20-or09_02												CSARSVRGPNTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGTACACCGCGGGACAGGGGTAAACAATGAGCAGTTCTTCGGGCCA	CATSDVHRGTGVNNEQFF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	5	9	3	24	39	58	48	61		TCRBV24-01,TCRBV24-or09_02												CATSDVHRGTGVNNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGAGGTCGCGGGGGGTCTTACGCAGTATTTTGGCCCA	CASSLEVAGGLTQYF	In	VDJ	1	19	2.4601201574476903E-4	2.927806456583712E-4	45	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	1	8	7	3	19	33	48	40	51		TCRBV05-06,TCRBV05-07												CASSLEVAGGLTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTTAGGGCCGGGGGGAGCACCATATATTTTGGAGAG	CASSFRAGGSTIYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	6	8	1	9	9	2	26	37	53	46	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSFRAGGSTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12	TCRBD02-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGCTCTGAACACTGAAGCTTTCTTTGGACAA	CASSFALNTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	10	0	0	1	2	26	40	43	41	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFALNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTTAATCGGGGGGCAGAGCGAGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	20	2.5896001657344105E-4		46	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	3	8	1	8	2	8	24	38	47	40	55		TCRBV06-05,TCRBV06-06												X+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACAGGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASNRGAGELFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	1	6	0	1	26	-1	44	36	45		TCRBV03-01,TCRBV03-02												CASNRGAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGCTAGACCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	2.5896001657344105E-4		47	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	5	3	2	0	6	26	-1	47	43	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTACTAGTATAGCGACAAAAAATGAAAAACTGTTTTTTGGCAGT	CSTSIATKNEKLFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	3	5	6	5	2	6	26	37	44	39	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSTSIATKNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGGCAAGAGACCCAGTACTTCGGGCCA	CSARDQGQETQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV20						TCRBJ02	TCRBJ02-05	01	0	5	3	2	3	0	26	40	-1	43	47		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGCGGGGGAACTAATGAAAAACTGTTTTTTGGCAGT	CSARDGGGTNEKLFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	0	7	2	1	2	0	26	40	-1	42	49		TCRBV20-01,TCRBV20-or09_02												CSARDGGGTNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCAGGGTGGCACGCAGTATTTTGGCCCA	CSARQGGTQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	3	9	1	4	26	37	43	38	47		TCRBV20-01,TCRBV20-or09_02												CSARQGGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTGGACCGGGGGGCACACAGATACGCAGTATTTTGGCCCA	CASSQDWTGGHTDTQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	1	2	6	2	23	40	53	46	55	TCRBV01,TCRBV04													CASSQDWTGGHTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCCGACGCGGGGGGGCAAGATACGCAGTATTTTGGCCCA	CATSDADAGGQDTQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	5	6	2	24	39	54	45	56		TCRBV24-01,TCRBV24-or09_02												CATSDADAGGQDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGACAGGGGGTCTCAGATACGCAGTATTTTGGCCCA	CATSDLGQGVSDTQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	1	1	4	0	3	24	-1	52	42	55		TCRBV24-01,TCRBV24-or09_02												CATSDLGQGVSDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTCCGGGACAGGGAGGGAGCGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	20	2.5896001657344105E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	0	3	4	3	8	24	41	53	44	61		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCTACCAACGAGGAGACCCAGTACTTCGGGCCA	CATSATNEETQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	9	5	0	8	24	-1	40	37	48		TCRBV24-01,TCRBV24-or09_02				01,02								CATSATNEETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGGCGACCAAGAGACCCAGTACTTCGGGCCA	CASSLGDQETQYF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	8	0	0	2	1	24	36	42	38	43		TCRBV24-01,TCRBV24-or09_02												CASSLGDQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGACAGCCACACTGAAGCTTTCTTTGGACAA	CASSLADSHTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	3	0	2	18	-1	41	35	43	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLADSHTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTGTATSTCTGTGCCAGCAGTCCCAGGGTATCGAACACTGAAGCTTTCTTTGGACAA	CASSPRVSNTEAFF	In	VDJ	1	20	2.5896001657344105E-4	3.081901533246013E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	1	3	4	19	30	38	33	42	TCRBV05,TCRBV11													CASSPRVSNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGCCAGCCGAGACAGGGGGTTACAATGAGCAGTTCTTCGGGCCA	CASRPAETGGYNEQFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	2	1	4	9	1	24	35	53	44	54	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASRPAETGGYNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TMSCTCCCAGACATCTGTRTACTTCTGTGCCATCAGTAACCCCGGACTAGCGGCCTTACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	21	2.7190801740211313E-4		56	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	1	5	0	6	5	24	36	52	42	57	TCRBV06,TCRBV10					01,02								X+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGTGGGGGAGTAGGGTCTCTGAGAGACCCAGTACTTCGGGCCA	CASSPVGE*GL*ETQYF	Stop	VDJ	1	21	2.7190801740211313E-4		51	TCRBV03						TCRBJ02	TCRBJ02-05	01	4	6	1	4	4	13	26	39	48	43	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPVGE*GL*ETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCTGGAGGGCCTGAATGAAAAACTGTTTTTTGGCAGT	CSALEGLNEKLFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	10	0	5	3	4	26	34	43	37	47		TCRBV20-01,TCRBV20-or09_02												CSALEGLNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD02-01*02	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCACCCGAGACAGGGGGCGTTGGATACGCAGTATTTTGGCCCA	CSATHPRQGALDTQYF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	0	6	9	4	26	36	55	45	59		TCRBV20-01,TCRBV20-or09_02												CSATHPRQGALDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAACCAGGGTAGCGAAAAACTGTTTTTTGGCAGT	CSARDNQGSEKLFF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	3	8	4	4	26	40	49	44	53		TCRBV20-01,TCRBV20-or09_02												CSARDNQGSEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGGRGACWCRGCWSTGTATCTCTGYGCCAGCCAACCGGGACAGGGACAGACCCAGTACTTCGGGCCA	CASQPGQGQTQYF	In	VDJ	1	21	2.7190801740211313E-4	3.2359966099083134E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	8	0	3	6	5	2	22	31	45	36	47	TCRBV07,TCRBV23													CASQPGQGQTQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTAGGCCAGGCCCCGACTAGCGCGCACAGATACGCAGTATTTTGGCCCA	CASSQD*ARPRLARTDTQYF	Stop	VDJ	1	21	2.7190801740211313E-4		60	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	6	1	14	1	15	32	54	46	55		TCRBV03-01,TCRBV03-02				01,02								CASSQD*ARPRLARTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGCTTGAAAGCGGGGGGGAAAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	2.7190801740211313E-4		59	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	6	0	0	9	2	22	39	58	48	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCCCGGGCAAGGGAGTGGAAACACCATATATTTTGGAGAG	CASSPGQGSGNTIYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	9	2	3	8	0	23	36	-1	44	49	TCRBV01,TCRBV05													CASSPGQGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGGTCCTCGGGCCTGAACACTGAAGCTTTCTTTGGACAA	CASRSSGLNTEAFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	42							TCRBJ01	TCRBJ01-01	01	6	8	0	0	6	1	24	35	45	41	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRSSGLNTEAFF+X+TCRBJ01-01			TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGCTTCTGGACAGGGAATACCGGGGAGCTGTTTTTTGGAGAA	CASSSFWTGNTGELFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	1	3	5	7	3	26	38	53	45	56		TCRBV03-01,TCRBV03-02												CASSSFWTGNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGGGACGGGCTACAATGAGCAGTTCTTCGGGCCA	CSAGTGYNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	6	0	7	3	1	3	26	34	40	35	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAGTGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCAGGGAAGGGACCCAGTACTTCGGGCCA	CSARVREGTQYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	3	7	1	4	26	39	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARVREGTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGTGGACAGGGAACTCTGGAAACACCATATATTTTGGAGAG	CSAREWTGNSGNTIYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	1	3	0	5	2	26	37	50	42	52		TCRBV20-01,TCRBV20-or09_02												CSAREWTGNSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTGAGGGGGTACGGCACAATGAGCAGTTCTTCGGGCCA	CSVEGVRHNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	1	5	3	6	26	33	42	36	48		TCRBV20-01,TCRBV20-or09_02												CSVEGVRHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGGAGACCCTACTAACTATGGCTACACCTTCGGTTCG	CASSQGDPTNYGYTF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	2	0	0	6	23	-1	42	37	48	TCRBV01,TCRBV04													CASSQGDPTNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTCCGCCGGGTCAGGTGGGAGATACGCAGTATTTTGGCCCA	CASSPPGQVGDTQYF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	4	4	5	9	4	22	34	47	43	51	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGQVGDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGAACTTCCGGGGAATGAGCAGTTCTTCGGGCCA	CASSELPGNEQFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	3	7	7	0	22	34	-1	41	46	TCRBV09,TCRBV12													CASSELPGNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGTAAACCTATACCCGTCCTACGAGCAGTACGTCGGGCCG	CASSVNLYPSYEQYV	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	TCRBV12						TCRBJ02	TCRBJ02-07	01	5	4	5	17	24	4	22	34	61	58	65		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVNLYPSYEQYV+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGCCTCCGGGACAGGGTGAATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	2.8485601823078515E-4		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	3	6	5	3	24	42	56	47	59		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAACCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	22	2.8485601823078515E-4		37	TCRBV06						TCRBJ02	TCRBJ02-02	01	2	3	7	4	1	0	23	38	-1	39	41		TCRBV06-01,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-X+TCRBJ02-02	TCRBV06		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCGCGGGGGACGGACCTCATGAAAAACTGTTTTTTGGCAGT	CASSAGDGPHEKLFF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	7	2	6	0	9	18	-1	37	30	46	TCRBV05,TCRBV11													CASSAGDGPHEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCSRGGGACTCAGCTGTGTATYTYTGTGCCAGCAGCCCAACTCCGGCCCACACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	2.8485601823078515E-4		44	unresolved						TCRBJ01	TCRBJ01-01	01	5	9	0	3	8	4	22	34	45	42	49	TCRBV07,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAACGAAAGGGATAAGAATCAGCCCCAGCATTTTGGTGAT	CASNERDKNQPQHF	In	VDJ	1	22	2.8485601823078515E-4	3.390091686570614E-4	42	unresolved						TCRBJ01	TCRBJ01-05	01	6	0	8	4	6	4	23	33	43	39	47	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNERDKNQPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGCGGGGGTTACAGATACGCAGTATTTTGGCCCA	CASSQEAGVTDTQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	45	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	2	3	1	2	26	43	51	44	53		TCRBV03-01,TCRBV03-02												CASSQEAGVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCTGGACCTTCGGATACGCAGTATTTTGGCCCA	CASSPGPSDTQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	1	7	6	2	5	26	39	45	41	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPGPSDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACTGAACACTGAAGCTTTCTTTGGACAA	CSARLNTEAFF	In	VJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	0	0	0	0	1	26	-1	38	-1	39		TCRBV20-01,TCRBV20-or09_02												CSARLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGCACAGGGGGAATGAACACTGAAGCTTTCTTTGGACAA	CSARDSTGGMNTEAFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	1	0	4	2	26	40	52	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDSTGGMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGACTAGCGGGGGGAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CSARGLAGGANTGELFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	0	1	0	0	2	26	-1	52	37	54		TCRBV20-01,TCRBV20-or09_02												CSARGLAGGANTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCGGGGGAGGGGTTCATGAACACTGAAGCTTTCTTTGGACAA	CSAPGEGFMNTEAFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	0	0	4	5	26	35	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSAPGEGFMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGACGGGAAGAGACACAGATACGCAGTATTTTGGCCCA	CATSGTGRDTDTQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	45	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	8	3	2	3	5	24	37	45	40	50		TCRBV24-01,TCRBV24-or09_02												CATSGTGRDTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCTCGTCGACTAGCGGGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSSSTSGGYNEQFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	2	2	3	6	0	24	35	-1	41	53		TCRBV24-01,TCRBV24-or09_02												CASSSSTSGGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGGCCTCGCGGTTGACAGGGTCCTACACCTTCGGTTCG	CASSLASRLTGSYTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	10	14	2	24	36	57	50	59		TCRBV24-01,TCRBV24-or09_02												CASSLASRLTGSYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCATAATTATTGGGTAGCGGGGGCACAAGAGACCCAGTACTTCGGGCCA	CSARDHNYWVAGAQETQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	57	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	2	2	14	2	24	38	61	52	63		TCRBV20-01,TCRBV20-or09_02												CSARDHNYWVAGAQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCCAAGATTTGGGACAGGGACTAGGTAACTATGGCTACACCTTCGGTTCG	CASSQDLGQGLGNYGYTF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	1	8	6	19	31	48	39	54	TCRBV03,TCRBV07,TCRBV11													CASSQDLGQGLGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCGGGACTAGCGGGGGAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSGTSGGNTGELFF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	2	0	1	19	-1	45	31	46	TCRBV07,TCRBV11													CASSGTSGGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCGGAAGACCGGGACAGGGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASSGRPGQGLSGNTIYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	54	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	0	3	0	8	3	19	31	48	39	51		TCRBV05-06,TCRBV05-07												CASSGRPGQGLSGNTIYF+TCRBV05-X+TCRBJ01-03	TCRBV05	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGGGGACTYRGCTKTGTATYTCTGTGCCAGCAGCCCAGAACTAGCGGGGGGACGCACAGATACGCAGTATTTTGGCCCA	CASSPELAGGRTDTQYF	In	VDJ	1	23	2.9780401905945723E-4	3.544186763232915E-4	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	3	1	1	1	2	22	38	51	39	53	TCRBV07,TCRBV09													CASSPELAGGRTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCCATATCCACCGGGGAGCTGTTTTTTGGAGAA	CASSPISTGELFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	39	TCRBV12						TCRBJ02	TCRBJ02-02	01	5	4	6	4	2	4	26	38	42	40	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPISTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGCGGGGCCGGCCAAGAGCAGTTCTTCGGGCCA	CASSLGGAGQEQFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	7	3	10	2	8	26	40	48	42	56		TCRBV12-03,TCRBV12-04												CASSLGGAGQEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGGCCCAGGGTCCTCCCTTTGTGGCTACACCTTCGGTTCG		Out	VDJ	1	24	3.1075201988812925E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	3	7	3	11	23	34	42	37	53	TCRBV01,TCRBV17													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTTGGTCAGGGGCTTTCACGGGGAGCTGTTTTTTGGAGAA	CASSQDLVRGFHGELFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	2	7	6	6	26	43	55	49	61		TCRBV03-01,TCRBV03-02												CASSQDLVRGFHGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGATTAGCGGGGTGCCCCAAGAGACCCAGTACTTCGGGCCA	CSARDQISGVPQETQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	5	3	1	6	4	26	40	54	46	58		TCRBV20-01,TCRBV20-or09_02												CSARDQISGVPQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCACGGACACTGAAGCTTTCTTTGGACAA	CSAPTDTEAFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	8	5	3	4	0	26	35	-1	39	42		TCRBV20-01,TCRBV20-or09_02				01,02								CSAPTDTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTTCGGACAGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CSAFGQGYQETQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	1	2	0	3	1	26	35	47	38	48		TCRBV20-01,TCRBV20-or09_02												CSAFGQGYQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCCGACAACTGCAAGAGACCCAGTACTTCGGGCCA	CATSDSRQLQETQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	6	2	3	4	24	40	47	43	51		TCRBV24-01,TCRBV24-or09_02												CATSDSRQLQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGGTTGGCAGCTATGAGCAGTACGTCGGGCCG		Out	VDJ	1	24	3.1075201988812925E-4		40	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	4	5	17	9	14	24	36	48	45	62		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCCTTCAGGGGAGTAACTATGGCTACACCTTCGGTTCG	CASSLQGSNYGYTF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	1	3	2	19	31	40	34	42	TCRBV11,TCRBV23													CASSLQGSNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMMTGTATCTCTGYGCCAGCAGCTTCCAGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSFQGSTDTQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	0	1	0	19	33	-1	34	40	TCRBV11,TCRBV23													CASSFQGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGCCCCGGACAGGGTATCAAGAGACCCAGTACTTCGGGCCA	CASSPPRTGYQETQYF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	2	7	3	19	31	46	38	49	TCRBV05,TCRBV11													CASSPPRTGYQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTTATGGGGGGCGCAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLWGAQNTGELFF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	2	6	0	1	3	3	19	33	42	36	45	TCRBV05,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLWGAQNTGELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTGTATCTCTGTGCCAGCAGCTTAGAAGGCACAGGGTATGGCTACACCTTCGGTTCG	CASSLEGTGYGYTF	In	VDJ	1	24	3.1075201988812925E-4	3.6982818398952153E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	5	4	0	19	36	-1	40	46	TCRBV07,TCRBV11													CASSLEGTGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCGAAGGAAGGTGCAGTTCTTCGGGCCA	CASSQDRRKVQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	39	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	8	12	5	4	26	43	51	48	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRRKVQFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTATATGGGACAGGGGGTTAATGAGCAGTTCTTCGGGCCA	CASSYMGQGVNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	1	7	5	2	26	38	54	43	56		TCRBV03-01,TCRBV03-02												CASSYMGQGVNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCACCCCATACCTCATGAACACTGAAGCTTTCTTTGGACAA	CSATPYLMNTEAFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	42	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	3	7	0	1	11	26	34	37	35	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSATPYLMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGAGACAGGGTTCACTACAATGAGCAGTTCTTCGGGCCA	CSARDRVHYNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	3	3	0	4	26	-1	45	40	49		TCRBV20-01,TCRBV20-or09_02												CSARDRVHYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGCCCCGGGACAGGGGATACAATGAGCAGTTCTTCGGGCCA	CSARPRDRGYNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	2	4	8	1	26	34	52	42	53		TCRBV20-01,TCRBV20-or09_02												CSARPRDRGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAACGGGTACGCAGTATTTTGGCCCA	CSARDQTGTQYF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	8	4	8	5	0	26	40	-1	45	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDQTGTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAACCAGCAGTCCAATGAGCAGTTCTTCGGGCCA	CSARNQQSNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	39	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	4	5	6	4	5	26	37	44	41	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARNQQSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGCCCCGGGCGGGGGGGTCCCATTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	3.2370002071680133E-4		55	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	0	1	10	6	26	35	54	45	60		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CACCWSCCARACAKCTKTGTACTTSTGTGCCAGCAGTGTCAACAGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASSVNRGSTDTQYF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	13	3	2	0	13	1	25	28	48	41	49	TCRBV06,TCRBV22													CASSVNRGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGGGACAGGGGGGTATACAATGAGCAGTTCTTCGGGCCA	CATSDRDRGVYNEQFF	In	VDJ	1	25	3.2370002071680133E-4	3.852376916557516E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	0	1	4	2	3	24	38	51	40	54		TCRBV24-01,TCRBV24-or09_02												CATSDRDRGVYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACCCGGACTTCTATCTAAGGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	25	3.2370002071680133E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	6	1	10	8	4	10	24	36	45	40	55		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACCTCCAATGGGGACACTGAAGCTTTCTTTGGACAA	CASSTSNGDTEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	6	2	3	9	0	26	38	-1	47	51		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTSNGDTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAACCCCGGACGGACCCAGATTTTACCATATATTTTGGAGAG	CSAKPRTDPDFTIYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	45	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	1	7	10	8	13	26	34	46	42	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKPRTDPDFTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCCGCAGGATACAATGAGCAGTTCTTCGGGCCA	CSARDPAGYNEQFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	4	4	5	1	26	40	49	45	50		TCRBV20-01,TCRBV20-or09_02												CSARDPAGYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTCAGAGCCGGGGGCTGAAGCTTTCTTTGGACAA	CSASSEPGAEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	2	6	8	0	26	37	-1	45	51		TCRBV20-01,TCRBV20-or09_02												CSASSEPGAEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTTTGGGGGAATTCACTGAAGCTTTCTTTGGACAA	CSASLGEFTEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	3	6	1	4	3	4	26	37	45	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASLGEFTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATCAAGGGGGGAAGGACAGATACGCAGTATTTTGGCCCA	CSAIKGGRTDTQYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	4	5	1	3	3	5	26	36	45	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAIKGGRTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACGAGAGGAGGGGACCACACTGAAGCTTTCTTTGGACAA	CASTRGGDHTEAFF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	11	10	0	3	8	4	24	31	45	39	49		TCRBV24-01,TCRBV24-or09_02												CASTRGGDHTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGATGGGAYTTTAGATACGCAGTATTTTGGCCCA	CASSLDGXLDTQYF	In	VDJ	1	26	3.366480215454734E-4	4.006471993219817E-4	42	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	0	0	10	5	2	2	19	35	43	37	45	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLDGXLDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGGGGGTTCCCCCGAACTCGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	26	3.366480215454734E-4		53	unresolved			unresolved			TCRBJ01	TCRBJ01-01	01	0	6	2	1	0	14	19	-1	39	35	53	TCRBV05,TCRBV11			TCRBD01,TCRBD02										X+X+TCRBJ01-01	unresolved	unresolved	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGGGACAGAGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRGTENTGELFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	5	1	1	1	26	37	45	38	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRGTENTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCTATCTGTAGGCGAAAAACTGTTTTTTGGCAGT	CASSLSVGEKLFF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	5	5	4	8	8	1	26	38	49	46	50		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSVGEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCGGGACTGGGTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGTGSGANVLTF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	5	0	10	1	3	3	26	38	47	41	50		TCRBV03-01,TCRBV03-02				01,02								CASSSGTGSGANVLTF+TCRBV03-X+TCRBJ02-06	TCRBV03	TCRBD02-01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAAACTCAACACAGGGGACTATGGCTACACCTTCGGTTCG	CSAKLNTGDYGYTF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	3	10	0	26	34	-1	44	51		TCRBV20-01,TCRBV20-or09_02												CSAKLNTGDYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CSASPGGSTDTQYF	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	0	0	2	0	26	37	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSASPGGSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCAAGTCGCCTGTACGGGACTAGCGGAACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	27	3.4959602237414543E-4		49	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	12	0	5	2	13	2	18	23	47	36	49	TCRBV07,TCRBV12					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTCCCCTCCTTAACGAGCAGTACGTCGGGCCG	CASSPLLNEQYV	In	VDJ	1	27	3.4959602237414543E-4	4.160567069882117E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	5	4	5	17	16	4	23	34	53	50	57	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLLNEQYV+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCATCAAGCGGGGGTGGAGATACGCAGTATTTTGGCCCA	CASSQSSSGGGDTQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	6	2	5	6	3	26	41	55	47	58		TCRBV03-01,TCRBV03-02												CASSQSSSGGGDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCTCACGGGGACAGGGGGTAACTATGGCTACACCTTCGGTTCG	CASSLTGTGGNYGYTF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	1	1	5	0	26	39	-1	44	55	TCRBV03,TCRBV12													CASSLTGTGGNYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGAAGACCCAAACAGGGAGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	28	3.625440232028175E-4		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	3	3	6	5	2	26	43	54	48	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTAGTAATCACCCGCGATGAGCAGTTCTTCGGGCCA	CSARLVITRDEQFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	4	8	8	0	12	26	-1	42	38	54		TCRBV20-01,TCRBV20-or09_02				01,02								CSARLVITRDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCGAGCGGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPSGGNTGELFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	6	2	1	4	0	22	33	-1	37	45		TCRBV12-03,TCRBV12-04												CASSPSGGNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGGGACTCRGCYGTGTAYKTCTGTGCCAGCAGTGAAAACAGGGCCCTCCAAGAGACCCAGTACTTCGGGCCA	CASSENRALQETQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	3	1	4	4	22	34	44	38	48	TCRBV11,TCRBV12													CASSENRALQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCCCCCCAGGATACGCAGTATTTTGGCCCA	CATSDSPQDTQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	5	6	5	0	24	40	-1	45	48		TCRBV24-01,TCRBV24-or09_02												CATSDSPQDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCCTTCTAGCGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLLAGTNTGELFF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	4	4	3	0	3	1	19	31	43	34	44	TCRBV05,TCRBV11													CASSLLAGTNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGTGACCGGGACAGGGGTTTATTGGAGACCCAGTACTTCGGGCCA	CASSDRDRGLLETQYF	In	VDJ	1	28	3.625440232028175E-4	4.3146621465444177E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	5	5	7	24	35	50	40	57	TCRBV02,TCRBV21													CASSDRDRGLLETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCCACGTGCCGACAGGGGCTGAGCAGTTCTTCGGGCCA	CASSSHVPTGAEQFF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	9	10	1	26	39	57	49	58		TCRBV12-03,TCRBV12-04												CASSSHVPTGAEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGAACACTGAAGCTTTCTTTGGACAA	CASSLGNTEAFF	In	VJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	36	TCRBV12						TCRBJ01	TCRBJ01-01	01	1	0	0	1	0	1	26	-1	42	-1	43		TCRBV12-03,TCRBV12-04												CASSLGNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGTACGACTGGAATTACGAGCAGTACGTCGGGCCG		Out	VDJ	1	29	3.7549202403148953E-4		47	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	17	6	18	26	43	53	49	71		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGCAGTGCCGGCGAGCCCCAGCATTTTGGTGAT	CSASSAGEPQHF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	36	TCRBV20						TCRBJ01	TCRBJ01-05	01	6	4	5	8	3	8	26	34	40	37	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASSAGEPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGAACCCGGGACAGGGAGCCACAATGAGCAGTTCTTCGGGCCA	CSAEPGTGSHNEQFF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	0	3	5	7	4	26	34	50	41	54		TCRBV20-01,TCRBV20-or09_02												CSAEPGTGSHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCWMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTCCAGACAGGGGCGGCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	29	3.7549202403148953E-4		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	2	2	3	3	3	23	36	47	39	50	TCRBV06,TCRBV27													X+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAACCTGACAGTTTTGGCACAGATACGCAGTATTTTGGCCCA	CATSEPDSFGTDTQYF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	5	1	4	5	24	38	47	42	52		TCRBV24-01,TCRBV24-or09_02												CATSEPDSFGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACAAGCTAGGTGGTGAAAAACTGTTTTTTGGCAGT	CATSDKLGGEKLFF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	4	8	7	4	4	24	38	46	42	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDKLGGEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCCGGACTAGCGGGGAGGCACAATGAGCAGTTCTTCGGGCCA	CASSPGLAGRHNEQFF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	1	3	5	4	4	24	35	51	39	55		TCRBV24-01,TCRBV24-or09_02												CASSPGLAGRHNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASSPGTANTEAFF	In	VDJ	1	29	3.7549202403148953E-4	4.4687572232067187E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	1	3	1	24	36	46	39	47		TCRBV24-01,TCRBV24-or09_02												CASSPGTANTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAACAGGCGAACACTGAAGCTTTCTTTGGACAA	CASSQEQANTEAFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	4	1	0	1	26	-1	48	43	49		TCRBV03-01,TCRBV03-02												CASSQEQANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATCAATTTGGGTGGACAGGGGGGTGAGAGACCCAGTACTTCGGGCCA	CASSHQFGWTGG*ETQYF	Stop	VDJ	2	30	3.884400248601616E-4		54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	1	4	11	3	26	40	61	51	64		TCRBV03-01,TCRBV03-02												CASSHQFGWTGG*ETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSLAKNIQYF	In	VJ	2	30	3.884400248601616E-4	4.622852299869019E-4	36	TCRBV03						TCRBJ02	TCRBJ02-04	01	4	0	0	0	0	1	26	-1	39	-1	40		TCRBV03-01,TCRBV03-02												CASSLAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGAAGGGGGGGTACCTTGAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	30	3.884400248601616E-4		43	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	8	9	0	3	3	7	26	35	45	38	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGGACAGGGATTGGCACTGAAGCTTTCTTTGGACAA	CSARTGIGTEAFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	4	2	5	26	34	44	36	49		TCRBV20-01,TCRBV20-or09_02												CSARTGIGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGGAGGGACAGGGGATACAATGAGCAGTTCTTCGGGCCA	CATSGRDRGYNEQFF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	4	3	1	24	37	50	40	51		TCRBV24-01,TCRBV24-or09_02												CATSGRDRGYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCGGCCCGGGACGTAGCACAGATACGCAGTATTTTGGCCCA	CATGPGRSTDTQYF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	42	TCRBV24						TCRBJ02	TCRBJ02-03	01	9	0	7	0	5	2	24	33	43	38	45		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATGPGRSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCTTAGCTGGACAGGGCAAAGGCTACACCTTCGGTTCG	CASSLAGQGKGYTF	In	VDJ	2	30	3.884400248601616E-4	4.622852299869019E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	1	3	8	1	4	19	36	45	37	49	TCRBV07,TCRBV11													CASSLAGQGKGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCTTAGATTACAGCCGATAGAACACTGAAGCTTTCTTTGGACAA	CASSLDYSR*NTEAFF	Stop	VDJ	2	30	3.884400248601616E-4		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	5	1	5	6	19	33	42	38	48	TCRBV05,TCRBV07													CASSLDYSR*NTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTCAGGCCAGCTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQASYSGANVLTF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	4	0	0	7	24	-1	40	36	47	TCRBV06,TCRBV10													CASSQASYSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGACGTTCGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	31	4.0138802568883363E-4		38	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	9	8	1	1	5	0	26	31	-1	36	43		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCAAACAGGGGGGTCCCCAGCATTTTGGTGAT	CSAPKQGGPQHF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	3	1	10	6	2	26	34	48	40	50		TCRBV20-01,TCRBV20-or09_02												CSAPKQGGPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTAGCATACAATGAGCAGTTCTTCGGGCCA	CSASLAYNEQFF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	4	7	4	1	1	26	37	43	38	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSASLAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCGGACTAGGCGGTGGTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	31	4.0138802568883363E-4		46	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	1	8	17	3	20	24	38	48	41	68		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAAGGACAGGGTATCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	31	4.0138802568883363E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	2	2	3	24	39	49	41	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCGATACGGGGGGGGAACAGATACGCAGTATTTTGGCCCA	XASSRYGGGTDTQYF	In	VDJ	2	31	4.0138802568883363E-4	4.7769473765313196E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	3	5	2	22	34	47	39	49	TCRBV04,TCRBV07,TCRBV17													XASSRYGGGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGACAGGGAATGGCTACACCTTCGGTTCG	CSARDQTGNGYTF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	6	3	1	26	40	50	43	51		TCRBV20-01,TCRBV20-or09_02												CSARDQTGNGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTTCTTGGGCCGGGAATGAGCAGTTCTTCGGGCCA	CSARVSWAGNEQFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	1	8	0	7	6	4	26	39	49	45	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVSWAGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGGGACTAGCGGGGGAGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSALGLAGESSYNEQFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	0	2	4	26	35	51	37	55		TCRBV20-01,TCRBV20-or09_02												CSALGLAGESSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCCGCCTCAATGACCGGGGAGCTGTTTTTTGGAGAA	CASSLSASMTGELFF	In	VDJ	2	32	4.143360265175057E-4	4.93104245319362E-4	45							TCRBJ02	TCRBJ02-02	01	6	4	6	5	10	3	24	36	48	46	51	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSASMTGELFF+X+TCRBJ02-02			TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACTCGTGGGGGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSPLVGVNTGELFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	48	TCRBV03						TCRBJ02	TCRBJ02-02	01	4	6	1	1	7	1	26	39	51	46	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLVGVNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACTCGACAGGGGATAACAGATACGCAGTATTTTGGCCCA	CSATRQGITDTQYF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	2	2	3	3	3	26	36	47	39	50		TCRBV20-01,TCRBV20-or09_02												CSATRQGITDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGAGACAGCGCAAACTATGGCTACACCTTCGGTTCG	CSARDRDSANYGYTF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	2	4	4	26	40	49	44	53		TCRBV20-01,TCRBV20-or09_02												CSARDRDSANYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGTGGAGAAGTTAATCAGCCCCAGCATTTTGGTGAT	CASSGEVNQPQHF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	5	10	2	4	0	5	22	-1	38	34	43	TCRBV09,TCRBV12													CASSGEVNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAAGGGACAGGGGGCGCCGATGGCTACACCTTCGGTTCG	CATSEGTGGADGYTF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	0	6	1	4	24	38	51	39	55		TCRBV24-01,TCRBV24-or09_02												CATSEGTGGADGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGACAGGGGAGCAATGAGCAGTTCTTCGGGCCA	CATSGQGSNEQFF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	2	6	0	2	24	-1	45	37	47		TCRBV24-01,TCRBV24-or09_02												CATSGQGSNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTAAGGGAGTAGACGGCTACACCTTCGGTTCG	CASSFKGVDGYTF	In	VDJ	2	33	4.2728402734617773E-4	5.085137529855921E-4	39	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	2	8	5	5	24	36	46	41	51		TCRBV24-01,TCRBV24-or09_02												CASSFKGVDGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAAGGGAAAGGTGAATGGCTACACCTTCGGTTCG	CASSLKGKVNGYTF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	42	TCRBV12						TCRBJ01	TCRBJ01-02	01	2	0	8	6	2	7	26	41	47	43	54		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLKGKVNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAGACTACCGCCGGATACGCAGTATTTTGGCCCA	CASSLRLPPDTQYF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	9	6	1	6	26	41	47	42	53		TCRBV12-03,TCRBV12-04				01,02								CASSLRLPPDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCGGCCSTGTATSTCTGTGCCAGCAGCTTGGGTCTTAGGGGCTTGGCTACACCTTCGGTTCG		Out	VDJ	2	34	4.402320281748498E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	7	5	2	20	36	46	41	48	TCRBV05,TCRBV11													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAAAAAAGGGGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	34	4.402320281748498E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	5	2	0	5	3	26	34	44	39	47		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATGGCAGTGACTGAAGCTTTCTTTGGACAA	CSARDMAVTEAFF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	5	5	5	2	26	40	48	45	50		TCRBV20-01,TCRBV20-or09_02												CSARDMAVTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGTAGAGGGGTACCAAGAGACCCAGTACTTCGGGCCA	CASSVEGYQETQYF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	6	5	2	0	5	1	22	33	43	38	44	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVEGYQETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATACTCAATCCGGGACAGGGGTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	34	4.402320281748498E-4		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	0	2	1	11	1	24	36	57	47	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCAGGCTGGGACTAGCGGATGGGATATACGGGACCCAGTACTTCGGGCCA	CASRLGLADGIYGTQYF	In	VDJ	2	34	4.402320281748498E-4	5.239232606518222E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	5	7	3	13	23	34	48	37	61	TCRBV02,TCRBV21					01,02								CASRLGLADGIYGTQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	35	4.531800290035219E-4		37	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	8	3	5	0	0	26	-1	-1	42	47		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGTGTTTCTAGCACAGATACGCAGTATTTTGGCCCA	CSARGGVSSTDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	6	2	0	0	7	26	-1	43	39	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGVSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTAGCGGGGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASSLAGGATDTQYF	In	VDJ	2	35	4.531800290035219E-4	5.393327683180522E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	0	2	0	2	18	-1	42	35	44	TCRBV07,TCRBV11													CASSLAGGATDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAACCGTTGTCACAGATACGCAGTATTTTGGCCCA	CASSQTVVTDTQYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	42	TCRBV03						TCRBJ02	TCRBJ02-03	01	2	3	7	2	0	6	26	-1	43	41	49		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTVVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGAGGACCAGAAGGAGCAGATACGCAGTATTTTGGCCCA	CSAGGPEGADTQYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	9	1	4	0	11	26	-1	40	34	51		TCRBV20-01,TCRBV20-or09_02												CSAGGPEGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGAACAGGTAGCGGATACACAGATACGCAGTATTTTGGCCCA	CATRTGSGYTDTQYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	5	5	2	6	3	24	35	47	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATRTGSGYTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGTCGGTACGGATCCCAAGATACGCAGTATTTTGGCCCA	CASSRYGSQDTQYF	In	VDJ	2	36	4.661280298321939E-4	5.547422759842823E-4	42	unresolved						TCRBJ02	TCRBJ02-03	01	5	1	8	5	6	5	23	35	44	41	49	TCRBV02,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRYGSQDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAATAGGAGGAGGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	37	4.79076030660866E-4		46	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	1	4	4	2	26	43	52	47	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGCAGGACCATGAACACTGAAGCTTTCTTTGGACAA	CASSQEGRTMNTEAFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	48	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	1	7	0	5	2	26	43	52	48	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGRTMNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGAGGGCGGGGGACGGGAGGACCCAGTACTTCGGGCCA	CSARERAGDGRTQYF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	7	2	7	4	7	26	40	51	44	58		TCRBV20-01,TCRBV20-or09_02												CSARERAGDGRTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTACAGGGGCTACGAACACTGAAGCTTTCTTTGGACAA	CASSTGATNTEAFF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	1	0	4	24	-1	43	36	47		TCRBV24-01,TCRBV24-or09_02												CASSTGATNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAGGCTCGCGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSQEARGSNQPQHF	In	VDJ	2	37	4.79076030660866E-4	5.701517836505124E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	2	7	4	1	7	0	20	35	-1	42	47	TCRBV04,TCRBV23					01,02								CASSQEARGSNQPQHF+X+TCRBJ01-05	unresolved	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGACACAGCACCGGGCCTCGGGGGGGCTACACCTTCGGTTCG	CASRHSTGPRGGYTF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	2	8	16	0	26	37	-1	53	59		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRHSTGPRGGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCTCCTCAATGAGCAGTTCTTCGGGCCA	CASSSLLNEQFF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	36	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	10	6	3	3	26	38	43	41	46		TCRBV03-01,TCRBV03-02				01,02								CASSSLLNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGGGTTCAAATAATGAAAAACTGTTTTTTGGCAGT	CSARVGSNNEKLFF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	42	TCRBV20						TCRBJ01	TCRBJ01-04	01	1	0	9	4	1	6	26	39	43	40	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVGSNNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAACCGGGACAGGGGGAATCTGAAGCTTTCTTTGGACAA	CSAEPGQGESEAFF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	1	6	5	3	26	35	51	40	54		TCRBV20-01,TCRBV20-or09_02												CSAEPGQGESEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTATGAATTCGAGGGGCGCGAGGGAGACCCAGTACTTCGGGCCA	CASSFMNSRGARETQYF	In	VDJ	2	38	4.920240314895381E-4	5.855612913167424E-4	51	unresolved						TCRBJ02	TCRBJ02-05	01	3	5	2	5	10	7	18	32	47	42	54	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFMNSRGARETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCACAGGGGTCGGCACTGAAGCTTTCTTTGGACAA	CASSQATGVGTEAFF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	3	2	4	2	4	26	42	51	44	55		TCRBV03-01,TCRBV03-02												CASSQATGVGTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGTGTGAACTGAACCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	39	5.049720323182101E-4		50	unresolved						TCRBJ01	TCRBJ01-02	01	4	2	7	4	18	0	23	36	-1	54	57	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCGACTGGCAATCAGCCCCAGCATTTTGGTGAT	CATSATGNQPQHF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	39	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	2	10	2	1	1	24	37	42	38	43		TCRBV24-01,TCRBV24-or09_02				01,02								CATSATGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTGGTACTAGCGGGGGCCTCCCACATAGATACGCAGTATTTTGGCCCA	CASSQDLVLAGASHIDTQYF	In	VDJ	2	39	5.049720323182101E-4	6.009707989829725E-4	60	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	2	5	6	10	21	38	55	44	65	TCRBV01,TCRBV04													CASSQDLVLAGASHIDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCTAAGTTTCGGACTAATGAAAAACTGTTTTTTGGCAGT	CASSQAKFRTNEKLFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	1	4	9	2	0	8	26	-1	45	42	53		TCRBV03-01,TCRBV03-02				01,02								CASSQAKFRTNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD02-01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGGACTCSGCCRTGTATCTCTGTGCCAGCAGCCAACCTCAGGGGGGATTTGTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	2	40	5.179200331468821E-4		52	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	1	3	6	7	20	32	45	38	52	TCRBV07,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATCAACGGGGGGAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASTGGSSYNEQFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	8	1	0	5	3	26	34	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSASTGGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCTAACTAGCGGGGGGGCAGGTAATGAGCAGTTCTTCGGGCCA	CSALTSGGAGNEQFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	3	0	7	4	5	26	34	51	38	56		TCRBV20-01,TCRBV20-or09_02												CSALTSGGAGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGACGACAGGGCCTTAATGAAAAACTGTTTTTTGGCAGT	CSAGRQGLNEKLFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	3	4	4	3	26	35	46	39	49		TCRBV20-01,TCRBV20-or09_02												CSAGRQGLNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCMTGTATCKCTGTGCCAGCAGCCTTCAAGGACAGACCGATACTAGCACAGATACGCAGTATTTTGGCCCA	CASSLQGQTDTSTDTQYF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	1	5	0	6	9	19	31	43	37	52	TCRBV05,TCRBV07													CASSLQGQTDTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCGCCGGACTAGCGGGGGGGTCGACCTACAATGAGCAGTTCTTCGGGCCA	CASSAGLAGGSTYNEQFF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	1	0	2	2	4	23	36	53	38	57	TCRBV09,TCRBV12													CASSAGLAGGSTYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAGCCTACGATGGCTACACCTTCGGTTCG	CASSEAYDGYTF	In	VDJ	2	40	5.179200331468821E-4	6.163803066492026E-4	36	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	4	9	6	6	2	23	34	43	40	45	TCRBV02,TCRBV09					01,02								CASSEAYDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGTAMSCTCYCAGACATCTGTGTACTTCTGTGCCAGCAGGGGGGGGACAGCGAACACTGAAGCTTTCTTTGGACAA	CASRGGTANTEAFF	In	VDJ	2	41	5.308680339755541E-4	6.317898143154326E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	6	0	5	1	4	1	24	35	46	39	47	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGGTANTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCGTCGTTCCATTTCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	41	5.308680339755541E-4		50	TCRBV03						TCRBJ02	TCRBJ02-05	01	5	9	0	5	0	20	26	-1	41	38	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGAGCCGGGCCAACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRAGPTNTGELFF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	8	0	0	4	3	26	37	45	41	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRAGPTNTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATATGGGACTAGCGGGGAGGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	42	5.438160348042263E-4		55	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	0	3	5	5	3	26	43	61	48	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATCTCTGTGCCAGCAGCTTCACAGGACTAGGGGGAGGCTACACCTTCGGTTCG	CASSFTGLGGGYTF	In	VDJ	2	42	5.438160348042263E-4	6.471993219816627E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	1	8	8	4	5	19	33	44	37	49	TCRBV05,TCRBV07					01,02								CASSFTGLGGGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGAGGCGGGACAGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQEAGQANTGELFF	In	VDJ	2	44	5.697120364615703E-4	6.780183373141228E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	0	4	0	6	0	26	40	-1	46	54		TCRBV03-01,TCRBV03-02												CASSQEAGQANTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTGAAATTCTTTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	2	44	5.697120364615703E-4		46	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	5	8	5	17	0	26	38	-1	55	58		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGTACGGCAGGGGGCACGAAACCAATCAGCCCCAGCATTTTGGTGAT	CSAREYGRGHETNQPQHF	In	VDJ	2	44	5.697120364615703E-4	6.780183373141228E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	0	3	6	7	26	40	54	46	61		TCRBV20-01,TCRBV20-or09_02												CSAREYGRGHETNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGGGACTATTCGAGCTTTCTTTGGACAA	CSASGTIRAFF	In	VDJ	2	44	5.697120364615703E-4	6.780183373141228E-4	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	0	9	10	3	4	26	35	45	38	49		TCRBV20-01,TCRBV20-or09_02				01,02								CSASGTIRAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTCCCGAAGGGTACAGGCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSRRVQAGANVLTF	In	VDJ	2	44	5.697120364615703E-4	6.780183373141228E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	3	4	2	10	0	18	31	-1	41	46	TCRBV07,TCRBV11													CASSSRRVQAGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGTGGGGGAGGGAAACATTCAGTACTTCGGCGCC	CASSLVGEGNIQYF	In	VDJ	2	44	5.697120364615703E-4	6.780183373141228E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	1	9	0	6	3	0	18	34	-1	37	44	TCRBV07,TCRBV11													CASSLVGEGNIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*02	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATCCCGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDPAGELFF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	8	6	6	3	0	26	43	-1	46	48		TCRBV03-01,TCRBV03-02				01,02								CASSQDPAGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGCCAGGTAGATACGCAGTATTTTGGCCCA	CASSQGQVDTQYF	In	VDJ	2	45	5.826600372902424E-4	6.934278449803529E-4	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	4	5	2	1	26	42	48	44	49		TCRBV03-01,TCRBV03-02												CASSQGQVDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCKGCYGTGTATKTCTGTGCCAGCAGCTTAGACGGGTTGGCGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	2	45	5.826600372902424E-4		46	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	7	5	3	7	0	18	35	-1	42	46	TCRBV03,TCRBV11					01,02								X+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTAGGACAAACCTATGGCTACACCTTCGGTTCG	CASSLLGQTYGYTF	In	VDJ	2	46	5.956080381189145E-4	7.08837352646583E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	6	4	4	3	26	40	49	44	52		TCRBV12-03,TCRBV12-04												CASSLLGQTYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGACAAAAGTGCTGCTGTCTGGATCCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	2	46	5.956080381189145E-4		56	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	3	1	6	17	0	35	18	-1	37	32	72	TCRBV05,TCRBV11			TCRBD01,TCRBD02										X+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCATCTCTACCGGGACAGGGAGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSHLYRDREGTGELFF	In	VDJ	2	47	6.085560389475865E-4	7.24246860312813E-4	54	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	3	4	10	4	26	38	57	48	61		TCRBV12-03,TCRBV12-04												CASSHLYRDREGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCGCTACAGCTCGGGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	47	6.085560389475865E-4		49	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	0	3	5	1	5	5	26	40	49	45	54		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGCCCGGGGACAGGGTGAGAGACACTGAAGCTTTCTTTGGACAA	CASSPPGDRVRDTEAFF	In	VDJ	2	47	6.085560389475865E-4	7.24246860312813E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	3	7	6	19	31	47	38	53	TCRBV05,TCRBV11													CASSPPGDRVRDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCTTATAGGGGCAAGAGGCTACACCTTCGGTTCG	CASSQDLIGARGYTF	In	VDJ	2	48	6.215040397762585E-4	7.396563679790431E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	2	8	6	5	23	40	51	46	56	TCRBV01,TCRBV04													CASSQDLIGARGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGARGACTCRGCYSYKTATCTYTGCGCCAGCAGCCAGGCCATACTAGCAGATACGCAGTATTTTGGCCCA	CASSQAILADTQYF	In	VDJ	3	49	6.344520406049306E-4	7.550658756452732E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	3	8	4	8	0	19	31	-1	39	44	TCRBV01,TCRBV05					01,02								CASSQAILADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGACATCAGGGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSRHQGENTEAFF	In	VDJ	3	50	6.474000414336027E-4	7.704753833115032E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	1	1	6	1	18	30	43	36	44	TCRBV07,TCRBV11													CASSRHQGENTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGGCTCACAGGGGGAGCCAAAAACATTCAGTACTTCGGCGCC	CASRLTGGAKNIQYF	In	VDJ	3	51	6.603480422622747E-4	7.858848909777333E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	3	1	0	4	0	26	37	-1	41	49	TCRBV02,TCRBV12													CASRLTGGAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCATCCTACCTCGAGGGGGTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSPSYLEGVAKNIQYF	In	VDJ	3	52	6.732960430909468E-4	8.012943986439634E-4	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	4	5	1	0	12	1	26	39	57	51	58		TCRBV03-01,TCRBV03-02												CASSPSYLEGVAKNIQYF+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCGGGTAATGGACAGCCTGCCCTAAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	3	52	6.732960430909468E-4		49	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	8	1	5	5	7	9	26	35	48	42	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGCCGGAGCCCAGGGGGATACGCAGTATTTTGGCCCA	CSAAGAQGDTQYF	In	VDJ	3	52	6.732960430909468E-4	8.012943986439634E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	2	6	10	0	26	34	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSAAGAQGDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACTAGCGGGGGCCCCTACCGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARD*RGPLPSYNEQFF	Stop	VDJ	3	52	6.732960430909468E-4		54	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	1	0	9	26	-1	50	40	59		TCRBV20-01,TCRBV20-or09_02												CSARD*RGPLPSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGCCAAAACTAGCGGAGAGCACAGATACGCAGTATTTTGGCCCA	CSARPKLAESTDTQYF	In	VDJ	3	52	6.732960430909468E-4	8.012943986439634E-4	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	3	3	5	0	6	2	26	37	51	43	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARPKLAESTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATCCCCAGGGTTCCGGGGAGCTGTTTTTTGGAGAA	CASSQDPQGSGELFF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	6	4	2	23	40	49	44	51	TCRBV01,TCRBV23													CASSQDPQGSGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCAGGGGGGAGCAGTTCTTCGGGCCA	CASSRRGEQFF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	33	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	4	1	10	1	0	26	39	-1	40	47		TCRBV03-01,TCRBV03-02												CASSRRGEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCACCCGGGCAGGGGCGGGGTGAAAAACTGTTTTTTGGCAGT	CASSPPGQGRGEKLFF	In	VDJ	3	54	6.991920447482909E-4	8.321134139764234E-4	48	TCRBV05						TCRBJ01	TCRBJ01-04	01	4	4	2	7	9	5	19	31	46	40	51		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPGQGRGEKLFF+TCRBV05-X+TCRBJ01-04	TCRBV05		TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGGGTGCTAGCACAGATACGCAGTATTTTGGCCCA	CSARDWGASTDTQYF	In	VDJ	3	55	7.121400455769629E-4	8.475229216426535E-4	45	TCRBV20						TCRBJ02	TCRBJ02-03	01	0	6	2	0	2	4	26	40	46	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDWGASTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCGCGAATCCCCTGAAGCTTTCTTTGGACAA	CASSRESPEAFF	In	VDJ	3	56	7.25088046405635E-4	8.629324293088835E-4	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	7	6	6	2	6	26	37	42	39	48		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSRESPEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTGGAGGGACTAATTCACCCCTCCACTTTGGGAAC	CASSFGGTNSPLHF	In	VDJ	3	56	7.25088046405635E-4	8.629324293088835E-4	42	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	6	10	0	6	3	2	24	36	45	39	47		TCRBV24-01,TCRBV24-or09_02												CASSFGGTNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24	TCRBD02-01*02	TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTCGTCGGTCCTAACTATGGCTACACCTTCGGTTCG	CSAVVGPNYGYTF	In	VDJ	3	58	7.509840480629791E-4	8.937514446413437E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	8	5	0	5	2	26	35	43	40	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSAVVGPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGCGTCGTGGGGTTACTTTCTTTGGACAA	CATSDPRRGVTFF	In	VDJ	3	59	7.639320488916511E-4	9.091609523075737E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	3	6	2	12	9	3	24	39	52	48	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDPRRGVTFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACGGTGGGGTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLRWGSYNSPLHF	In	VDJ	3	62	8.027760513776673E-4	9.553894753062639E-4	48	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	6	2	1	7	1	24	36	47	43	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRWGSYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTAACTAGCGGGGGGGCAGAGGATACGCAGTATTTTGGCCCA	CASSLVTSGGAEDTQYF	In	VDJ	3	62	8.027760513776673E-4	9.553894753062639E-4	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	3	0	6	4	5	19	33	50	37	55		TCRBV05-06,TCRBV05-07												CASSLVTSGGAEDTQYF+TCRBV05-X+TCRBJ02-03	TCRBV05	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGTCCGACAGGGGGAGGAGAGACCCAGTACTTCGGGCCA	CASSPTGGGETQYF	In	VDJ	3	63	8.157240522063394E-4	9.70798982972494E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	2	1	4	3	3	18	29	41	32	44	TCRBV07,TCRBV11													CASSPTGGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCACGGGACAGGGTGGGAAACACCATATATTTTGGAGAG	CSARDRVGNTIYF	In	VDJ	3	65	8.416200538636834E-4	0.0010016179983049541	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	0	3	4	2	2	26	34	45	36	47		TCRBV20-01,TCRBV20-or09_02												CSARDRVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACATCTTGAGGGGGGGCACAATGAGCAGTTCTTCGGGCCA	CSARHLEGGHNEQFF	In	VDJ	3	65	8.416200538636834E-4	0.0010016179983049541	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	9	0	5	8	1	26	38	53	46	54		TCRBV20-01,TCRBV20-or09_02												CSARHLEGGHNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGATGGACCGTTAGATACGCAGTATTTTGGCCCA	CASSLDGPLDTQYF	In	VDJ	3	65	8.416200538636834E-4	0.0010016179983049541	42	unresolved						TCRBJ02	TCRBJ02-03	01	0	1	7	5	1	4	18	35	40	36	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDGPLDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGAATGTCGATGAACGCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	3	67	8.675160555210276E-4		44	TCRBV24						TCRBJ01	TCRBJ01-01	01	4	2	8	4	5	7	24	38	45	43	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCTTCGGGCTGACAGGCCGCCGAGAGACCCAGTACTTCGGGCCA	CASSFGLTGRRETQYF	In	VDJ	3	67	8.675160555210276E-4	0.0010324370136374143	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	4	4	6	6	19	33	45	39	51	TCRBV05,TCRBV11													CASSFGLTGRRETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGACAGATACGCAGTATTTTGGCCCA	CSARSTDTQYF	In	VDJ	4	70	9.063600580070438E-4	0.0010786655366361044	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	8	6	3	1	0	26	38	-1	39	41		TCRBV20-01,TCRBV20-or09_02				01,02								CSARSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGGAGGGGGGGCGTCCCTAAGCAATCAGCCCCAGCATTTTGGTGAT	CSAPGGGASLSNQPQHF	In	VDJ	4	70	9.063600580070438E-4	0.0010786655366361044	51	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	9	0	1	6	8	26	35	48	41	56		TCRBV20-01,TCRBV20-or09_02												CSAPGGGASLSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCGGACAGAGGGCTGCGGGGGGGCCTGATACGCAGTATTTTGGCCCA	CASGQRAAGGPDTQYF	In	VDJ	4	72	9.322560596643878E-4	0.0011094845519685646	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	6	12	3	19	28	49	40	52	TCRBV05,TCRBV11													CASGQRAAGGPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCGGGGGGCAGGGAGGGCACTGAAGCTTTCTTTGGACAA	CSASPGGREGTEAFF	In	VDJ	4	74	9.58152061321732E-4	0.0011403035673010248	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	1	4	2	9	26	37	46	39	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSASPGGREGTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCTTCGGGGGCCCAAACGGATACGCAGTATTTTGGCCCA		Out	VDJ	4	75	9.71100062150404E-4		43							TCRBJ02	TCRBJ02-03	01	2	6	0	6	1	7	18	32	39	33	46	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-03			TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAAGACAGTATGGCTACACCTTCGGTTCG	CASSQERQYGYTF	In	VDJ	4	81	0.0010487880671224362	0.0012481701209646353	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	5	5	2	0	26	43	-1	45	50		TCRBV03-01,TCRBV03-02												CASSQERQYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCATCAGGGAGAGGGACACTGAAGCTTTCTTTGGACAA	CASSIRERDTEAFF	In	VDJ	4	85	0.0011005800704371245	0.0013098081516295555	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	4	3	3	2	6	23	35	42	37	48	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIRERDTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGCGACAGCACAGATACGCAGTATTTTGGCCCA	CASSQGDSTDTQYF	In	VDJ	4	87	0.0011264760720944686	0.0013406271669620157	42	unresolved						TCRBJ02	TCRBJ02-03	01	1	2	7	0	2	0	23	39	-1	41	44	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGDSTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCTTAGATCCCGCAGGGTCAAGTGGCTACACCTTCGGTTCG	CASSLDPAGSSGYTF	In	VDJ	5	89	0.0011523720737518126	0.0013714461822944756	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	7	6	5	18	34	45	40	50	TCRBV07,TCRBV11													CASSLDPAGSSGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTGAGAGGGGGGCCCACAGATACGCAGTATTTTGGCCCA	CASSLRGGPTDTQYF	In	VDJ	5	93	0.001204164077066501	0.001433084212959396	45	unresolved						TCRBJ02	TCRBJ02-03	01	3	5	1	2	3	3	18	32	41	35	44	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLRGGPTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTAGGTAATAGCGGGGGAGTATCTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	5	93	0.001204164077066501		53	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	5	2	4	4	7	18	34	47	38	54	TCRBV05,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGAAACAGGGAGGCCCTATGGCTACACCTTCGGTTCG	CASSQDETGRPYGYTF	In	VDJ	5	94	0.001217112077895173	0.001448493720625626	48	TCRBV03						TCRBJ01	TCRBJ01-02	01	0	3	3	4	4	5	26	43	53	47	58		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDETGRPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGCTCTAACTATGGCTACACCTTCGGTTCG	CASSQGSSNYGYTF	In	VDJ	5	94	0.001217112077895173	0.001448493720625626	42	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	1	10	2	0	0	2	26	-1	46	42	48		TCRBV03-01,TCRBV03-02												CASSQGSSNYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCTCCTCATTTTGGACTAGCGAAGGGTCGAGCGGGGAGCTGTTTTTTGGAGAA	CASSSFWTSEGSSGELFF	In	VDJ	5	95	0.001230060078723845	0.001463903228291856	54	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	1	6	7	10	10	26	35	54	45	64		TCRBV03-01,TCRBV03-02				01,02								CASSSFWTSEGSSGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAATCGGGGGACAGGCTCAACAATGAGCAGTTCTTCGGGCCA	CAISESGDRLNNEQFF	In	VDJ	5	95	0.001230060078723845	0.001463903228291856	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	4	5	4	4	23	38	50	42	54	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISESGDRLNNEQFF+X+TCRBJ02-01		TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACGATCTAGCGGGGGGGCCTTAAGAGACCCAGTACTTCGGGCCA	CASSHDLAGGP*ETQYF	Stop	VDJ	5	97	0.0012559560803811892		51	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	4	0	3	4	4	26	40	56	44	60		TCRBV03-01,TCRBV03-02												CASSHDLAGGP*ETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGCGGGTGGTCTGGGGGGAAACACTGAAGCTTTCTTTGGACAA	CSAAGGLGGNTEAFF	In	VDJ	5	97	0.0012559560803811892	0.0014947222436243162	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	1	2	12	1	26	34	52	46	53		TCRBV20-01,TCRBV20-or09_02												CSAAGGLGGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGGAACCGGGACAGGGGACTATGGCTACACCTTCGGTTCG	CASSQGTGTGDYGYTF	In	VDJ	5	98	0.0012689040812098613	0.0015101317512905463	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	3	7	0	26	40	-1	47	57		TCRBV03-01,TCRBV03-02												CASSQGTGTGDYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCGTAAGACTAGCGGGGGGGCTCGAGGCAGATACGCAGTATTTTGGCCCA	CASSVRLAGGLEADTQYF	In	VDJ	5	107	0.0013854360886679097	0.0016488173202866168	54	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	2	0	4	4	7	23	35	53	39	60	TCRBV01,TCRBV04													CASSVRLAGGLEADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCAGCTCGGGACAGGTTACCCCGTCTGCAGCTTTCTTTGGACAA	CASSSGQVTPSAAFF	In	VDJ	6	111	0.0014372280919825978	0.0017104553509515372	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	10	3	13	23	34	45	37	58	TCRBV02,TCRBV12													CASSSGQVTPSAAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ACTCGGCCGTGTATSTCTGTGCCAGCAGCTTTTGGGTCTAGAGGAGGGACAGGGGGGTGGTCACAAAACATTCAGTACTTCGGCGCC		Out	VDJ	6	114	0.001476072094468614		64				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	1	5	14	8	17	31	56	45	64	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02,TCRBV11-03												X+X+TCRBJ02-04		TCRBD01-01*01	TCRBJ02-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAAGCTCGGGACTGATCTACGAGCAGTACGTCGGGCCG	CASSLSSGLIYEQYV	In	VDJ	6	119	0.0015408120986119744	0.0018337314122813776	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	17	8	17	24	36	50	44	67		TCRBV24-01,TCRBV24-or09_02				01,02								CASSLSSGLIYEQYV+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAGCGGGGGGGGAAATACGCAGTATTTTGGCCCA	CASSQDSGGGNTQYF	In	VDJ	6	122	0.0015796561010979905	0.0018799599352800679	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	5	0	7	0	3	23	-1	51	40	54	TCRBV01,TCRBV04													CASSQDSGGGNTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATCTTGGACAGGGGACTGAAGCTTTCTTTGGACAA	CASSQDLGQGTEAFF	In	VDJ	6	126	0.0016314481044126788	0.001941597965944988	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	5	6	0	20	35	-1	41	50	TCRBV01,TCRBV23													CASSQDLGQGTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTATAGTGAGACCCAGTACTTCGGGCCA	CASSQDYSETQYF	In	VDJ	7	131	0.0016961881085560389	0.0020186455042761385	39	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	8	5	3	1	26	43	49	46	50		TCRBV03-01,TCRBV03-02				01,02								CASSQDYSETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAAATCGCAGGGCTGGGATGACCGGGGAGCTGTTTTTTGGAGAA	CASSLNRRAGMTGELFF	In	VDJ	7	132	0.001709136109384711	0.0020340550119423684	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	3	5	5	8	18	33	43	38	51	TCRBV07,TCRBV11													CASSLNRRAGMTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCCGGGACAGGACCCGGAAAACTGTTTTTTGGCAGT	CASSSGTGPGKLFF	In	VDJ	7	143	0.0018515641185001036	0.0022035595962708993	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	4	10	2	6	18	31	41	33	47	TCRBV07,TCRBV11													CASSSGTGPGKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAAAACAGGGGTGGAAAAACTGTTTTTTGGCAGT	CASSEKTGVEKLFF	In	VDJ	8	148	0.001916304122643464	0.0022806071346020496	42	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	2	8	3	2	23	38	48	41	50		TCRBV06-01,TCRBV06-08												CASSEKTGVEKLFF+TCRBV06-X+TCRBJ01-04	TCRBV06	TCRBD01-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCATCGAAGTAGCGGGACTAGCACAGATACGCAGTATTTTGGCCCA	XASSHRSSGTSTDTQYF	In	VDJ	8	155	0.002006940128444168	0.00238847368826566	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	5	3	0	6	2	23	37	51	43	53	TCRBV01,TCRBV04,TCRBV07,TCRBV17													XASSHRSSGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCTCCACCCTACGAGCAGTACGTCGGGCCG		Out	VDJ	8	163	0.0021105241350735447		37	TCRBV24						TCRBJ02	TCRBJ02-07	01	6	4	5	17	16	4	24	36	55	52	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCACCCGAGCCCGCCGCCAAGAGACCCAGTACTTCGGGCCA	CASTRARRQETQYF	In	VDJ	8	165	0.0021364201367308887	0.0025425687649279606	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	6	7	1	4	6	26	36	43	40	49		TCRBV03-01,TCRBV03-02				01,02								CASTRARRQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATAAGGCAGGGGACCCCCTTGGCTATGAGCAGTTCTTCGGGCCA	CASSQDKAGDPLGYEQFF	In	VDJ	9	166	0.002149368137559561	0.0025579782725941905	54	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	8	5	12	26	43	54	48	66		TCRBV03-01,TCRBV03-02												CASSQDKAGDPLGYEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAACCAGACAGCTCTTTACTTCTGTGCCACCAGTCCCCGGGGTCGGGACTAGCGGACAGCAATGTCAATACGCAGTATTTTGGCCCA		Out	VDJ	9	166	0.002149368137559561		59	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	7	10	12	22	34	55	44	67		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTGGGGGACACAAGAGACCCAGTACTTCGGGCCA	CSARRWGTQETQYF	In	VDJ	9	167	0.002162316138388233	0.002573387780260421	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	0	6	2	6	0	26	38	-1	44	50		TCRBV20-01,TCRBV20-or09_02												CSARRWGTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGCTGTGTATTTCTGTGCCAGCAGCCAAGAAACCCCCGCTGACAGGGCGCTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	9	175	0.0022659001450176094		61	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	3	0	10	5	13	30	47	40	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTACTCTCTAGCGGGGGTGTTCGAGCAGTACGTCGGGCCG		Out	VDJ	9	180	0.0023306401491609697		46	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	17	4	15	18	33	47	37	62	TCRBV07,TCRBV11													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGGGAAAGATACGCAGTATTTTGGCCCA	CSATGKDTQYF	In	VDJ	11	214	0.0027708721773358194	0.0032976346405732336	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	5	0	2	26	-1	41	36	43		TCRBV20-01,TCRBV20-or09_02												CSATGKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTGGGAAGAGACCCAGTACTTCGGGCCA	CASSQDWEETQYF	In	VDJ	12	225	0.002913300186451212	0.0034671392249017645	39	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	0	9	3	2	0	26	43	-1	45	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDWEETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATAATTCGGGAACTGGAAACACCATATATTTTGGAGAG	CASSQDNSGTGNTIYF	In	VDJ	12	240	0.003107520198881293	0.0036982818398952153	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	8	3	2	5	1	23	40	50	45	51	TCRBV01,TCRBV04													CASSQDNSGTGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCGCAACGGGGGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASATGATNEKLFF	In	VDJ	13	248	0.003211104205510669	0.0038215579012250557	42	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	11	8	2	0	6	0	24	31	-1	37	43		TCRBV24-01,TCRBV24-or09_02												CASATGATNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD02-01*01	TCRBJ01-04*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATGGGCCGCGAAGCGACGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDGPRSDGANVLTF	In	VDJ	13	251	0.0032499482079966853	0.003867786424223746	54	unresolved						TCRBJ02	TCRBJ02-06	01	2	8	0	4	3	11	20	35	42	38	53	TCRBV04,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGPRSDGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATTTCCACGAGTACTAGCTACCACAGATACGCAGTATTTTGGCCCA	CSARFPRVLATTDTQYF	In	VDJ	13	262	0.0033923762171120778	0.004037291008552277	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	3	7	2	11	3	26	38	55	49	58		TCRBV20-01,TCRBV20-or09_02				01,02								CSARFPRVLATTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCCCAGGGGGCCCGGGGATGTCAATCAGCCCCAGCATTTTGGTGAT	CASSPRGPGDVNQPQHF	In	VDJ	15	291	0.0037678682411435675	0.0044841667308729485	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	4	0	3	1	10	23	36	45	37	55	TCRBV01,TCRBV04													CASSPRGPGDVNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGCGCTCACCCAGAACAACAATGAGCAGTTCTTCGGGCCA	CSARDLALTQNNNEQFF	In	VDJ	17	322	0.004169256266832401	0.0049618614685260805	51	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	3	6	5	17	0	26	40	-1	57	60		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDLALTQNNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTGAAGGATACGCAGTATTTTGGCCCA	CSARVKDTQYF	In	VDJ	18	352	0.0045576962916925624	0.005424146698512982	33	TCRBV20						TCRBJ02	TCRBJ02-03	01	1	2	8	6	1	2	26	39	42	40	44		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARVKDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAACGCGGCAGGGGGTAGGGAATGAGCAGTTCTTCGGGCCA	CASSETRQGVGNEQFF	In	VDJ	19	380	0.00492024031489538	0.005855612913167424	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	1	7	6	5	23	38	51	44	56	TCRBV02,TCRBV09													CASSETRQGVGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCGGAGTCTTGAAGCTTTCTTTGGACAA	CSASRSLEAFF	In	VDJ	22	435	0.005632380360472343	0.006703135834810078	33	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	2	7	2	3	26	37	43	39	46		TCRBV20-01,TCRBV20-or09_02												CSASRSLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*02	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGTAGAGACAGGGGGCTCTATGGCTACACCTTCGGTTCG	CASSQDRRDRGLYGYTF	In	VDJ	28	541	0.007004868448311581	0.008336543647430465	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	0	4	7	1	23	40	57	47	58	TCRBV01,TCRBV04													CASSQDRRDRGLYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACCGGGGGTCAGGGAATAGTAGGGGAGACCCAGTACTTCGGGCCA	CASTGGQGIVGETQYF	In	VDJ	30	577	0.007470996478143774	0.008891285923414746	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	7	8	2	5	1	16	23	33	40	34	56	TCRBV02,TCRBV09													CASTGGQGIVGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCAGGGGTATAGGCAATCAGCCCCAGCATTTTGGTGAT	CSARGRGIGNQPQHF	In	VDJ	32	615	0.007963020509633312	0.00947684721473149	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	2	2	3	5	26	37	46	40	51		TCRBV20-01,TCRBV20-or09_02												CSARGRGIGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGACCTCGGAACAGGGCGGGCTTTCTTTGGACAA		Out	VDJ	37	726	0.00940024860161591		40	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	11	9	3	26	39	54	48	57		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGTCCCTTGAAGCTTTCTTTGGACAA	CSARRSLEAFF	In	VDJ	67	1301	0.01684534907810234	0.02004776947376531	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	4	7	0	5	26	-1	41	38	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRSLEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCGAATCCTGATGGCACAGATACGCAGTATTTTGGCCCA	CASSSNPDGTDTQYF	In	VDJ	153	2976	0.03853325046612803	0.04585869481470067	45	unresolved						TCRBJ02	TCRBJ02-03	01	4	2	8	1	1	9	18	31	34	32	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSNPDGTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	4425B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				4440	3730	508	200	0	1884	1592	266	26	0	77232	64895	8844	3493	0	0.169601262	8.83263969	0.167138159	9.06118965				41184	0.0903458968	0.0555050448	0.0466386974	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:18	Age (Range):65+ Years (Old Age),Age:67 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 328,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 176,type of chemo:carbo/taxol	0.8400900671922403	MSKCC- Snyder- P01-02		3721.0	
